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Sommario
In questa tesi, vengono proposti nuovi algoritmi e modelli per affrontare prob-
lemi biologici. L’informatica svolge un ruolo chiave nella proteomica e nella
ricerca genetica dovuto alla gestione delle grandi moli di dati biologici. Nel
contesto dello studio di proteine, ho sviluppato nuovi metodi per la predizione
delle loro funzioni basati su principi di reperimento dell’informazione. Utiliz-
zando fonti eterogenee di conoscenza, come la ricerca su grafi e la similarita`
di sequenze, ho progettato uno strumento chiamato INGA che puo` essere uti-
lizzato per annotare interi genomi. Questo e` stato valutato imparzialmente
dal Critical Assessment of Function Annotation, e ha dimostrato di essere
uno degli approcci piu` efficaci per l’inferenza di funzione.
Per meglio caratterizzare le proteine dal punto di vista strutturale, ho pro-
posto una strategia di rilevamento delle conformazioni delle proteine basata
su rete di interazione di residui (RIN). Le reti RIN sono state quindi es-
tese per gestire le fluttuazioni temporali delle coordinate atomiche. Tali
grafi sono stati infine generati automaticamente da algoritmi di clustering.
Un’implementazione chiamata RING MD ha evidenziato efficacemente i prin-
cipali amminoacidi noti per essere funzionalmente rilevanti nell’Ubiquitina.
Questi aminoacidi sono infatti molto importanti per spiegare la dinamica
strutturale della proteina. Con la stessa logica, sono stati usati i grafi RIN
anche per prevedere l’impatto delle mutazioni all’interno di una struttura
proteica. Combinando informazioni sul nodo mutante in una rete e le sue
caratteristiche, una rete neurale artificiale e` stata addestrata per stimare la
variazione di energia libera di Gibbs all’interno di una proteina. Cambia-
menti estremi nell’energia interna potrebbe portare all’unfolding della pro-
teina, ed eventualmente ad una malattia. D’altro canto, anche la riduzione
della flessibilita` proteica puo` ostacolare la sua funzione. Ad esempio, le flut-
tuazioni estreme osservate nelle proteine intrinsecamente disordinate (IDP)
sono fondamentali per le loro attivita`. Per studiare le IDP, ho contribuito
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alla raccolta del piu` grandi dataset di regioni disordinate mai esistito. Nella
seguente analisi e` stato dimostrato quali sono le funzioni tipiche di queste
sequenze e i processi biologici in cui sono coinvolte. Data l’importanza della
loro identificazione, una valutazione globale di predittori del disordine e` stata
eseguita per mostrare quali sono i metodi piu` efficaci e le loro limitazioni.
Nel contesto della genetica, mi sono concentrato sulla previsione di fenotipi.
Durante il Critical Assessment of Genome Interpretation (CAGI), ho pro-
posto nuovi approcci per l’analisi dei dati dell’esoma progettati per valutare
il rischio di morbo di Crohn e di ipercolesterolemia. Queste sono spesso
definite come malattie complesse, dal momento che il meccanismo alla base
della loro insorgenza e` ancora sconosciuto. Nel mio studio, i campioni umani
con un arricchimento di mutazioni in geni critici sono stati predetti come
soggetti a rischio genetico elevato. Oltre ai geni associati alla malattia, le
reti di interazione proteiche sono state considerate per valutare l’accumulo
di varianti in pathway biologici. Tale strategia ha dimostrato di essere tra le
migliori secondo gli organizzatori del CAGI. Nel caso piu` semplice dei tratti
mendeliani, con BOOGIE ho progettato un metodo per la predizione dei
gruppi sanguigni umani basata su dati di esoma. Esso utilizza una versione
specializzata dell’algoritmo nearest neighbour al fine di far corrispondere le
varianti genetiche in un esoma non annotato con quelle disponibili in una
base di conoscenza di riferimento. L’esempio piu` simile e` usato per trasferire
il gruppo sanguigno. Con una precisione superiore al 90 %, BOOGIE e` un
prototipo che mostra le potenziali applicazioni della predizione genetica, e
puo` essere facilmente esteso a qualsiasi tratto mendeliano.
Riassumendo, questa tesi e` una risposta parziale alla crescita esponenziale
di sequenze disponibili che necessitano ulteriori esperimenti. Integrando in-
formazioni eterogenee e la progettazione di nuovi modelli predittivi basati
su apprendimento automatico, ho sviluppato nuovi strumenti per l’analisi di
dati biologici e per la loro classificazione. Tutte le implementazioni sono liber-
amente disponibili per la comunita` e potrebbero essere utili durante indagini
future come in studi di malattie e nella progettazione di farmaci.
Abstract
In this thesis, I propose new algorithms and models to address biological
problems. Computer science in fact plays a key role in proteomics and ge-
netics research due to the advent of big datasets. In the context of protein
study, I developed new methods for protein function prediction based on in-
formation retrieval principles. By using heterogeneous source of knowledge,
like graph search and sequence similarity, I designed a tool called INGA that
can be used to annotate entire genomes. It has been benchmarked during
the Critical Assessment of Function Annotation challenge, and it proved to
be one of the most effective approach for function inference.
To better characterize proteins from the structural point of view, I proposed
a protein conformers detection strategy based on residue interaction network
(RIN) data. RIN graphs were extended to deal with the time-dependent pro-
tein coordinate fluctuations, and were generated by clustering algorithms. An
implementation called RING MD highlighted effectively the key amino acids
known to be functionally relevant in Ubiquitin. These amino acids in fact
are very important to explain the protein three-dimensional dynamics. With
the same rationale, RIN graphs were used also to predict the impact of muta-
tions within a protein structure. By combining information about a mutant
node in the network and its features, an artificial neural network was trained
to estimate the free Gibbs energy change of a protein. Extreme changes in
the internal energy might lead to the protein unfolding, and possibly to dis-
ease. The reduction of a protein flexibility may hamper its function as well.
As an example, the extreme fluctuations observed in intrinsically disordered
proteins (IDPs) are fundamental for their activities. To better understand
IDPs, I contributed in the collection of the largest dataset of disordered re-
gions. In the following analysis, it was shown what are the typical functions
of these sequences and the biological processes where they are involved. Due
to the importance of their detection, a comprehensive assessment of disorder
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predictors was performed to show what are the state-of-the-art methods and
their limitations.
In the context of genetics, I focused on phenotype prediction. During the
Critical Assessment of Genome Interpretation (CAGI), I proposed new ap-
proaches for the analysis of exome data to prioritize the risk of Crohn’s disease
and abnormal cholesterol levels. These are often defined as complex disease,
since the mechanism behind their insurgence is still unknown. In my study,
human samples with an enrichment of mutations in critical genes were pre-
dicted to have an high genetic risk. In addition to disease associated genes,
protein interaction networks were considered to better account for variants
accumulation in biological pathways. Such strategy was shown to be among
the best approaches by CAGI organizers. In the simpler case of Mendelian
traits, with BOOGIE I designed a method for human blood groups prediction
based on exome data. It uses a specialized version of nearest neighbor algo-
rithm in order to match the gene variants in an unannotated exome with the
ones available in a reference knowledge base. The most similar hit is used
to transfer the blood group. With an accuracy above 90%, BOOGIE is a
proof-of-concept that shows the potential applications of genetic prediction,
and can be easily extended to any Mendelian trait.
To summarize, this thesis is a partial answer to the exponential growth of
sequences available that need further experiments. By integrating heteroge-
neous information and designing new predictive models based on machine
learning, I developed novel tools for biological data analysis and classifica-
tion. All implementations are freely available for the community and might
be helpful during future investigations like in drug design and disease studies.
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Chapter 1
Introduction
1.1 The cell machinery: genes and proteins
In the early stages of genomics the study of single proteins and genes was the
principal topic for molecular biologists. Focused analytical approaches deter-
mined as much properties as possible about a research subject, lead to a very
deep understanding for a small set of interesting targets. Things changed
with the advent of high-throughput instruments like Next-Generation Se-
quencing (NGS) technologies, which analyze a huge spectrum of molecules
in parallel. This observation of thousand to million variables enabled the
quantitative analysis of complex systems in the whole, shifting the research
from a single protein or gene to the entire cell metabolism. As a result,
modern biology requires very often the use of computer science and statisti-
cal methods to handle large volumes of experimental data and generate new
knowledge - all tasks typically managed in bioinformatics research.
The main topics addressed in bioinformatics are genes, proteins and their in-
teractions under different conditions. From the biochemical point of view, a
gene is the sequence of nucleotides (adenine, cytosine, guanine, and thymine)
containing the information necessary for the production of one or more pro-
teins. More than 20.000 genes are known in the human genome, but the
overall number can vary a lot in different organisms. Inside a gene, one can
identify (see Fig. 1.1) a set of coding regions (exons), a set of non-coding re-
gions (introns) and a promoter region (UTR). Exons contain the information
to produce a protein, while the promoter region and introns are responsible
respectively for the gene expression regulation and the alternative splicing.
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Whenever a gene sequence is copied by the polymerase enzyme, a sophisti-
cated process transforms the mRNA into a protein.
Proteins are responsible for a vast amount of different roles, like enzymatic,
Figure 1.1: Diagram of the gene-to-protein process. The structure of a gene
is also shown.
signaling, structural and mechanic activities. They are formed by sequences
of 20 amino acids (or residue) which can be determined directly from the
nucleotide triplets in the exons. What’s important about amino acids is
their different atomic composition and structure resulting in different chem-
ical properties. The inter-atomic interactions of residues lead to the protein
folding, which is the three-dimensional arrangement of atoms with minimal
internal energy. From the structural point of view, one can identify four
information levels (Fig. 1.2):
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Primary structure: the amino acids sequence, which can be encoded as a
string with a 20 character alphabet. This information is typically used
to emphasize evolutionary information, like genetic similarity among
different organisms.
Secondary structure: the first effect of amino acids chemical composition
is the local rearrangement of atoms into α-helix, β-sheet, coils and
intrinsic disorder. Such structure is determined uniquely by the amino
acid sequence. Unlike helices and sheets, which show a static structure,
the latter two have high flexibility.
Tertiary structure: the tree-dimensional coordinates of the entirely folded
protein sequence. In this large structure, one can detect a set of protein
domains, representing peculiar folding related to well defined protein
functions.
Quaternary structure: sometimes two or more proteins are combined to-
gether to form a larger complex. This set of proteins might change
their tree-dimensional arrangement due to local atomic interactions.
Roughly speaking, one can think that protein sequence determines structure,
while protein structure determines function. However, things are more com-
plicated in reality, due to additional factors that perturb the environment
of a protein. As an example, proteins interact among themselves and with
other molecules (e.g. water, metals and ligands) to perform their activities
in the so called interactome. Such interactions and natural molecular dy-
namics may result in structural changes, which have very often a functional
relevance. The same gene expressed in different tissue or cellular compo-
nents can have a diverse protein folding and behaviour, so it is important to
evaluate precisely the environmental context in bioinformatics research.
1.1.1 Data banks
Data openness has become more and more important in recent years, as it
enables research reproducibility and promotes data reuse. This increasing
amount of public information stored in the data banks of National Cen-
ter for Biotechnology Information (NCBI) and in the European Bioinfor-
matics Institute (EBI) helped bioinformatics development, and is nowadays
one of the main sources of data. In terms of genomic data, the Ensembl
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Figure 1.2: The primary, secondary, tertiary and quaternary structure of
a protein. Each level emphasizes information ranging from amino acids to
protein complexes.
database [1] (www.ensembl.org) contains the whole genome for 69 organ-
isms, with meta-data about gene expression levels for different tissue and
mutations as well. The 1000 Genome project [2] (www.1000genomes.org)
also managed to characterize human genetic variants frequency in order
to analyze population structure and potential links with disease. Lots of
knowledge about human mutations and diseases can also be obtained from
dbSNP [3] (www.ncbi.nlm.nih.gov/SNP/) and GWAS central database [4]
(www.gwascentral.org), providing functional annotation for thousands sin-
gle nucleotide polymorphisms (SNP).
Protein level annotations are collected in the UniProt database [5] (www.
uniprot.org), where functional terms, pathways, mutations and structural
details are available. In the current release 2014 11 there are almost 90
million sequences, with their number growing exponentially due to the fast
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development of sequencing technologies. Over 98% of sequences have no
existing evidence at the protein or transcript level, and even less contain
experimental annotation. This lack of knowledge is the key motivation that
lead to the development of bioinformatics in recent years. For example, the
use of the transfer learning principle can generalize the results of long and ex-
pensive experiments among similar proteins. Similarity can be measured in
countless way, like sequence analysis, structural comparison, data mining in
databases and from protein-protein interaction (PPI) networks. The String
database [6] (string-db.org) is a clear instance of PPI, where proteins are
represented as nodes and their interactions are encoded by edges. Different
relationship types are possible, like co-expression in a tissue, neighborhood
in a organism genome and experimentally validated. There are also examples
of interacting proteins in the Protein Data bank [7] (PDB, www.rcsb.org),
with more than 100,000 protein and DNA structures available. In fact, almost
5,000 structures show protein complexes, providing insights at the molecular
level. From the experimental point of view, the most typical approaches to
solve a protein structure are x-ray and nuclear magnetic resonance (NMR)
crystallography, and in both cases one can obtain three-dimensional coordi-
nates for all protein atoms.
Clearly, these are just few of the hundreds [8] databases useful for bioin-
formatic research, which demonstrates the ongoing effort in terms of data
openness. Additional data banks and specific details will be introduced in
the next sections to clarify research goals and methods.
1.2 Data science
The human ability to create accurate tools and measure events was one of the
major contributing factors for the understanding of key natural principles.
With the advent of high throughput technologies and big data, the detection
of relevant signal is no more an easy task. The combination of heterogeneous
skills becomes a critical factor to succeed in modern research, and bioin-
formatics lies exactly in the very important intersection between computer
science, statistics and biology. As a data scientist, one has to start from a
raw dataset and perform several operations to find out meaningful knowl-
edge. The knowledge discovery in database [9] (KDD) process summarize
the main steps that needs to be performed (see Fig. 1.3).
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Figure 1.3: The KDD workflow, as shown in [9]. Five steps can transform
raw data in useful knowledge. A very important concept is the iterative
structure of the process, because any novel piece of information can suggest
new scientific hypothesis that deserve analysis.
Selection given a scientific hypothesis, one should select from biological
databases variables of interest and as much samples as possible. Sample size
is strictly related to the specific research, and might be limited to a very
small number. At this early stage, it is convenient to evaluate if statistical
challenges can be addressed with the available data. As an example, in the
context of pathogenic SNP analysis, one might try to compare the distribu-
tion of rare alleles in human UTRs and exons (CDS) using data from the
1000 genome (1000G) project. UTRs are the untranslated regions of a gene,
while CDS are its coding part.
Preprocessing and transformation data sources can be very heteroge-
neous and hard to manage like web pages, text documents and images. As a
rule of thumb, the “garbage in, garbage out” principle applies well in KDD,
so one should be very careful during an initial data cleaning. Typical steps
are the elimination of noisy samples and outliers, the management of missing
variables and the normalization of observed attributes. The cleaning process
can lead to a dramatic reduction in dataset size, so one should reconsider if
samples are enough in statistical terms. Finally, all data have to be mapped
to a unique and convenient format which is composed by the sample fea-
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tures (the attributes). Features can be very complex and might require a
combination of multiple data sources to help in the research question. To
continue with the SNPs distribution example, one has to use a gene defini-
tion database like GENCODE [10] to map chromosome coordinates to either
UTRs and CDSs (integration). Introns and intergenic SNPs are removed,
as they are not important for the initial goal. Few genes have overlapping
coordinates in the chromosome, leading to an apparent SNPs duplication in
these regions that needs to be managed.
Variables of interest in bioinformatics research are generally related to gene
and proteins sequences. In section 1.3 they will be introduced in depth.
Data mining seeking knowledge from complex data requires the use of
sophisticated data mining and statistical methods. Common activities are
cluster analysis [11], which is the discovery of unknown data subclasses (e.g.
find automatically organism populations in a study), association rule min-
ing [12], which variable relationships is found (e.g. find SNPs related to a
disease) and outlier detection [13], which is the identification of unexpected
behaviours (e.g. eco-system disturbances). In the SNPs example, one has to
generate a probability distribution function of variants frequency for UTRs
and CDSs (see Fig. 1.4) and compare them. The comparison can be tested
by the null hypothesis of “identical frequency distribution for UTR and CDS
variants” and the alternative hypothesis “CDS variants have lower frequen-
cies than UTR SNPs” with the Wilcoxon rank-sum test. The p-value is
close to 0, suggesting that there is a statistically significant difference in the
variants distribution.
Interpretation the statistical significance of extracted patterns can be
used to give confidence about the automatic data processing. However, the
functional implication of correlated variables must be clear from the biolog-
ical point of view. In the SNPs example, it seems that the distribution of
variants is quite different for UTR and CDS variants. The former type is
the most common for SNPs with frequency greater than 0.002. On the other
hand, CDS are the most common when looking at lower frequencies. This
is likely to be the result of strong evolutionary constraints in CDS regions,
which reduces such regions variability .
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Figure 1.4: Probability distribution function of UTR and CDS variants with
frequency below 5%. Exons contains a lower amount of common polymor-
phisms.
1.2.1 Machine learning
In order to use any knowledge for decision-making, one can replace the data
mining step of KDD with machine learning (ML). A ML project will probably
start from the results of a KDD research, so any feature proven to be discrim-
inative for a biological process will be used to build computational models
using supervised [14], unsupervised [15] or reinforcement learning [16]. Ex-
amples of algorithms are neural networks [17], support vector machines [18]
and Bayesian networks [19]. To continue with the SNP frequency exam-
ple, it is possible to predict whether a genome region is either a UTR or
CDS. By looking at the consecutive variants frequency in a sequence, the
enrichment of rare SNPs (minor allele frequency lesser than 0.01) can be de-
tected using Hidden Markov Models just like in the unfair casino problem
[20]. This very simple approach can be inaccurate, thus additional features
like the sequence nucleotides can be considered for the prediction. UTRs
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in fact have an high GC-content, but this is not the sole property of these
sequences: many attributes can be used to build a multivariate observation,
which will be automatically managed by algorithms designed to compute op-
timized classification models. Classification is always related to thresholds
that separates data in a optimal way. In the SNPs case a specific variant fre-
quency could be used as a threshold as part of the learning strategy. Rather
than using points, the classification of multidimensional data is achieved by
hyperplanes (see Fig. 1.5).
Classification [21] is the process of predicting values into categories with the
most used being simple binary categories. When the goal in machine learn-
ing becomes the estimation of a continuous variable, like the amount of an
expressed gene, regression algorithms [21] are adopted. Hyperplanes can be
once again the solution, even though non-linear functions can be preferred to
minimize the error. Algorithms can have different classification performance
Figure 1.5: Linear classifier and regression. During the development of a
machine learning method, hyperplanes and non-linear functions can be used
to model data. Left: black and white points represents the categories. Clas-
sification and regression errors are common, even though they are minimized
by means of an optimization process.
depending on how they compute thresholds, thus a fair comparison will help
to pick the best one for the scientific problem at hand. To do it properly,
data have to be divided in three equal chunks called training set, validation
set and test set [21]. The former two are used respectively to parametrize
the model (e.g. the hyperplane) and to perform its quality assessment. As
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an example, neural networks optimize each neuronal unit weight by mini-
mizing the classification error on the training set using a stochastic process.
Different neural networks are trained in parallel, and the one whose random
optimization lead to best performance on the validation set is selected. The
test set is used at the end to evaluate fairly the best neural network, and
to perform a comparison with other published methods. K-fold cross vali-
dation is a similar model validation approach where data division, training
and testing are repeated multiple times in order to minimize the risk of bad
data partitioning.
Quality measure Classification of an unseen target can be imprecise, so
it is important to adopt performance measures which clarify the expected
behaviour of a ML tool. In a test set it is possible to count true positives TP,
true negatives TN (correct prediction for the two classes of interest), false
positives FP and false negatives FN (wrong model prediction). These four
value are sufficient to calculate all quality measures.
SENS =
TP
TP + FN
PREC =
TP
TP + FP
ACC =
TP + TN
TP + FP + TN + FN
SPEC =
TN
TN + FP
F = 2× PREC × SENS
PREC + SENS
These formulas are respectively sensitivity, precision, accuracy, specificity,
and F-score. They can give an idea about the overall performance of a
classifier. These measures can be affected negatively by unbalanced classes,
so the Matthews correlation coefficient can be considered as well:
MCC =
TP × TN − FP × FN√
(TP + FP )(TP + FN)(TN + FP )(TN + FN)
Correlation is an important concept, which can be generalized for the re-
gression problem. However, all these quality measures should be considered
together, as they describe important aspects of a ML method performance.
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1.3 Protein features and representation
Currently the distinct three-dimensional coordinates of proteins amount to
35 thousand. This was accumulated over a 50 year period and usually each
can be found in the Protein Data Bank [7] (PDB). This data is of vital im-
portance for medical research and biotechnology, where it plays a key role
in drug and enzyme design. Research projects in structural bioinformatics
typically aim to predict structural and functional information using as much
data as possible, but experimental noise and missing observations require
the use of statistical approaches to generate knowledge. Determinism is in
fact an exception when dealing with complex datasets, so the use of machine
learning, data mining and statistical methods is the only way to pick up sig-
nificant signal. As an example, the goal of protein modeling is the prediction
of a protein structure from its amino acid sequence.
Figure 1.6: Left: the three-dimensional structure of an amino acid. The
backbone is composed by nitrogen, carbon, oxygen and hydrogen. Right:
Ramachandran plot. The backbone atoms in an amino acid have three de-
gree of freedom from the geometrical point of view. The angles with most
variability are φ and ψ, and their arrangement is associated with secondary
structure.
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The ab initio [22] approach exploits physical laws to generate a protein
structure with minimal internal energy. On the other hand, the homology
modeling [23] approach takes advantage of the knowledge in the PDB, and
tries to use sequence-structure relationships to create a protein structure.
These relationships are extracted from the data, so one can measure directly
their likelihood, and use them to generate the most probable structure. The
Ramachandran plot [24] (see Fig. 1.6) is a clear example of knowledge that
can be obtained from protein structure data, providing a probability density
function that guides the placement of an amino acids in a predicted struc-
ture. Best implementations use a mixture of concepts from ab initio and
homology modeling, since their joint combination lead to the idea of efficient
conformation exploration and proper quality evaluation of the final model.
In general, sequence and structural information are the most commonly used
in structural bioinformatic projects due to their availability, so they will be
introduced properly in the next paragraphs. It is important to note that
such information becomes useful when it is used to predict unseen variables
and protein properties that are hard to obtain without expensive and time-
consuming experiments. Last but not least, predictions are a guess, so one
should always try to evaluate with well established quality measure the ac-
curacy of a computational method.
1.3.1 Sequence features
With an alphabet of just 20 residues, one can encode all protein genetic infor-
mation exactly in FASTA files (see Fig. 1.7). A first macroscopic difference
among proteins is primary sequence length, which ranges from few dozen
residues to the ∼ 30, 000 amino acids of Titin protein, with an average of 317
according to UniProt 2014 11 [25]. The main challenge is therefore the inter-
pretation of these protein “recipes”. With an alphabet size roughly similar
to the one used in the western countries, bioinformatics keeps working on the
process of understanding the basic words of protein language, but their se-
mantic and relationships remain still unclear. Sequence similarity [26] is the
key concept developed in bioinformatics research that motivated the use of
computer science approach to meet biologist needs: given a protein sequence,
a single amino acid random mutation probably will have no impact in terms
of protein folding and function. Moreover, there are amino acids with similar
chemical properties, which makes them interchangeable. Stochastic sequence
variations are very common in the daily life of any organism, and form the
1.3. PROTEIN FEATURES AND REPRESENTATION 13
Figure 1.7: FASTA file example. The header line, starting with the > char-
acter, denotes protein meta-data. The sequence is reported from the second
line onward.
basis of evolution. Any sequence change with equal or increasing fitness will
be kept in a population, while the ones with pathogenic effect tend to be re-
moved. Lots of work was done to measure the maximum amount of residues
that can be mutated while keeping the folding and function unchanged, re-
sulting in the development of protein alignment tools [27]. These methods
are designed to match the residues of two protein sequences, and therefore
highlight similar sequence regions related to a common ancestry. From a
practical point of view, in case of sequence similarity it is possible to transfer
evidence observed in previously studied sequences to uncharacterized ones.
This generalization comes with error risks, which can still be estimated by the
sequence similarity score. This possibility to extend the knowledge gained
from expensive experiments to million sequences automatically is the main
strength of machine learning and statistical approaches.
Another important concept often used is sequence modularity. As an exam-
ple, local sequence composition is critical for secondary structure (see Section
1.1), especially in the case of α-helix, and intrinsic disorder. In order to use
protein sequence information to make structural and functional prediction,
sequence modularity can be exploited by means of m-sized sliding windows.
These windows are vectors in Rm describing a consecutive sequence region,
where the first dimension encode for the residue observed at the i-th position
of the protein sequence, the second dimension for the i + 1-th position and
so on. Therefore, one can compute n−m+ 1 different sliding windows from
a protein with length n. As a potential application of these multivariate
vectors, it is possible to find statistical associations between short sequences
and secondary structure. However, a concrete analysis of data collected us-
ing sliding windows needs a way to compare these vectors. Each element is
an amino acid encoded using characters, so the fundamental mathematical
operations are not defined (e.g. the concept of distance between residue is un-
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clear, and the lexicographic distance is not helpful). To overcome this issue,
characters must be converted to meaningful values in R. Possible solutions
are the one-hot encode, where each residue is represented as a 20-dimensional
binary vector. Just a single element equals one in such vectors, while all other
elements are set to zero. As an example, the first amino acid in lexicographic
order is encoded with the one in the first position, while the second residue
according to the alphabet set to one the second position of the vector and so
on. According to this definition, non-identical amino acids are orthogonal. In
the Atchley encode [28], each residue is represented in a 5-dimensional space,
which accounts respectively for polarity, secondary structure, molecular vol-
ume, codon diversity, and electrostatic charge. One can use just a subset of
these features, if the research topic does not require some particular informa-
tion. An effective practice adopted in the pathogenicity prediction problem
[29] (i.e. predict whether a SNP will cause a protein loss of function) is the
use of residue conservation value to encode amino acids. Conservation is
obtained from a multiple alignment by evaluating the frequency of an amino
acids in a given position (see Fig. 1.8). Conserved residues have very often
a functional role, so this value is often considered an important attribute.
Figure 1.8: A protein alignment. Each row corresponds to an organism
specific protein sequence. Sequence positions where amino acids does not
change are conserved (black columns), while the lighter colors highlights lack
of conservation.
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All the one-hot, Atchley and conservation encoding preserve the amino
acids order, but they are strongly related to the size of the sliding window.
When considering a large window size, one incurs in statistical and compu-
tational issue called curse of dimensionality. The sequence composition is
an alternative encoding immune to this issue which simply stores in a 20-
dimensional vector the frequency of each amino acids in a given sequence.
As a results, a whole protein can be encoded using few aggregated variables,
at the cost of amino acids ordering.
Many other attributes exists and can be conceived to emphasize informa-
tion relevant for a particular research. As a rule of thumb, having a valid
hypothesis about the important sequence-based features for protein predic-
tion problems is the best starting point to succeed in machine learning and
biostatistics.
1.3.2 Structural features
Shifting the focus from one-dimensional data to three-dimensional data pose
great challenges. Sequences encoded in a simple textual format with no miss-
ing information are replaced with protein structure files [7] (PDB), which
contain three-dimensional coordinates for each atoms in the protein (see Fig.
1.9), plus additional data for ligands and DNA. As a natural consequence
of proteins large size and flexibility uncertainty may arise even in wet lab
experiments.For example, missing atom coordinates or low quality values are
often observed in protein structure data. In fact, solving a crystal struc-
ture requires by itself the use of complex statistical methods to interpret a
electron density maps for x-ray PDBs, thus noise is an expected drawback.
NMR structures by definition allow multiple model in different conformation,
emphasizing flexibilities.
Despite these challenges in using this data, structural information can easily
address problems otherwise unsolvable. As an example, secondary structure
is an information directly available, and can be extracted with automatic
tools [30]. In addition, missing amino acids coordinates in x-ray or highly
fluctuating residues in NMR can be interpreted as disorder. One can dis-
tinguish buried and exposed amino acids by looking at their position, and
assign them a solvent accessibility score [31]. The presence of additional ele-
ments like metals, molecules and post-translational modifications (PTM) can
be identified, which is clearly unpredictable from a sequence. Cavities and
holes, along with the orientation of amino acid side chains and surface elec-
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Figure 1.9: The coordinates section of a PDB. The format is positional, and
encode for 15 protein attributes. The former 8 are atom identifiers, while the
following 5 describe respectively 3D coordinates and crystallization quality
(defined in terms of occupancy and temperature factor).
trostatic charge are the key players in the development of drugs that could
target a protein [32].
All this information is readily available, and can be used to train machine
learning methods. The approach is similar to what was introduced in the
previous paragraph: one can enrich the protein sequence vectorized repre-
sentation by adding residue attributes about secondary structure, solvent
accessibility and electrostatic charge. In parallel with respect to sequence
composition encoding, there is a structure-based corresponding representa-
tion. Given a reference amino acids, the frequency of all residues within a
sphere radius r is computed [33]. In other words, rather than counting the
amino acids inside a sliding window, a virtual three-dimensional sphere is
considered. Despite the similarities of the two encodings, the main difference
lies in the new definition of residue neighborhood. This idea gained relevance
with PDBs, since distant residues in the sequence (more than 25 positions)
can be very close in a three-dimensional space, and might interact with each
other. Hydrogen bonds, ionic bonds and Van-Der-Waals interactions are just
few of the most common chemical bonds, and their existence are essential
for the protein folding and function. From the practical point of view, con-
tact maps [34] are matrices emphasizing these interactions (see Fig. 1.10).
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They can also be transformed in residue interaction networks [35] (RINs), a
protein graph where nodes correspond to amino acids, while edges represent
interactions. By working directly in these interaction-centric structures, the
concept of neighborhood is highlighted. One can also try to exploit the solid
theoretical background of networks to extract protein structural features. In
fact, high node centrality is very often a common feature for functionally
relevant amino acids [36], so it can be used as a discriminative attribute for
protein analysis.
Figure 1.10: A sample contact map. A point at 〈x, y〉 coordinate shows
that the x-th and the y-th residues share an hydrogen bond. Other type
of interactions are possible, like hydrogen bonds, pi-cation interactions, pi-pi
stacks, ionic bonds, disulfide bonds and Van-Der-Waals interactions.
An interesting sequence-based interaction between residue is mutual in-
formation [37], a statistical measure that estimates the co-evolution of amino
acids. It is computed from a multiple alignment on sequence position pairs
by looking at mutual residues change in different organisms. To put it sim-
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ple, mutual information shows from the statistical point of view how much
the presence of an amino acid influence a second one in a different position.
Evolution is the key actor, as structurally and functionally related residues
are expected to co-evolve.
To conclude, contact maps, RINs and PDBs are all equivalent protein repre-
sentations, but each of them is very useful to emphasize a particular type of
information. All the structural data that they encode can be either the ob-
jective function of a sequence-based predictor (like in the case of secondary
structure prediction or protein structure modeling), or a new feature that
will be considered by a machine learning predictor. Such addition will lead
obviously to higher prediction accuracy, at the cost of extra prior knowledge.
When users expect high predictive power, like in drug design, the use of
three-dimensional data is critical.
1.3.3 Protein annotation
The PDB reports primary amino acid sequence and their corresponding struc-
tural information. A third level of heterogeneous meta-data called annotation
is used very often to associate additional knowledge to proteins. Unlike the
information introduced in the previous paragraphs, annotation in general is
not a property of an amino acid, but an attribute of the whole protein. As
an example, the UniProt database [25] reports that NOD2 protein interacts
with another 29 proteins, shows few mutations associated with Crohn’s dis-
ease and is highly expressed in bone marrow and leukocytes. Very often, the
goal in bioinformatics is the prediction of this information for uncharacter-
ized proteins, even though in some cases it can be used as feature to build
a predictor. Predicting the protein function from sequence and interactome
data is just one of the possible applications, so it is important to be aware
of the available knowledge:
Organism and phylogenetics the taxonomy lineage, ortholog proteins and
phylogenetics trees can specify organism relationships with other species
and improve sequence alignments. As an example, one might decide to
use only sequences of closely related organisms, or try to find all the
sequence paralogs in mammals of a given protein.
Protein function the gene ontology (GO) [38] defines formally all the known
molecular function, biological process and cellular components. It is
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a vocabulary more than 40,000 terms, which are organized in tree-
like data structures where nodes can have multiple parents (a directed
acyclic graph). This formal and hierarchical representation of specific
concepts is of great importance, but most of this annotation comes from
predictions with no experimental validation. The Critical Assessment
of Function Annotation [39] (CAFA) challenge is a scientific experi-
ment covered in this manuscript that aims to assess the state of the art
in terms of GO prediction. The problem will be discussed with more
details in section 2.2.
Protein domains a whole protein sequence is like a sentence, and domains
are equivalent to words. These regions of various length have a spe-
cific functional role and structural topology. The PFAM database [40]
(pfam.xfam.org) reports almost 15,000 different domains, which are
detected using Hidden Markov Models on aligned sequences. Even
though 3,000 have no functional characterization yet, nearly 80% of
proteins in UniProt are annotated with a PFAM domain, enabling a
quick and simple categorization of sequences. In the context of the
CAFA challenge described in section 2.2, this information was of great
relevance for protein function prediction.
Variants and disease biology is very often a human-centric research. There-
fore, protein variants observed in humans and the corresponding ge-
netic disease are reported in order to clarify the protein role in medical
terms. Recently, this information was used effectively to train methods
for pathogenicity prediction [29] and disease gene prioritization [41].
This data source was a starting point during the Critical Assessment
of Genome Interpretation (CAGI) challenge (described in detail in sec-
tion 5.2), where human exomes were ranked according to their genetic
risk to develop specific diseases.
Interactions proteins are the main actors inside a cell, but their activity
is not meaningful if considered outside their interaction network [6].
Proteins in fact can create larger complexes and might alter each other
to transmit a signal, like in the case of post-translational modifica-
tions. Research on protein protein interaction (PPI) networks showed
that biological networks are scale-free, so they are structurally tolerant
to the presence of faulty proteins due to the limited amount of cen-
tral nodes. PPI databases are very important to interpret biological
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processes, but the available knowledge graph is incomplete and impre-
cise. This source of information was used both in the CAFA and CAGI
challenges to contextualize the analyzed proteins.
Expression when considering a specific tissue, the overall amount of a cer-
tain protein can express its function in the cell. There are ubiquitous
proteins, which are important for cell survival, while proteins specific
to few tissues are the ones with a differential role. Comparative gene
expression studies can provide insight about interacting proteins and
disease risk.
Literature references with more than 20 millions published papers in Pub-
Med, a huge amount of knowledge encoded in natural language is in
reality buried, waiting to be indexed effectively in a database. Manual
curators populate many datasets with high quality annotation, and re-
port citations to the original source material. In the next future, text
mining techniques for the extraction of published knowledge are likely
to be the only sustainable option, and computer science will play a
key role with the development of modern natural language processing
techniques.
There is clearly much more in public databases, but the vast majority of
knowledge needed for this manuscript is covered by these concepts. Lots
of this information is very useful in medicine and biology, and therefore
become the objective function for a machine learning tool. As already pointed
out, no one expects deterministic knowledge due to the huge complexities
related to the prediction of molecular mechanisms or disease. However, the
development of computational methods that prioritize experimental choices is
a rational approach to investigation, which motivates bioinformatics research.
1.4 The scientific contribution of this thesis
To summarize, my research was focused on protein annotation and pheno-
type prediction. My contribution on each project was mainly related to the
integration of heterogeneous information and the design of new predictive
models useful to analyze biological data, which can be labeled as data sci-
ence. With the background introduced in the previous sections it will be
easier to understand the scientific topics addressed in this thesis, as they are
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all biological problems where machine learning and data mining represent
the state-of-the-art approach.
Molecular dynamics
Molecular Dynamics (MD) simulations [42] are well known to provide good
insight about the possible three-dimensional conformations of a protein us-
ing force fields that emulates the classical physics of molecules in water.
They are commonly used for drug design, as they can predict the affinity
between a protein and a drug. Unfortunately, these simulations produce a
overwhelming amount of data, which is often hard to interpret. Moreover,
a MD user might aim to get an overview of the simulation before start-
ing any investigation. During my work I focused on a MD case study (the
Ubquitin protein), and I proposed a statistical model of RINs [35] for pro-
tein dynamics.Time-dependent RINs were constructed, and their relation-
ships were captured using k-means algorithm and Hidden Markov Models
(HMM). As a result, protein conformational states were detected, and their
representative structures could be obtained to simplify the analysis of a MD.
In addition, state transitions were parametrized, providing insight about the
relationship among states. This kind of analysis was performed for six types
of residue interactions, like hydrogen bonds and ionic bonds, allowing a de-
tailed study of a target protein. The model itself can be used also for the
comparison of different MD of the same protein, like in the case where wild-
type and mutant proteins are evaluated for the study of a disease. The work
was awarded as one of the best posters in Proteine 2014 conference.
Protein disorder
Large protein flexibility is often a product of protein disorder [43]. This
is a relatively new research topic and it is providing new insights about
the dynamic behavior of proteins. I contributed in the construction of a
new collection of disordered sequences using missing coordinates in x-ray
PDBs. By doing this, we extracted the largest dataset of disordered sequence
regions with one order of magnitude more samples with respect to previous
studies. Over 1,700 proteins contained long disordered regions of at least 30
residues, suggesting that they could play a functional role. By means of such
unique dataset, I evaluated the accuracy of state-of-the-art tools for disorder
prediction. Best tools and practices for disorder prediction were highlighted,
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even though it seems that current methods still lack the desired precision for
a proper protein annotation. Moreover, there is a clear bias in the training of
most methods (like the use of short disorder fragments and the focus on PDB
chains rather than protein sequences), which might affect future investigation
on the field.
Protein function prediction
With the unprecedented increase of sequences deposited in public database,
automatic function prediction is the only feasible solution to characterize
millions of proteins. Protein function space is defined by Gene Ontology
(GO) [38], which describes the actual Molecular Function, the Cellular Com-
ponent where the function is performed and the Biological Process. From
the machine learning perspective, this is a multi-class problem, since the
whole ontology contains 41,947 classes that have to be associated to new
sequences. Given a query protein, three automatic information retrieval
systems were built to extract potentially useful annotation from sequence
databases, PFAM protein domains database and STRING-db protein in-
teraction networks. The three predictions were integrated in a consensus
based on generalized additive models which resulted in higher predictive
power compared to the single ones. An implementation of this consensus
called Interaction Network GO Annotator (INGA) is freely available for the
community (url: protein.bio.unipd.it/inga). INGA has been tested in
the Critical Assessment of Function Annotation [39] experiment (CAFA,
url: biofunctionprediction.org), a community scientific challenge where
about 50 research group predicted GO terms for 100,000 protein sequences.
In that event, my approach was recognized as a top performer.
Protein stability
Given a protein sequence, a residue change (i.e. a non-synonymous Single
Nucleotide Polymorphism) can lead to marked differences in its final struc-
ture due to increased compactness or flexibility. This might cause severe
damage for to a protein, and eventually cause a loss of function and possibly
a disease. The variation in the Gibbs free energy ∆∆G is a physical measure
of such structural change [44]. In the context of protein stability prediction,
the goal is the evaluation of ∆∆G upon mutations. To estimate this value
1.4. THE SCIENTIFIC CONTRIBUTION OF THIS THESIS 23
in the presence of a mutation, I combined sequence and structural informa-
tion according to a data fusion paradigm. In particular, the novelty of the
work lies in the use of Residue Interaction Networks [35] (RIN) for protein
structure representation. In RIN graphs, nodes are amino acids, while edges
represent residue interactions. RINs can be used to evaluate the importance
of a residue using graph centrality measures, which can be thought as de-
scriptors of the overall protein structure. I trained a regression model of the
data using a neural network, and tested it in well a established dataset. The
NEtwork Enthalpic MOdelling (NeEMO) is the publicly available implemen-
tation of this work (url: protein.bio.unipd.it/neemo), which was shown
to have higher accuracy compared to other state-of-the-art tools, mainly due
to RIN features contribution.
Phenotypes and Genetics
The sharp reduction of genome sequencing cost is opening new possibilities
for disease studies and medical diagnostics. This huge opportunity raised
nevertheless complex scientific and technological question, which are still
largely unsolved. When profiling the genetic information, the big amount
of information is the first challenge that has to be addressed. Gigabites of
data per sample must be managed to reconstruct a human genome, and the
following analysis is even more complex [45]. In the context of disease risk
prediction, the Critical Assessment of Genome Interpretation (CAGI) is an
international challenge where participants are asked to detect the health sta-
tus for the samples given their genetic data. As an example, in the Crohn’s
Disease challenge the exomes of 66 people had to be classified for disease risk.
Similarly, the Familial Combined Hyperlipidemia challenge (FCH) goal was
the prediction of the cholesterol and triglycerides level for a family composted
by 5 individuals. Potentially dangerous mutations had to be found and pri-
oritized. Given the general absence of training data in CAGI, my approach
was mainly related to the KDD process. All coding variants placed in genes
associated with the disease of interest were taken into account. To increase
the coverage of genes potentially involved in the disease onset, protein in-
teraction networks were used to retrieve pathway variants. Several features
were extracted for the selected mutations in order to evaluate their disease
association. In agreement with burden tests idea [46], the presence of many
overrepresented variants in a single individual was used to rank the samples
in the dataset. In other words, the higher the number of mutations, the
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stronger the disease risk evidence. Using this simple but powerful method,
we ended up among the top performers among 30 groups for the two chal-
lenges mentioned above.
In the context of CAGI phenotype prediction, I also developed BOOGIE, a
tool for the prediction of blood groups (like ABO or Rh) using genotype data.
Mutations relevant for the blood type were collected from the BGMUT public
database [47], and processed in order to match them with current gene defini-
tion database. Genetic knowledge about a given blood group was represented
as binary rules, and constituted the reference database where I could map
the DNA of a new sample. The matching method uses jointly a k-nearest
neighbor algorithm and a haplotype phasing technique to match a patient
allele set to the database just described. Even though accuracy for ABO and
Rh is high (higher than 90%), it is not as good as the experimental serologi-
cal tests. However, BOOGIE is a proof-of-concept: it shows that important
traits can be detected from genetic data. It also predicts minor blood groups
(like Vel, and other 30 systems) which are normally ignored in the medical
practice during transfusions. The tool is freely available for the community
(url: protein.bio.unipd.it/download), and can be parametrized to pre-
dict additional phenotypes.
Last but not least, I contributed in the development of a Petri network [48]
for the Von Hippel-Lindau (VHL) cancer pathway, which is useful to simulate
the effect of gene knockout and the resulting effects in terms of changes in
the substrate concentration.
Bioinformatic infrastructure and technologies
As pointed out in the early pages of this manuscript, IT infrastructure and
technologies are central for bioinformatics research. Fresh data is stored
in public databases and open source libraries for of biological data analy-
sis can speed up the data processing. With Repeats DB (url: repeatsdb.
bio.unipd.it), I contributed in the development of a tandem repeat pro-
tein annotations database. Hundreds of repeated proteins were analyzed and
classified semi-automatically to highlight potentially new domains. Almost
20 protein repeat categories were employed with additional manually curated
annotation for significant cases.
To simplify the management of PDBs, the C++ Victor library (Virtual Con-
struction Toolkit for Proteins) was also published and is currently maintained
(url: protein.bio.unipd.it/victor). It provides advanced functions for
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sequence alignment, PDB manipulation and statistical estimation of physical
energy. This library contributed in nearly half works presented in this thesis,
thus it can be considered a basic software implementation for bioinformatics
data management.
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Chapter 2
Protein Function Prediction
Protein function prediction from sequence using the Gene Ontology (GO)
classification is useful in many biological problems. Its has recently at-
tracted increasing interest, due to the overwhelming amount of unannotated
sequences in public databases and to the CAFA (Critical Assessment of Func-
tion Annotation) [39] challenge.
In this thesis I introduce two computational methods for GO terms pre-
diction. GAS (Guilty by Association on STRING) is a first tool designed to
predict protein function exploiting protein-protein interaction networks with-
out sequence similarity. The assumption is that whenever a protein interacts
with other proteins, it is part of the same biological process and located in the
same cellular compartment. GAS retrieves interaction partners of a query
protein from the STRING database [6] and measures enrichment of the asso-
ciated functional annotations to generate a sorted list of putative functions.
A performance evaluation based on CAFA metrics and a fair comparison
with optimized BLAST [27] similarity searches are provided. The consen-
sus of GAS and BLAST (GAS-C) is proven to improve overall performance.
The PPI approach is shown to outperform similarity searches for biological
process and cellular compartment GO predictions. Moreover, an analysis
of the best practices to exploit protein-protein interaction networks is also
provided. GAS description and its details are reported in Section 2.1.
A second tool called INGA extends GAS-C. It exploits information encoded
in PFAM domains [49] to better prioritize sequence patterns. The method
was used to predict GO terms and their likelihood for more than 100,000
sequences in CAFA 2014 edition, and proved to be one of the most effective
strategies among over 50 predictors. All details about INGA are shown in
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section 2.2.
2.1 Protein Function Prediction Using Guilty
by Association from Interaction Networks
The large amount of available protein sequences requires usage of in silico
methods for automatic large-scale function prediction. The annotation pro-
cess, assigning functions to target proteins, is generally based on the transfer
by homology principle [50]. Protein space can be partitioned in subsets (fam-
ilies) that groups proteins with a common ancestor and, possibly, the same
function. Whenever evolutionary relationships between two different pro-
teins are available, all features from one protein are transferred to the other.
Sequence comparison is used to infer homology and collect evidence about
membership in a given family. However it requires to properly choose sim-
ilarity measures and related cut-off values in order to avoid false positives
(and, conversely, false negatives). As each family has its own story and is
the result of different and complex evolutionary phenomena, available data
are usually not sufficient to trace an unambiguous phylogenetic tree [51].
Any time two sequences appear to greatly diverge, it becomes impossible to
find annotated homologs. On the other hand, the same protein can perform
different functions when placed in a different organism, and sequence infor-
mation alone cannot distinguish such situations. Within the CAFA (Critical
Assessment of protein Function Annotation) experiment [39], it has been
stated that the currently best methods to predict protein function rely on
sequence similarity searches for conserved regions or homologous proteins
[52, 53]. Moreover, it has been recommended to extend standard homology
search with new methods that use different sources of information on protein
function [54, 55]. The CAFA experiment also provided standard criteria for
the evaluation of the predictions, e.g. the dataset used for the blind test
and the definition of function space through Gene Ontology (GO) terms [38].
The scoring metrics for comparing function predictions in CAFA are mainly
based on precision-recall curves.
New effective experimental techniques to find genome-wide interactions make
protein-protein interaction data widely available and ready to be used for
functional annotation [56, 57, 58]. Approaches exploiting interaction net-
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works have been widely used for annotation of the Yeast genome [59, 60,
61, 62, 63]. At the same time, many tools which analyze biological network
properties are already available. Some of them use interaction networks to
prioritize genes that are part of disease pathways. These applications use en-
riched functional terms to describe clusters of interacting proteins or genes.
The STRING interaction database [6] itself provides tools to compute GO
term enrichment in selected sub-networks. To the best of our knowledge,
functional enrichment in protein-protein interaction networks has never been
used effectively as a tool for predicting function of unknown proteins.
For example, the χ2 test has been used to rank the functional terms asso-
ciated to a group of interacting partners by comparing the frequency of the
terms within the group and with the expected distribution in the whole net-
work [62]. Another work, PRODISTIN [59], focuses on the clusterization of
the entire Yeast interaction graph by means of a distance measure to de-
fine groups associated with the same functional class. A Bayesian approach
[61] has been applied to calculate the posterior probability that a given pro-
tein has the function of interest. This method takes into account the prior
probability of the entire network but it does not consider the dependencies
among terms. Another method, FunctionalFlow [63], treats annotated nodes
as “sources” and propagates the associated annotation through the connect-
ing edges following some simple rules. These rules take into account the
distance between two nodes and the number of alternative paths connecting
them to produce a score.
All of these methods are based on a single model organism and cannot easily
be compared with other state-of-the-art methods like those participating in
CAFA. Moreover, they used a very small ad hoc ontology for Yeast which
is two orders of magnitude smaller than the full GO. It is also difficult to
evaluate their impact on the coverage of genome annotation, as the number
of interactions available today is not comparable with networks available a
few years ago.
In this section we introduce GAS (Guilty by Association on STRING) to pre-
dict protein function exploiting protein-protein interaction networks without
sequence similarity measures. We also provide an analysis on the imple-
mentation details and parameters necessary to maximize accuracy as well
as important considerations about best practices to exploit protein-protein
interaction networks.
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2.1.1 Methods
GAS
Protein-protein interaction (PPI) networks provide relevant information about
protein function. The aim GAS is to exploit the annotation of the neighbor-
hood of a protein to transfer the function. The choice of the network, the
definition of the set of interacting partners, the strategy to transfer annota-
tion and the method to build the consensus represent key factors to improve
accuracy and implement an effective prediction tool. The idea at the basis
of GAS arises from the analogy with the “Guilty-by-association” principle.
This concept asserts that qualities of one object are inherently qualities of
another, merely by an independent association. In our case it means that
if a protein physically interacts (association) with other proteins it should
share a similar function (quality). Proteins in a living cell have many physi-
cal interactors, each group of interacting proteins is expected to participate
in the same biological process and to operate in the same subcellular com-
partment. Given a protein with unknown function, GAS uses the STRING
[6] network to collect the set N of directly interacting nodes. All experimen-
tal GO terms are then associated to the annotated proteins retrieved from
SwissProt [64] and ranked by a measure representing their specificity in the
collected set. We estimated this specificity, by measuring enrichment with
respect to the entire training set (i.e. the remaining STRING nodes). The
P-value associated to the enrichment is computed according to Fisher’s exact
test, which represents the probability that a specific term, GOI , is associated
to a given set by chance (null hypothesis). For each collected term GOI , the
contingency table is shown in Table 2.1. The P-value is generated with the
following standard formula:
P − value(GOi) =
(
a+b
a
)(
c+d
c
)(
n
a+c
)
GAS was evaluated on two different protein interaction networks. In the
first case we focused on highly confident STRING interactions (edge score
≤ 900). In the second one, we selected all STRING interactions with edge
score ≤ 500. All nodes in the STRING network were mapped to the Uni-
Ref90 database to extend the number of interacting nodes and increase the
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Table 2.1: Contingency table. Cluster indicates the set N of directly inter-
acting nodes and DB represents the rest of nodes in STRING associated to
experimental GO terms.
chance of collecting experimental GO terms as well as to make GAS compa-
rable with our version of BLAST (see GAS-C).
GAS-C
GAS-C, where “C” indicates Consensus, is an extended version of the algo-
rithm that merges GAS with BLAST predictions. For each input protein,
GAS-C first computes GAS and BLAST predictions independently and then
combines them. BLAST hits are retrieved running the program with default
parameters discarding hits with e-value higher than 10−3 sorted by bit-score
(default output), since it maximizes performances [39]. The presence of large
groups of homologous proteins with high sequence similarity in the sequence
database may affect a BLAST prediction. The UniRef90 [65] database was
used to address the redundancy issue. For each hit corresponding to the
representative sequence of a UniRef90 cluster, all experimental GO terms
associated to all cluster members are transferred. This strategy increases
sensitivity, allowing to retrieve hits with lower sequence identity but possi-
bly richer annotations. To make GAS comparable with BLAST, we mapped
UniRef90 clusters to the interacting nodes and transferred functional anno-
tation from all members belonging to these clusters. Since the F-score was
found to be poorly correlated with the native output score (Bit-score and
P-value), the F-score computed on the rank position was considered instead.
For BLAST, the rank corresponds to the hit position in the output list, e.g.
at rank 1 we find GO terms (plus ancestors) transferred from the first hit,
the one with best Bit-score. For GAS, the rank is given by the P-value,
e.g. at rank 1 we find terms (plus ancestors) with the lowest P-value. The
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values ftr, converted to the F-measure of the r-th (or higher) ranked terms
for target t. From these data, the expected rank-dependent performance was
evaluated through an exponential curve emphasizing the correlation between
the ranking r of the predicted term and the F-measure:
E[F (r)] = ea+b·r + c
where a, b and c were estimated through a nonlinear least square on the
predictions and corresponding F-measures. Next, the corresponding rank-
dependent score SI and SB were assigned to each GO term predicted by
GAS and BLAST respectively. Whenever the same GOI was predicted by
both approaches, its score was updated as follows:
Scombined = 1− (1− SB(GOi)) · (1− SI(GOi))
Finally, all scores are propagated to the root of the ontology guaranteeing
that each ancestor node always inherits the maximum probability from its
children.
Training and test sets
The evaluation set for the prediction models is made of protein sequences with
experimental annotation from SwissProt. It includes previously unannotated
proteins that accumulated GO terms annotation in one year, accounting for
8,976 proteins from 283 organisms. 4,432, 3,931 and 3,194 sequences were
counted for the MF, BP and CC sub-ontologies respectively. It was obtained
as the difference between the SwissProt releases v2012 07 and v2013 07, ap-
plying a filtering criterion for automatically predicted terms. Experimental
(“trusted”) annotation were considered as those terms which are associated to
the evidence codes EXP, IDA, IMP, IGI, IEP, TAS and IC. Figure 2.1 shows
that the organism distribution of new annotated sequences differ strongly.
1,940 new sequences (22% of the entire test set) come from “other” organ-
isms. The training set was obtained by randomly sampling 10,000 targets
from the experimentally annotated sequences in SwissProt v2012 07.
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Figure 2.1: Distribution of SwissProt entries annotated experimental GO
terms and categorized by organism. Dark bars (“New annotation”) represent
the number of sequences that accumulated experimental annotation in one
year and that were used as test set.
Performance evaluation
Two different strategies to evaluate GAS and GAS-C models, one based on
a target-by-target comparison and the other based on the whole dataset were
adopted. In the former approach, for each target protein, predicted GO
terms by their ranking position were evaluated (as described in the GAS-C
paragraph) and then the mean on the entire test set for all possible rank-
ing r computed. In the whole dataset strategy all targets were considered
together and performance was calculated for all possible score thresholds t.
The scores in this case correspond to the P-value, Bit-score and Scombined re-
spectively for GAS, BLAST and GAS-C predictors. For FANN-GO we used
the score as it is provided by the tool and for the Na¨ıve method the frequency
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in the SwissProt database. We used the following well established measures
adopted in CAFA to evaluate performance:
precision(r) =
|GOt ∩GOp(r)|
|GOp(r)|
recall(r) =
|GOt ∩GOp(r)|
|GOt|
where GOt represents the set of true terms associated to a protein in the
test set, while GOp is the set of predicted terms. Precision and recall are
measures of correctness and completeness for a method respectively. They
both depend on r, which corresponds to the ranking in the target-by-target
approach and to the score threshold in the whole dataset strategy. A third
useful metric is the F-measure, which is obtained by calculating the harmonic
mean of precision and recall:
F (r) = 2 · precision(r) · recall(r)
precision(r) + recall(r)
2.1.2 Results
We introduce GAS (Guilty by Association on STRING), a tool to predict
protein function exploiting protein-protein interaction networks without se-
quence similarity measures. The assumption is that whenever a protein inter-
acts with other proteins, it is part of the same biological process and located
in the same cellular compartment. Two proteins exhibiting the same interac-
tion partners can reasonably be inferred to have the same function. Given the
sequence of an unknown target protein, GAS is able to retrieve its interact-
ing partners from the STRING network and measures the enrichment of the
associated functional annotations to generate a sorted list of putative func-
tions. In the following, we will present some experiments that explain how
protein interaction networks can contribute to solve the problem of protein
function prediction. We will start with an analysis of the STRING network
and then we will provide a comparison with some methods. The list of eval-
uated tools includes BLAST [27], which is known as the standard baseline
tool for function prediction based on homology inference, the Na¨ıve method
implemented as described in CAFA and FANN-GO that was the only one
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available as standalone software, and trained on an old dataset. Finally, we
show that the GAS-C consensus model can increase performance accuracy
using both GAS and BLAST predictions.
Experimental annotation in STRING
We implemented GAS using STRING as the reference interaction network.
STRING is the largest database of protein-protein interactions including ex-
perimental derived data, third party information coming from other databases
and predicted interactions [6]. However, GAS does not use the entire net-
work but only a portion composed by only those nodes that can be mapped
to SwissProt entries and annotated with experimental terms. Exploitation of
functional information coming from protein protein interaction networks re-
quires minimization of false positive interactions. STRING provides a score
representing an edge quality estimate that also tracks the information source.
Figure 2.2 shows the distribution of STRING edge scores for different inter-
action types coming from different sources.
Most of the STRING edges connecting SwissProt entries have low qual-
ity values and come from text-mining and co-expression data, 53% and 40%
of the total interactions respectively, while only 5.7% are confirmed exper-
imentally (Table 2.2). When multiple sources of information support the
existence of an interaction, they result in a higher global score. We evalu-
ated GAS performances by filtering the STRING network for different edge
confidence values. An edge cut off of 900 on one hand guarantees the selec-
tion of reliable protein interactions, often confirmed in third party databases,
but also reduces the amount of available interacting partners and therefore
the annotation that can be transferred. On the contrary, a relaxed threshold
yields a higher chance of collecting experimental GO terms useful for the
prediction. One of the major limitations of function prediction from interac-
tome data is coverage (see Fig. 2.3). In fact, when no restriction in terms
of alignment coverage and identity is applied, BLAST is capable of generat-
ing new GO terms in almost the totality of targets. For GAS, we are able
to find experimentally annotated interacting nodes for our target protein in
29% to 47% of the cases, depending on the ontology. We tested GAS per-
formance by filtering edges for different cut off values. All tables and figures
in the chapter refer to the GAS predictions coming from a high confidence
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Figure 2.2: Distribution of STRING edge types by edge quality. Frequencies
are calculated using entries with experimental GO terms in SwissProt. Text
mining and coexpression edges are the most common among the low qualities,
while interactions from database are the most reliable.
STRING sub network with a cut off of 900. In Figure 2.3 we reported the
same comparison relaxing the edge filtering at a cut off of 500. The ability
to predict new potential functions increases greatly, ranging between 57%
to 68% coverage. Moreover filtering out low confidence edges significantly
decreases false positive interactions resulting in a slightly greater accuracy
(data not shown).
Target-by-target performance
We compared GAS, GAS-C and the other tools by evaluating their per-
formance on the test set using the same approach adopted by the CAFA
assessors. To clarify the evaluation procedure, in Figure 2.4 we provides two
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Table 2.2: Edge types distribution of experimentally annotated proteins in
STRING.
Figure 2.3: Prediction coverage on the dataset for GAS at STRING edge
weight cutoffs 900 and 500, as well as GAS-C.
examples of GAS and BLAST predictions. On the left the GAS enrichment
with the target connected with its direct interactors in STRING (grouped in
the blue box). Red and gray circles nearby interactors represent GO terms
and their size is correlated with the corresponding P-value. On the right is
represented the BLAST output, the green box represents the best experimen-
tally annotated hit. Precision recall measures are calculated by comparing
the truth graph (red circles) with the predicted graphs (GAS predictions in
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blue and BLAST in green).
Figure 2.4: GAS prediction on the left, BLAST on the right and the com-
parison with the real target annotation in the middle (GAS predictions in
blue and BLAST in green).
Table 2.3 reports the target-by-target maximum F-score (see Section 2.1.1),
computed on the test set targets where all listed methods are able to make
a prediction. The first consideration is that different methods behave differ-
ently for the three ontologies. Protein protein interaction networks contain
useful information about the biological process (BP) and the cellular com-
partment (CC) of a target. GAS does not produce good results for molec-
ular function (MF). This is not surprising, since interacting proteins, even
if they participate in the same biological process, usually carry out different
biochemical reactions. For example two proteins may be involved in the reg-
ulation of the cell cycle, but the first can be a regulatory protein performing
phosphorylation and the second a transcription factor with a completely dif-
ferent biochemical attitude.
The second observation is about the difference in terms of performance
observed for the three ontologies in general. The BP terms are definitely
the hardest to predict due to the more complex structure of the sub ontol-
ogy. Focusing the attention to the BP ontology is possible to observe the
effectiveness of combining GAS and BLAST in the GAS-C consensus, that
2.1. GAS METHOD 39
Table 2.3: Target-by-target performance. Performances are computed for
entries where methods can make a prediction (Targets). The maximum F-
score is used to select the corresponding precision and recall. The cutoff
explain the number of top rank scores that should be considered to achieve
the best f-score. The best performance for each ontology is highlighted in
bold. * FANN-GO does not predict cellular component.
rewards those terms predicted by both methods (see Section 2.1.1). GAS-C
obtains the maximum F-score over all methods even if the recall is penalized
compared to GAS itself. To better appreciate the predictor performance we
plotted the precision-recall curves for all methods (Figure 2.5). Another im-
portant observation is the good performance obtained by the Na¨ıve method
for the MF terms in Table 2.3. This behavior was already observed during
the CAFA experiment and is due to the very high frequency of proteins an-
notated with some shallow leaf terms very close to the root of the ontology.
Na¨ıve reaches a very high accuracy since it always predicts two ancestors of
these leaf terms in the first positions (“protein binding” and “catalytic activ-
ity”). FANN-GO is subjected to the same phenomenon but it achieve better
results since the machine learning approach overcomes Na¨ıve limitations.
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Figure 2.5: Precision-recall curves. FANN-GO is missing in the cellular com-
ponent chart because the tool does not provide prediction for that ontology.
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Whole dataset performance
One important aspect about the different predictors can be highlighted by
a correlation analysis. For BLAST, we observed a limited relationship be-
tween the Bit-score and the F-measure for each target, with values below
0.290 for the three ontologies. Surprisingly, the same low correlation is also
observed when considering sequence identity (not shown), suggesting that is
very difficult to find a specific identity threshold useful for discriminating a
good source of annotation. For GAS the same result holds for the enrich-
ment P-value (correlation below 0.225). Such a limited correlation between
F-score and the predictor confidence score suggested the use of ranks to im-
prove results. We observed that BLAST generally achieved best results by
just picking the GO terms associated to the first hit, i.e. sequence with the
highest Bit-score. GAS ranks GO terms rather than sequences and has to
consider up to the first three predicted terms, depending on the sub-ontology,
to achieve optimal performance (see Table 2.3, column Rank Cutoff). This is
likely to be the reason why GAS shows a higher maximum precision in gen-
eral, while BLAST has a higher maximum recall (Table 2.3). Interestingly,
the GAS-C score is strongly correlated with the expected F-score (correlation
higher than 0,406), and outperforms the rank-based strategy as shown in Ta-
ble 2.4. This is likely to be a consequence of a good fitting procedure. The
increased predictive power shows that GAS and BLAST generate different
knowledge. The consensus enables a better prioritization of predicted terms
by using two orthogonal sources of information jointly and can truly guide a
user to select GO terms depending on the expected annotation quality.
2.1.3 Discussion
In this chapter we presented a novel strategy to predict protein function ex-
ploiting protein-protein interaction (PPI) networks, developing a statistical
significance estimation to rank GO terms. To the best of our knowledge,
this is the first attempt to fairly evaluate the contribution of network inter-
action data to predict protein function. GAS is based on the “Guilty-by-
association” principle applied in the contest of PPI networks. If a protein
physically interacts with other proteins it should share a similar function.
For example, when all interacting partners operate inside the nucleus, it is
reasonable to believe that the subcellular localization of a given target will
be the nucleus itself.
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Table 2.4: Whole dataset performance. The performance is calculated over
the same target set of Table 2.3 but for all possible thresholds for the score
provided by the tools themselves. Score Cutoff indicates the score threshold
where the tool get the best F-score. For every tool the scores are: GAS =
P-value; GAS-C = Tool score; BLAST = Bit-score; NAI¨VE = Frequency;
FANN-GO = Tool score. The best performance for each ontology is high-
lighted in bold. * FANN-GO does not predict cellular component.
However, even if the principle is very simple, some details need to be con-
sidered to implement an effective tool. Some aspects are related to the PPI
network and others to the scoring function applied for ranking the predicted
terms. The size of the PPI network and the reliability of the interactions
affect the prediction in two different ways. A big network increases the prob-
ability of finding interacting partners endowed with GO annotation while
filtering low quality interactions corresponds to a gain in the precision of the
prediction. The other key factor is the method used to sort and prioritize
the transferred GO terms. We found that the P-value generated by measur-
ing the enrichment of each collected annotation can be conveniently used to
sort terms but there is not a linear relationship between the P-value and the
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F-score that measures the quality of a prediction. In other words it means
that is not possible to say which could be an optimal P-value threshold that
guarantees a good annotation. This is also true for BLAST where the Bit-
score provided by the tool correlates very poorly with the F-score (Table 2.4).
Conversely both the Bit-score and the P-value provide a good sorting of GO
terms and we found a good correlation between the F-score and the position
(ranking) in the output list (compare GAS and BLAST F-score in Table 2.3
and Table 2.4). The comparison between GAS and BLAST highlighted im-
portant differences among the three GO sub ontologies. As expected, PPI
data is very effective for the CC and BP cases. On the other hand, evolu-
tionary inference from sequence similarity represents a better discriminative
approach for MF. This fact is consistent with the idea that network pre-
diction can infer knowledge from the local neighborhood. Conversely, the
molecular function cannot be directly inferred from the interactome, since
the interacting proteins participating in a given biological process contribute
themselves with different specific activities and biochemical reactions.
As shown in the first CAFA experiment the performance of consensus meth-
ods is generally higher than standard tools. We implemented GAS-C that is
able to generate a consensus prediction by combining both BLAST and GAS
results. The implemented consensus strategy is extremely fast and simple,
consisting in a score transformation, which can be generated in linear time
with respect to the number of predictions. GAS-C achieves better results
for all the three ontologies compared to BLAST and GAS themselves (Table
2.3 and Table 2.4). It also outperform FANN-GO for the BP ontology. A
particular discussion has to be done for the the Na¨ıve performance in the
MF ontology. The good F-score was already observed during the CAFA ex-
periment and is due to a bias in SwissProt of some shallow leaf terms very
close to the root of the ontology (see results).
In general all presented results in terms of F-score, precision and recall are
slightly underestimated compared to the numbers provided by the first CAFA
experiment. This happened because we evaluated all the predictions with-
out filtering those terms in the test set not yet available one year before
in 2012. However that does not affect the validity of this work since all
methods were affected equally by this problem. At the moment, sequence
similarity approaches outperform GAS in terms of target coverage, but we
believe that good quality interaction data is going to increase consistently,
resulting in a better capacity to generate new hypotheses. Moreover, PPI
networks represent a complementary source of knowledge compared to evo-
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lutionary information, and will be even more effective in the future, when
entire organism interactomes will become available.
2.2 The Critical Assessment of Function An-
notation1
A newly sequenced genome contains several thousands genes, but a thorough
functional characterization is unfeasible due to high experimental costs. The
Critical Assessment of Function Annotation (CAFA) is a community experi-
ment where tools designed for protein function prediction are benchmarked.
In 2014 edition, more than 50 submissions were compared in the same test
set by the CAFA assessors, providing an unbiased overview of the state-of-
the-art in this field. The challenge starts with the publication of a large
sequence dataset (more than 100,000 in 2014), where few of them are com-
pletely uncharacterized (scenario 1 ), while others have existing GO anno-
tation (scenario 2 ). This latter situation is interesting for proteins with
partial characterization, but requiring further efforts for a comprehensive
understanding of their activity. When targets get published by the organiz-
ers, research groups can submit within a deadline the predicted GO terms
for all sequences and a confidence score. After six months, the new annota-
tions gathered in databases like UniProt [25] enable the assessment for few
sequences. In other words, the ground truth is not known at the beginning of
the challenge, but it is obtained from the natural growth of public databases.
As a reference baseline, BLAST [27] is used to show the performance of a well-
established algorithm. In addition, a ranking scheme called Naive assigned
to all GO terms a score based on their prior probability. Therefore, common
terms are given high score for all CAFA targets, while rare GO terms are
associated with a lower score, proportional to the probability distribution in
public databases. This represents the background “random” distribution of
terms. To evaluate submissions performance, precision, recall, F-score (see
Section 1.2.1) and Semantic Distance (S) [66] are used. All quality measures
require to take into account the prediction score when computing aggregated
results. Given a threshold t, one can compute recall (or other measures) in
whole CAFA dataset (mode 1 ), or just on the subset of proteins where a
1Figures and results are taken from CAFA online presentations (URL:
biofunctionprediction.org).
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submitter gave a prediction score ≥ t (Mode 2 ). In other words, mode 1 la-
bels as misclassified targets with no high quality predictions. This penalizes
methods unable to predict confidently new terms for all proteins.
2.2.1 Methods
We decided to participate with an extended version of GAS (see Section 2.1)
called INGA, where we combined BLAST homology search [27], knowledge
of PFAM domains [49] and STRING [6] protein-protein interaction network
to build an effective information retrieval (IR) method. The key addition is
PFAM domains, which are sequence regions expected to have a functional
role especially in terms of GO Molecular Function [38]. Likewise in GAS, the
statistical association of a GO term with respect to a given PFAM sequence
was estimated using Fisher’s exact test in UniProt database. We also imple-
mented two versions of STRING network search based on high (≥ 900) and
medium (≥ 700) edge quality. The two models were designed to have dif-
ferent capabilities in terms of accuracy and coverage. High coverage is very
important for computational methods, since the ability to predict GO terms
for all targets make them good baseline approaches. With the same rationale,
we used BLAST search to detect homologue sequences to CAFA targets using
a strict cut-offs in terms of minimal identity similarity (≥ 40%) and coverage
(≥ 80%). The two versions of BLAST search used respectively UniProt and
UniRef databases. UniRef is the non-redundant version of UniProt, which
avoids the detection of nearly identical sequences and solves statistical issue
related to very large sample size at the cost of lower coverage. The accurate
version of network-based and BLAST search used just the most reliable GO
terms (with evidence codes EXP, IDA, IMP, IGI, IEP, TAS and IC), while
the implementation focused on coverage exploited any type of annotation.
The combination of these strategies is based on generalized additive models,
similarly to the idea introduced by GAS. Overall, we achieved 95% coverage,
showing that we managed to predict GO terms for the largest part of CAFA
targets.
2.2.2 Results
An early assessment of CAFA predictions was presented during the Auto-
mated Function Prediction meeting in July 2014. After six months from the
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submissions, 232 proteins obtained annotation for MF, 410 for BP and 608
for CC (scenario 1). As can be seen in Fig. 2.6, INGA (labeled as Tosatto)
performed very well in terms of precision-recall curve, with a maximum F-
score of 0.667. Sequence information is very significant for MF, suggesting
that PFAM domains probably played a central role for such result. Just a
single method did slightly better than our consensus, while baseline strate-
gies (BLAST and Naive) were largely outperformed. It is interesting to note
that BLAST achieved higher accuracy when used in UniProt 2011 database
rather than in 2014 version. This is the result of a recent data curation
process in UniProt, which increased the quality of information at the cost
of removing available entries. When MF performance are compared by se-
mantic distance, there is a mild rearrangement of methods that penalizes our
approach (Fig. 2.7). However, our information retrieval system proved once
more to be one of the best methods on unseen data.
Figure 2.6: Precision-recall curve for the top ten methods in the MF ontology.
Semantic distance performance of INGA is very high also for BP and CC
2.8. It is important to note that there are limited S value changes between
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Figure 2.7: Semantic distance for the top five methods in the MF ontology.).
mode 1 and 2, proving that there are few targets with no high quality pre-
diction. On the other hand, there are better methods when evaluating the
targets by means of F-score. Surprisingly, none did well with this measure in
CC: Naive achieved among the highest results, showing that a nearly random
prediction is comparable to state-of-the-art methods.
Figure 2.8: Semantic distance for the top five methods in the BP and CC
ontology.
In the case of scenario 2, there are better methods as well. This was
expected, since we did not exploited GO covariance to perform better pre-
dictions. Our submission is focused on the common case of newly sequenced
genomes where no annotation is available at all. For the future, the ex-
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ploitation of priorly available GO terms in a given target will surely increase
performance.
To conclude, CAFA is a very challenging experiment, where a very large
volume of data has to be managed. Targets represented very often the en-
tire genome of model organisms, which ranged from humans to plants. The
evaluation task of submissions is clearly complex due to frequent updates of
the Gene Ontology that might remove and create new terms. The graph-like
structure of the ontology also poses big problems, which motivated the in-
troduction of S performance measure. Despite these issue, CAFA succeed in
the goal of creating a community focused in protein function prediction. Re-
sults comparison with the previous edition proves an increased accuracy for
all methods, showing that there is still room for improvement and a strong
commitment to solve this scientific challenge.
Chapter 3
Protein Structures: Dynamics
and Repeats
Tree-dimensional structures are among the most useful source of information
to study proteins. As pointed out in section 1.3.2, protein sequence and struc-
ture representation and manipulation requires dedicated software libraries to
support methods of increasing complexity. In section 3.1 I introduce the Vic-
tor (VIrtual Constrution TOol for pRoteins) C++ library, an open source
platform dedicated to enabling inexperienced users to develop advanced tools
and gathering contributions from the community. The provided application
examples cover statistical energy potentials, profile-profile sequence align-
ments and ab initio loop modeling. Victor was used over the last fifteen
years in several publications and optimized for efficiency. It is provided as
a GitHub repository (URL: protein.bio.unipd.it/victor/) with source
files and unit tests, plus extensive on-line documentation, including a Wiki
with help files and tutorials, examples and Doxygen documentation. Victor
was also used as a starting point to design a method for the analyses and
interpretation of Molecular Dynamics (MD) simulations. MD simulations in
fact have gained increasing relevance over the last years, but the complexity
related to their study is still one of the major challenges for most users. With
RING MD, I propose a new approach to identify the most important frames
(PDB structures) and key residues that cause different conformers to be ob-
served, providing a simple interpretation useful for non-expert users. Section
3.2 shows implementation details and compare RING MD results with the
classical analysis of a MD simulation.
In addition to new methods and libraries for protein structure manipulation
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and analysis, with RepeatsDB I contributed in the development of a database
of annotated tandem repeat protein structures. Tandem repeats pose a diffi-
cult problem for the analysis of protein structures, as the underlying sequence
can be highly degenerate. Using state-of-the-art repeat detection methods
and manual curation, the Protein Data Bank was systematically annotated,
predicting 10,745 repeat structures. In all, 2797 structures were classified ac-
cording to a recently proposed classification schema, which was expanded to
accommodate new findings. In addition, detailed manual annotations were
performed in a subset of 321 proteins. RepeatsDB is an ongoing effort to
systematically classify and annotate structural protein repeats in a consis-
tent way. In section 3.3, RepeatsDB database and its implementation are
presented. To conclude, this chapter describes few answers to the most typ-
ical needs in bioinformatics - tools and technologies for structural analysis.
All implementations can be downloaded and used freely, thus contributing
directly in the sharing of open applications for the community.
3.1 The Victor C++ library for Protein Struc-
ture Management1
Structural bioinformatics methods require valid software libraries to repre-
sent and manipulate proteins efficiently. A number of widely used tools have
been developed over the years to visualize proteins, e.g. Chimera [67], Swiss-
PdbViewer [68], MolIDE [69] and VMD [70] to name a few. Software libraries
to manipulate proteins efficiently provide basic data representation and more
advanced functionality with a different focus each. ESBTL [71] is mainly a
PDB file parser. Biskit [72] additionally provides functionality for analysis
of molecular dynamics simulations, while PTools [73] focuses on molecular
docking. OpenStructure [74] places more attention on structure visualization
and energy calculation. The latter is also supported by MSL [75] and Tin-
ker [76], while BALL [77] in addition provides many advanced optimization
algorithms. Finally, StrBioLib [78] extracts sequence information from the
protein structure and can be used as an interface to several available third-
party tools.
1The results of this chapter have been published in Hirsh, L., Piovesan, D., Giollo, M.,
Ferrari, C., Tosatto, S. C. (2014). The Victor C++ library for protein representation and
advanced manipulation. Bioinformatics, btu773.
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The Critical Assessment of techniques for protein Structure Prediction (CASP)
series of experiments [79] demonstrates that structure prediction is increas-
ingly becoming an engineering problem, where sophisticated methods have
to be combined into extensive pipelines in order to provide state-of-the-art
results [80]. This has raised the barrier for entry into the field to a point
where little new developments are possible, considering that most software
libraries used in CASP are proprietary and not available as open source.
Here, we propose the open source Victor (VIrtual Constrution TOol for
pRoteins) C++ library as a way to mitigate this problem. Victor is both
an efficiently designed C++ library, able to manipulate protein structures
with minimal CPU time, and a collection of advanced components for pro-
tein sequence and structure manipulation. In particular, Victor provides
three sample applications: profile-profile sequence alignments [81], statisti-
cal potentials [82] and loop modelling [83]. Each of these three applications
has been extensively described in the literature and is beyond the scope of
this writing. To the best of our knowledge, neither is available as an open
source C++ library yet. Profile-profile sequence alignments, in particular,
have been widely used to improve target-template alignment in CASP [84].
Victor is composed of over 60,000 lines of code and still expanding as it is
used in the main authors teaching. It was developed in-house over the last
fifteen years with the contribution of tens of developers and has reached a
high level of maturity. Victor is released to provide a platform for contribu-
tions from the interested community. It provides extensive online material
in the form of a Wiki with help files, tutorials, Doxygen documentation
and a list of applications built using Victor can be accessed from the URL:
http://protein.bio.unipd.it/victor/. The actual GitHub repository
with C++ source files, a precompiled Ubuntu 64-bit version and unit tests
are available from URL: https://github.com/BioComputingUP/Victor.
3.1.1 Core Library
The Victor C++ library currently contains two components for data repre-
sentation and manipulation in separate directories: tools and Biopool. Tools
provides basic manipulation methods, e.g. vector coordinates and file I/O.
The core of the library is provided by the Biopool module, which defines all
relevant data structures and algorithms to represent protein structures and
manipulate them at a higher level of abstraction. The core data structures
were carefully developed using design patterns [85], in order to provide an
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elegant and simple, yet powerful set of C++ classes. In order to allow the
simple manipulation of protein structure through the more intuitive torsion
angles, automating low level geometric transformations, atom positions are
coded both explicitly in 3D coordinates and as a position relative to the pre-
vious atom on a graph structure. This ensures consistency in the structure,
while allowing the programmer to change the protein conformation rotat-
ing a torsion angle with a single line of code. Computational efficiency is
guaranteed by updating the corresponding Cartesian coordinates only when
necessary. All low level geometrical transformations remain transparent to
the user. Biopool is able to read properly all existing PDB files. Additional
tools are also provided, such as protein secondary structure automatic assign-
ment with an ad hoc implementation of the original DSSP algorithm [30].
Extensive online documentation allows the interested programmer to learn
how to manipulate the Biopool data structures.
3.1.2 Applications
The Victor library provides three main examples to demonstrate the range of
possible applications, which are included as separate subdirectories: Energy,
Align and Lobo. Extensive documentation, including detailed tutorials, is
provided online in order to allow users to become familiar with the software
and build on existing knowledge. Energy contains everything that is nec-
essary to develop statistical potentials to evaluate protein structures. Two
sample implementations of published methods included in the library, FRST
[82] and TAP [86], can serve as a guide to develop additional methods. Both
are contained in the Energy subdirectory and functioning code is provided
both to generate the statistical potential itself as well as to use it on a PDB
structure to calculate the potential energy. The interested user can thus eas-
ily develop additional statistical potentials.
The Align directory provides basic sequence alignment algorithms [87] aug-
mented with secondary structure element [88]. Many different profile-profile
scoring schemes [81] are implemented, which have been extensively used in
CASP to detect remotely homologous protein sequences. Code is also pro-
vided for variable gap penalties with additional terms for sequence to struc-
ture fit [89] and advanced weighting schemes such as PSIC [90]. Alignment
parameters have been extensively benchmarked and the default parameters
are optimized for performance.
Last but not least, the Lobo directory contains an application of ab initio
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loop modeling using a fast divide and algorithm [83]. This makes exten-
sive use of the functions to construct novel amino acids and manipulate the
protein structure locally, providing sample code for more complex structural
manipulations. It can easily be extended for ab initio structure prediction in
combination with statistical potentials as target function.
3.1.3 Conclusions
The Victor library is an open source project devoted to the structural bioin-
formatics community. It provides a unique combination of methods for se-
quence and structure manipulation. Expansion is ongoing both through in-
house development, as it is the basis for several more publications (e.g. RING
[35] and NeEMO [91]), and as part of the authors teaching activities, which
include software development projects for students. We hope that the Victor
library will contribute towards an easier development of advanced methods
for structural bioinformatics.
3.2 RING MD: Gathering Time Into Struc-
tures
Molecular dynamics (MD) is nowadays a key toolbox for disease studies
[92, 93, 94, 95] and protein characterization [96, 97, 98, 99]. MD gained
further relevance after a Nobel Prize award for Chemistry was assigned for
insights in this field [42]. Despite its proven effectiveness, the knowledge
required to interpret and gather information from classical MD output still
represents the greatest issue for the scientific community. RING MD is a
tool designed to simplify the analysis and interpretation of MD experiments,
which are otherwise dependent on human expertise. Networks [100, 101] are
increasingly used in biology, but little work was done to analyze MD simu-
lations [102, 103]. Residue Interaction Networks (RINs) forms the basis of
this work, thanks to their proven ability in the representation of key pro-
tein features and contacts [100, 101]. Every MD simulation can be seen as
multiple snapshots of the same structure, changing its conformation and fluc-
tuating around the so-called equilibrium state. As the conformation changes,
the respective RIN changes as well. The RING web server [100] computes
a RIN where 6 different chemical interactions are identified, namely hydro-
gen bonds, pi-cation interactions, pi-pi stacks, ionic bonds, disulfide bonds
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and van-der-Waals interactions. Generating a network from a single ex-
perimental PDB is nevertheless a rough approximation of the true RIN,
as the stochastic molecular fluctuations can modify the edges in the pro-
tein network. Ideally, RIN interactions should be extended to highlight (i)
possible or (ii) time-dependent edges (see Fig. 3.1). We performed RING
MD analysis on 50ns MD simulations [104, 70, 105, 106] on Ubiquitin pro-
tein [107] to validate the tool. For each snapshot of the simulation, RING
MD computes different conformer networks called Time-Dependent Contact-
Maps (TDCM)[102, 108, 109], which describes the possible states explored
during time. These networks are different, as the intrinsic protein flexibility
highlights different protein states. To address the high sparcity of amino acid
interactions, we encoded RINs to a set of binary values associated with each
residue. Amino acids involved in a chemical bond are the only active vari-
ables (see Fig 3.1). We captured protein variability using k-means clustering
algorithm [108], which grouped RINs into k similar protein conformers that
model part of the MD. The amount of clusters k is a tradeoff between model
likelihood and number of parameters as defined by the Bayesian information
criterion (see Section 3.2.1).
3.2.1 Methods
A protein r can be represented as a Rn×3 matrix, where n is the number
of amino-acids that need a 3-dimensional representation. Let ri be the i-th
residue, then we can compute the so-called contact map m ∈ [0, 1]n×n , which
is defined as follows:
mij =
{
1 if ‖ri − rj‖ < c
0 otherwise
Where ‖.‖ is the well known euclidean norm and c is a user-defined cutoff
(typically set to 6-12 A˚). Contact maps are intimately related to RINs, and
any result obtained in the former can be immediately extended to the latter.
In our work, we introduced the concept of Time-Dependent Contact-Map
(TDCM), which is based on the following set of contact matrices:
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Figure 3.1: RING MD Workflow. Starting from a MD, a user can easily sam-
ple representative PDB structures of the whole simulation. With RING MD,
the corresponding Residue Interaction Networks and contact maps are com-
puted, and converted into a novel data structure called contact vector. This
representation emphasizes at the residue level the interacting amino-acids by
removing the sparse information about the contact partners. A clustering
procedure is then used to select different conformers based on contact vec-
tors. Structures belonging to highly diverse protein states are provided to
the user, along with a prioritization of the amino-acids explaining conformers
diversity. Finally, the interaction frequency for each residue is reported in the
selected structures, which summarize the intra-cluster contacts variability.
mij(t) =
{
1 if ‖ri(t)− rj(t)‖ < c
0 otherwise
where p(t) is the set of 3-dimensional coordinates of the protein r at
discrete time t ∈ T of MD simulation. The first straightforward implementa-
tion of TDCM is proposed in [102], where authors proposed to calculate the
mean of m(t) matrices to easily summarize the MD. In order to generalize
this concept, we represent each contact-map m(t) as a vector by means of
the vectorization operator vec():
vec(m) = [m1,1, . . . ,mn,1,m1,2, . . . ,mn,2, . . .m1,n, . . . ,mn,n]
T
and use the concept of convex hull to denote the space of possible contact-
maps:
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conv(m(t1), . . . ,m(t|T |)) =
{∑
t∈T
atvec(m(t))
∣∣∣∣∣ ∀t : at ≥ 0 ∧∑
t∈T
at = 1
}
In other words, the space of conformers observed during the MD is de-
scribed by a linear combination of the contact-maps. This is an interesting
formulation, as it consider explicitly all the possible states of the protein. In
particular, if we set at = |T |−1∀t ∈ T , we obtain the formulation proposed
in [102]. On the other hand, a given protein of interest explores different
conformers during the MD, and none of them will be described accurately
by the mean contact map proposed in [102]. To overcome this limitation, we
propose to use clustering methods to better represent TDCM. In our work,
we used k-means algorithm [108] to identify k similar contact maps:
argminS
k∑
i=1
∑
m(t)j∈Si
||m(tj)− µi||
Thus, contact-maps are assigned to different clusters in S, and their means
1, ..., k can be used to summarize states-dependent interactions. In other
words, the convex hull is basically segmented by assigning a coefficient of
aj = |Si|−1 to all contact-maps that belonging to certain cluster Sj and 0
otherwise. As results, we obtain a set of contact maps that are likely to
be generated from similar conformers, and therefore good representative of
a that protein state. The number k of conformers has been estimated by
means of the Bayesian information criterion (BIC) [108], which is a well-
known model selection technique. It is defined as follows:
−2 ln(P (m(t)|µ, S)) + k · n2 · ln(|T |)
The objective function is dependent on two aspects: the likelihood of the
k-means fitting, and a penalty related to the k · n2 number of parameters
needed for k clusters. Thus, BIC aims to select a model representing a com-
promise between fitting quality and its complexity. In order to speed up
the computations, we simplified the contact map representation using a map
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function f : Rn×n → Rn . This function transform the matrix m(t) into a a
vector m′(t) where:
m′i(t) =
{
1 if
∑n
j=1mi,j(t) > 0
0 otherwise
Indeed, for each residue, we set to 1 those ones that are currently involved
in an interaction. This is a critical improvement, since it is practically in-
feasible to run clustering algorithms on thousands of protein frames where
the number of residues is high (e.g. greater than 1,000). In addition, it is
common to focus only on contact maps with main chain-side chain and side
chain-side chain interactions, as they are the most informative bonds [109].
These contact maps are highly sparse matrices, so the information lost by
means of our function f is very limited. Finally, this has also an impact in
the BIC model selection process, as it reduces the penalty term related to the
model complexity and allowing the discovery of additional useful conform-
ers. It should be noted that the parameters obtained from clustering can be
interpreted as a mixture model. Therefore, one can use such a model to test
if a different MD of the same protein is generated from the same stochastic
process. A clear instance of this idea is the evaluation of mutations impact
in the protein dynamic or in its stability.
3.2.2 Results
Clustering validation
In order to validate RING MD clustering methodology, we used and idea
from CoDNaS [110], a database of known experimental conformations for
thousands of proteins. In their work, the authors suggested to use hier-
archical clustering on the protein structure coordinates to determine PDB
similarities. Such an approach enables the detection of largely different con-
formers describing diverse native states. Ideally, we expect to observe agree-
ment between RING MD and CoDNaS-based clustering for MD simulated
conformers. In agreement to CoDNaS definition, we computed the pairwise
distance of MD frame coordinates using the Bio3D package [111], and cal-
culated a dendrogram. Using in-house code, we obtained the conformers
dendrogram represented from simplified contact maps (SCM). In Table 3.1,
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the clustering similarity is evaluated by means of Cophenetic correlation.
For Ubiquitin, hydrogen bonds seems the main cause of tridimensional con-
formation switch. The joint combination of multiple types of interactions
(denoted as all) has a correlation value of almost 0.5, and demonstrates the
high explanatory power of RINs in the detection of different protein native
states. A second appealing strength of RINs is their ability to spot the type
of interactions promoting conformational changes. This is a clear abstraction
of the whole dynamics, and enables the quick detection of key factors for the
protein stability and its fluctuations. A last important consideration arises
when we compare the average number of interactions for a given residue dur-
ing the MD with its root mean square fluctuation. As shown in Table 3.2,
the inter-atomic contacts explain a significant part of the amino-acid degree
of freedom. This is obvious in practice, and is also well modeled by our RIN-
based MD representation.
We also explored the use of Hidden Markov Models (HMM) to better summa-
rize the dynamics. However, the increasing number of parameters and higher
computational burden and this approach provided a similar data separation,
confirming the effectiveness of simpler clustering methods.
Table 3.1: Cophenetic correlation of PDB clustering and RING MD average
clustering. There is good agreement between the dendrograms produced from
the different type of protein representations. The “All” row represents the
sum of all the interactions but the inter-atomic contacts, and describes the
existence of any bond.
3.2. RING MD 59
Table 3.2: Correlation of RING MD mean number of interactions of a residue
with respect to amino acid RMSF. Total amount of Van-der-Waals contacts
correlates with the residue fluctuations.
In depth analysis
A comparison between classical MD analysis and RING MD output is shown
in Fig. 3.2. The RMSD [Fig.3.2a] of two Ubiquitin [107] ionic interactions
(residues K27-D52 and D39-R72) is compared with the RING MD summary
structure [Fig. 3.2d-e]. We focused on R72 as it has widely been demon-
strated to be involved in several ubiquitin interactions and cleavage phenom-
ena [110, 112, 113]. Particularly, in 2011 Ralat and coworkers demonstrated
that Ubiquitin is a target of Insulin-degrading-enzyme (IDE). The catalytic
activity of this enzyme passes through a first cleavage, involving the terminal
glycine dimer and forming the 1-74 Ubiquitin segment, being R74 exposed to
solvent. A second and slower cleavage follows the first one, and targets R72
forming the 1-72 Ubiquitin segment [110]. In RING MD summary structure,
residues are highlighted based on their interaction frequencies (see Fig. 3.2).
The interaction between residues D39 and R72 is less frequent compared to
K27-D52, which instead occurs almost in every frame. Therefore, according
to RING MD, the slower IDE activity towards R72 could be explained by
the formation for the 37% of the frames of R72-D39 ionic interaction, not
allowing R72 to participate in the cleavage reaction. Indeed, IDE catalytic
chamber has been proven to show protease activity towards highly flexible
chains [114]. Furthermore, RING MD provides an interaction-based trajec-
tory clustering, with the conformers observed during the MD described by a
linear combination of the contact-maps. In the reported case study, 4 clus-
ters were obtained (see Fig. 3.2c). Particularly, structural clusters 3 and 4
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represent molecular conformers not suitable for the cleavage reaction, con-
taining R72 tightly locked with D39. On the contrary, in clusters 1 and 2
R72 is not involved in ionic interactions, and free to participate in other
biochemical mechanisms. These protein states can clearly coexist, with the
probability of observing them changing during time. Figure 3.2c represents
the stochastic dynamic process, and facilitate in finding relationships among
conformer transitions and periodicity. Extending the concept of RINs over
a time dependent scenario proved that the joint combination of multiple
simplified contact maps contains all the initial RIN information. In fact,
RING MD can reconstruct automatically the initial contacts with no infor-
mation loss (see automatically coloured interacting residues in [Fig. 3.2b]).
Moreover, the integration of the clustering results with the structural view
can explain in detail the reasons of conformational changes. The output of
the entire analysis is provided in supplementary information Fig. 3.1, high-
lighting changes in ionic, h-bond, and overall interactions. Conformational
changes identified by the RING MD clustering show a good agreement with
structure-based analysis (Tab. 3.1)[110], and can be used to highlight the
type of interactions relevant for these changes. It is important to note that
classical clustering is based on 3D coordinates comparison of the structure,
while TDCM compare graphs. Highly fluctuating residues, like N and C ter-
mini have high impact in terms of coordinates change, leading to a potential
overestimation of structural distance. On the other hand, contact maps are
robust to these irrelevant fluctuations and therefore more likely to provide a
good final clustering. In this context, RING MD can play a key role in Con-
formational Ensembles for the analysis of intrinsic disorder proteins [112],
since the classical structural comparison is known to be ineffective. We also
observed that Inter-atomic interaction probabilities calculated with RING
MD correlate significantly with Root Means Squared Fluctuations (RMSF)
(Tab. 3.2), thus explaining well the degrees of freedom of protein residues.
Figure 3.2 description
a) Root mean square deviations (RMSDs) of ASP52-LYS27 (red) and ASP39-
ARG72 (black), and ASP58-ARG54 (green) interactions. The distance in the
plot is expressed in angstroms. b) Time Dependent Contact Map (TDCM)
of the ionic interactions occurring in Ubiquitin MD simulation. Highlighted
in red ASP52 and LYS27, in black ASP39-ARG72 and in green ASP58 and
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Figure 3.2: Results of Ubiquitin RING MD analysis.
ARG54. c) Clusters deriving from k-means analysis of 1000 frames. a, b
and c share the x axis, which is time (frames) of the MD simulation. The
colouring scheme is the following: cluster 1 is light orange, cluster 2 is violet,
cluster 3 is light blue and cluster 4 is light green. d) Summary structure
reporting the frequencies of interaction between ASP39-ARG72 (light blue),
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LYS27-ASP52 (red) and ASP58-ARG54 (light blue and red, respectively).
The thicker regions of this structure depict where ionic interactions (not
highlighted) are occurring more frequently. e) Clusters structures. In cluster
1 ASP52-LYS27 is the only interaction occurring frequently. In cluster 2
ASP39-ARG72 and ASP52-LYS27 are occurring. In cluster 3 ASP52-LYS27
and ASP58-ARG54 are interacting and no interaction is found for ASP39
and ARG52. In cluster 4 all the chosen ionic couples are interacting.
3.2.3 Conclusion
The capability of molecular force-fields in simulating macromolecular sys-
tems provided a plethora of useful insights to scientific development. RING
MD fits perfectly in this background, providing the user speed and reliability
in analysing key features of a given system. The tool allows to quickly recog-
nize structural hot spots in protein structures MD simulations, providing a
fertile ground to improve protein biophysics knowledge in a faster and easier
way. The results obtained with RING MD, compared to the literature, re-
vealed that RING MD analysis could match hot spot residues with a simple
trajectory analysis [113, 114, 115].
3.3 RepeatsDB: a database of tandem repeat
protein structures2
A large portion of proteins contain repetitive motifs, which are generated by
internal duplications and frequently correspond to structural and functional
units of proteins. Many repetitions in protein sequences can be identified
by using different approaches [116, 117, 118, 119]. A more difficult problem
for identification is however posed by repeats in protein structure, which
can be highly degenerate [120, 121]. In fact, it is possible for a protein
to maintain a repetitive structure even in the presence of massive amounts
of point mutations [122]. Several repeat families have been studied so far
due to their relevance in different biological processes such as health [123],
2The results of this chapter have been published in Di Domenico, T., Potenza, E.,
Walsh, I., Parra, R. G., Giollo, M., Minervini, G., Piovesan D, Ihsan A, Ferrari C, Kajava
A, Tosatto, S. C. (2013). RepeatsDB: a database of tandem repeat protein structures.
Nucleic acids research, gkt1175.
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neurodevelopment [124] and protein engineering [125, 126, 127], to name just
a few.
Repeats have been previously divided into five broad classes, primarily as
a function of repeat length [128, 129]. At the lower end of the repeat length
spectrum, i.e. less than five residues, very short repeats can either form in-
soluble aggregates (crystallites, class I) or long and winding helices of fibrous
structures like collagen and α-helical coiled-coils (class II). At the other end
of the spectrum, repeats containing >∼50 residues appear to fold mostly as
domains forming beads-on-a-string structures (class V). In between, for unit
lengths of 540 residues, the known repeats can form either open elongated
solenoids (class III) or closed toroids (class IV). Due to their fundamental
functional importance, classes III and IV contain the most studied types of
tandem repeat proteins. Solenoid folds appear to follow the distribution of
repeat lengths rather closely, from all-beta (e.g. anti-freeze proteins) [130] to
mixed alpha/beta (e.g. leucine-rich repeats) [131, 132] to all-alpha structures
(e.g. Armadillo and HEAT repeats) [133, 134, 135]. They are characterized
by some of the largest known autonomously folding domains, with 500 or
more residues forming a single structure [136]. Rapid addition or deletion of
repeat units even between close homologs is of particular note for solenoid
structures [137]. Toroids on the other hand are restricted in overall size by
their closed circular nature. Known toroid structures include the highly ver-
satile TIM barrel and large outer membrane beta-barrels [138]. Perhaps a
more interesting fold is the beta propeller (e.g. WD repeats), which can
accommodate variable numbers of repeat units while maintaining a closed
circular structure [139, 140].
An open question regarding repeat proteins is the existence of other com-
mon structures that may have gone undetected. After all, the most common
way to detect repeat families so far was to manually annotate the sequence
family first and only afterwards visually recognize their structural repet-
itiveness. Such an approach is obviously difficult when dealing with the
entire Protein Data Bank (PDB) [141], especially considering the many un-
characterized protein structures deposited by the main structural genomics
consortia [142]. The systematic description of repeat structures becomes a
question of using automated methods to detect them in protein structures.
This field is relatively new, with only few available methods. One of the first
attempts was made by the Thornton group [143], but is unfortunately no
longer available. Some methods [119, 144, 145, 146, 147, 148] were developed
to detect internal symmetries in proteins, but these may be difficult to adapt
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to the systematic classification of repeats. Recently, our group has developed
RAPHAEL [149] in an attempt to fill the gap for repeat detection from struc-
ture. Widely used structural classifications such as CATH [150] and SCOP
[151] also do not explicitly annotate repeats in protein structures, although
it may be possible to leverage individual annotations to find similar repeats.
Some databases exist for the detection of repeats from sequence [152, 153],
but usually these are limited to short tandem repeats and do not take into
account divergent repeats, such as solenoids or toroids. The main domain
sequence databases such as Pfam [49] and SMART [154] do not excel at the
annotation of these repeat types either, as coverage is rather low and many
repeat units go undetected. For Pfam most of the largest clusters of human
sequence regions not covered were recently found to be repeats [155]. To
the best of our knowledge, no database or classification is currently available
for repeat structures. This is the motivation for our present work, and we
introduce RepeatsDB as a way to fill this gap. The database was developed
to provide a central resource for the systematic annotation and classification
of repeats. Given the fact that the structure-based search and classification
of repeat proteins is more complete than on the basis of sequences or key
words, our database will allow more accurate assignment of proteins with
repeats to the corresponding families. For example, it will be used to suggest
a better subdivision of alpha-solenoid proteins where at present the bound-
aries between the structures with Armadillo, HEAT, TPR and other repeat
types are frequently blurred.
3.3.1 Database description
Data curation
The initial dataset for RepeatsDB was extracted from the PDB [7]. Repeat
candidates were identified from the reduced PDB dataset with RAPHAEL
[149], which uses a geometric approach imitating the work of a human cu-
rator (score cutoff ≥ 1). The resulting dataset consisted of >10,000 repeat
candidates, stored in the database as predicted entries, which underwent a
classification and curation process.
The dataset of predicted repeats was manually curated using a two-level
annotation system. The first manual annotation level (manually classified)
classifies an entry into structural repeat class and subclass. This classification
is based on previous work [129], where five classes of repeat structures are
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proposed, which are then further divided into subclasses. Class assignment is
based mainly on repeat unit length and subclass assignment on secondary and
tertiary structure features. The second manual annotation level (detailed)
consists in providing information about the start and end positions of the
repeat units, repeat regions and/or insertions. We define a repeat unit as the
smallest structural building block that is repeated to form a repeat region. A
repeat region is a group of at least three repeat units. Inclusion of proteins
with two repeat units would significantly complicate classification because
many typical globular domains have this type of architecture. Insertions are
non-repeated segments of structure that occur either inside a repeat unit or
between two of them. These are particularly interesting because they break
the repeat symmetry, and represent a challenge both for automatic detection
and for the analysis of repeat structures [149].
Several curators annotated each protein undergoing manual classification
by consensus. For first-level annotations, at least 75% of the curators had to
agree in order for a protein to be included, otherwise it would be excluded and
placed on a reserve list for future annotation. The rationale for this choice is
that ambiguous cases are generally difficult to classify but may occasionally
represent a novel repeat class. For second-level annotations, the threshold for
consensus was at least 65% agreement (typically two of three curators). In
case of discrepancy, an expert would arbitrate the final annotation based on
the alternative proposals. Proteins with detailed annotations were also used
to search for similar sequences in proteins from the PDB. Any PDB chain
with at least 40% sequence identity and a coverage of at least 80% of the
classified protein, belonging to the initial list of predicted entries, is added to
the classified by similarity annotation level. The similarity thresholds were
selected to exclude possible false-positives (data not shown).
Implementation
RepeatsDB was designed with a multi-tier architecture, using separate mod-
ules for data management, data processing and presentation functions. To
simplify development and maintenance, all tiers handle the common JSON
(JavaScript Object Notation) format, thereby eliminating the need for data
conversion. The MongoDB database engine is used for data storage and
Node.js as middleware between data and presentation. RepeatsDB exposes
its resources through RESTful web services, by using the Restify library for
Node.js. The Angular.js framework and Bootstrap library were selected to
66 CHAPTER 3. PROTEIN STRUCTURES
provide the overall look-and-feel. Angular.js to Bootstrap integration is avail-
able through the angular-ui project. A customized version of the BioJS [156]
sequence component is used as sequence visualizer. Additional information
is added to entries by querying the PDB web services at the structure and
chain level. At the structure level, annotations like organism and experimen-
tal method used when resolving the structure are provided. At the chain
level, secondary structure and links to other databases, among others. Re-
peatsDB offers users both graphical web interface access and RESTful web
services from URL: http://repeatsdb.bio.unipd.it/.
3.3.2 Using RepeatsDB
The user interface presents an intuitive tree-based browsing mechanism,
where the root of the tree is the full database, second-level nodes repeat
classes and third-level nodes subclasses. When clicking on a node, the user
is presented with the list of RepeatsDB entries corresponding to the selected
category. Each row of the list shows basic information about the entry, like its
entry ID, title and organism. All annotated chains corresponding to an entry
are displayed in a single page. The user interface presents a structure and
sequence visualization widget (Figure 3.3). The user may choose to visualize
the structure in four static images, or by using the 3D visualizer. If the en-
try features detailed annotations, the repeat regions, units and/or insertions
are displayed using a combination of colours. The sequence visualization
widget displays the sequence and secondary structure corresponding to the
structure. It displays the same colour coding as the structure visualization
widget, associating repeat annotations in the structure and sequence views.
Additional information at the structure and chain levels is also provided.
The RepeatsDB search toolbar, available on top of every page, allows to
search for entries either by database IDs or UniProt text query. The database
ID search allows comma-separated PDB or UniProt IDs. The UniProt text
search query uses the full UniProt search engine, see online documentation.
RESTful web services are directly accessible through HTTP URLs. All data
available on RepeatsDB are also available for programmatic access. Please
refer to the Help section of the website for details on using the RepeatsDB
web services. Datasets can be downloaded in JSON, XML or text format
using the browse function or RESTful web services.
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Figure 3.3: Screenshot of a sample RepeatsDB entry results page (PDB
entry 1ikn). The sequence viewer and the structure viewer are shown in the
middle of the page, towards the left and the right, respectively. Additional
annotations at the structure and chain level are displayed, including links to
other databases (above) and classifications (below).
Statistics
Analysis of the full PDB dataset yielded 10 745 repeats predicted by RAPHAEL,
of which 2797 were finally classified into the RepeatsDB schema. Table 3.3
shows the distribution between classes and subclasses. The bulk of the an-
notations (<90%) consist of entries belonging to classes III and IV. No effort
was made to balance the distribution of entries between classes in this ini-
tial release. As coverage increases in the future, we expect the balance to
approximate the real distribution more closely, although it may be neces-
sary to fine-tune RAPHAEL. Of the classified entries, 321 representatives of
the entire dataset were annotated in detail with information about the start
and end of repeat regions, repeat units and/or insertions (Table 3.3). It
is interesting to note the different distribution of insertions between classes.
Apparently, some classes such as β-solenoid (class III.1) or TIM barrels (class
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IV.1) have stronger propensity to accommodate insertions.
3.3.3 Conclusions and future work
RepeatsDBs goal is to provide the community with a resource for high-quality
tandem repeat protein structure annotations. The user can either interac-
tively analyse his proteins of interest via the user interface, or create and
download datasets for offline use. Far from being a static classification pro-
cess, the annotation effort for the initial RepeatsDB dataset alone already
motivated the extension of the original classification schema [129]. Some of
the curated structures, while clearly representing structural repeats, did not
belong to any of the pre-defined subclasses. To allow them to be classified,
subclasses IV.5 (α/β prism) and IV.6 (α-barrel) were added to the initial
schema [129]. Class V also underwent a re-classification according to the
secondary structure content of the single domain repeats (beads) to allow a
broader classification range beyond individual repeat families, as the list of
possible beads-on-a-string folds may be considerably larger than currently
appreciated. The other subclass was also added to allow collection of repeats
that do not fit into the current classification scheme. RepeatsDB provides
the community with a previously unavailable opportunity to easily create
datasets of tandem repeat proteins. The detailed annotation subset further
presents a unique opportunity to better understand the nature of tandem
repeat proteins.
Beyond its initial release, RepeatsDB is a continuous effort to expand,
revise and improve tandem protein repeat annotations. Predictions for new
PDB structures are simple and fully automated, allowing regular database
updates every 3 months. Manual curation of new entries for inclusion is
also ongoing, aiming at regular and steady updates. Options to involve the
community into the annotation process through crowd-sourcing tools are
currently being analysed. A main goal for future versions is the extension
of the annotation of repeats at the sequence level, starting from annota-
tion for intrinsically disordered regions from MobiDB [157]. We anticipate
that RepeatsDB should prove valuable towards the understanding of the
sequencestructure relationship in tandem repeat proteins and their evolu-
tionary relationship.
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Chapter 4
Intrinsic protein disorder
Intrinsically disordered regions are key for the function of numerous proteins.
They are commonly defined from missing electron density in x-ray struc-
tures. Due to the difficulties in experimental disorder characterization, many
computational predictors have been developed with various disorder flavors.
Their performance is generally measured on small sets mainly from experi-
mentally solved structures, e.g. Protein Data Bank (PDB) chains. MobiDB
[157] annotates disorder for UniProt sequences, and enabled the retrieval of
25,833 different sequences with X-ray crystallographic structures. From this
unique dataset, section 4.1 reports the first large-scale assessment of fast
disorder predictors. In addition to a comprehensive ranking of methods, the
analysis produced interesting observations about bias and limitations of com-
putational tools. Experimental evidence for long disorder regions (LDRs) of
at least 30 residues in the dataset deserved the specialized analysis of section
4.2. Here, I describe the first comprehensive and fully automated large-
scale study of experimental LDRs for 1,758 unique proteins, demonstrating
a recent increasing coverage of intrinsic disorder in the Protein Data Bank.
Overall, the chapter is mainly related to the characterization of disorder and
its features. The knowledge discovery in database process (section 1.2) will
be the main actor from the methodological point of view, but its results
will represents the basis for future predictors. In fact, all findings presented
here will be critical for the next generation of machine learning tools and for
disorder pattern recognition in proteins.
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4.1 Comprehensive Large Scale Assessment
of Protein Disorder1
The rigid structure of proteins has been considered the determinant of func-
tion for many years. Recently, an alternative view is emerging with respect
to non-folding regions, suggesting a reassessment of the structure-to-function
paradigm [158] [159] [160]. Flexible segments lacking a unique native struc-
ture, known as intrinsic disordered regions [161], are widespread in nature,
especially in eukaryotic organisms [162]. These regions have been shown to
play important roles in various biological processes such as cell signaling or
regulation [163], DNA binding and molecular recognition [164]. Their mal-
leable properties allow multiple binding partners [165] with the flexible region
often becoming folded on binding [166].
Despite an emerging consensus regarding their existence, there is no single
definition of disorder. As a result, various flavors of disorder have been pro-
posed [167]. These disorder flavors have become diverse with some based on
amino acid composition [167], flexibility [168] and functional roles coupled
with conservation [169]. Perhaps the simplest flavor distinction is the length
of a disordered region, separated into short and long. Long regions seem to
behave differently [170] and are difficult in structural determination, causing
them to be underrepresented in the Protein Data Bank (PDB) [171]. The
PDB contains structural information from X-ray crystallography and nuclear
magnetic resonance (NMR) spectroscopy, which can be used indirectly to
study disorder. A plethora of computational predictors have also appeared,
with special efforts to capture different flavors. Available methods can be
broadly divided into three classes: biophysical, machine learning and consen-
sus based. Biophysical methods [172] [173] [174] [175] derive pseudo-energy
functions from residue pairings in rigid structures (i.e. non-disorder) to rec-
ognize sequence regions with high energy as disordered. Machine learning,
especially neural networks, has been widely used to predict protein disorder
[176] [177] [178] [179] [180], [181] [182] [183]. Many are tuned for the disor-
der style used in the Critical Assessment of techniques for protein Structure
Prediction (CASP), where the goal is to detect missing residues in the X-ray
1The results of this chapter have been published in Walsh, I., Giollo, M., Di Domenico,
T., Ferrari, C., Zimmermann, O., Tosatto, S. C. (2014). Comprehensive large-scale assess-
ment of intrinsic protein disorder. Bioinformatics, btu625. For Supplementary Material,
check the on-line version of the paper.
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crystal [184]. Others attempting to move away from this disorder style mea-
sure some form of protein backbone flexibility. For example, ESpritz [181]
can predict mobile NMR regions and DisEMBL [179] loops regions with high
B-factor (high flexibility). The most recent disorder predictor category uses
a consensus of various biophysical and machine learning methods [185] [186]
[187] [180] [188]. Consensus approaches are frequently more accurate, but at
the computational cost of running several predictors in parallel and averaging
their output. Because there is no consensus on how to define disorder, pre-
dictors often vary in their parameter setting and disorder output. In nearly
all cases, disorder is defined at the residue level, and the goal of the predictor
is to maximize recovery of correct residues.
Among applications of disorder prediction, we can distinguish at least two
different scenarios. The first is the CASP experiment [184], i.e. methods are
used to predict a relatively small number of proteins with maximum accu-
racy and consensus predictors aiming for maximum accuracy should clearly
excel. A more practical scenario is represented by high-throughput analysis
of protein disorder on entire genomes [159]. Over the years, most prediction
methods have addressed the first problem, with comparatively little atten-
tion to the practicalities of large-scale predictions [181]. MobiDB [189] is
a large-scale disorder database containing experimental information on the
entire PDB and predictions for all UniProt [5] sequences. Here, we use the
vast quantity of disorder data for a first large-scale assessment. While most
assessments are performed with hundreds or a few thousand examples, we
have analyzed > 25,000 UniProt sequences combining all available X-ray
crystallographic structures. All disorder assessments so far are carried out
on single PDB chains, whereas here the UniProt sequence is the final target.
The UniProt annotation is unique and we compare it with standard PDB
chain analysis for further insights.
4.1.1 Methods
Datasets and classifications
All UniProt [5] sequences with at least one X-ray annotation in MobiDB [189]
were downloaded on the May 13, 2013 (25,833 entries). Where more than
one MobiDB annotation was available, a majority vote was used (Fig. 4.1)
to produce a more stable disorder definition, filtering rare conflicts due to
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experimental conditions. Where MobiDB cannot find annotation for part of
the UniProt sequence, residues are annotated as unknown and ignored. Each
PDB [171] chain that covered UniProt entries was also extracted for com-
parison and identical chains majority voted (Fig. 4.1). Similar chains were
removed at 90% pairwise sequence identity using CD-HIT (101,338 chains
reduced to 24,669). See Table 4.1 for statistics. Each UniProt entry was
assigned to CATH using SIFTS [190]). Gene Ontology (GO) terms [38] were
downloaded from UniProt and expanded to the ontology root. For a deeper
analysis, the UniProt dataset was further split according to the following
rules (Supplementary Table S1): removing short (<30 residue) PDB frag-
ments, excluding conflicting residues, up to 10 non-consecutive disordered
residues, >10 disordered residues.
Figure 4.1: Human P53 (UniProt ID: P04637) disorder annotation. The
top bar shows the majority voting scheme, with blue for order and red for
disorder. For simplicity, only a subset of PDB hits was shown. Missing
regions are not considered. The bottom bar shows an example majority
voted chain used in the PDB chain analysis.
Predictors
Predictors were selected with the condition that they must be available as an
executable and fast, ideally returning predictions in <1 min. The following
11 programs were used (disorder definition used in parenthesis): ESpritz (X-
ray, NMR and DisProt; [181], IUPred (short and long; [172], DisEMBL (hot
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Table 4.1: Number of proteins, residues and region size.
loops and remark 465; [179], RONN (X-ray; [183] and VSL2b (combination
of X-ray and Disprot; [191], GlobPlot (globularity; [174] and FoldIndex (fold-
ing; [175]. This resulted in a total of 11 predictors with different disorder
flavors. A short description of the predictors is given in the Supplemen-
tary Material. Predictor similarity was calculated on their residue scores
(e.g. probability of disorder) was shown as a dendogram based on SOV per-
formance. Low-complexity regions are parts of the sequence with strongly
biased compositions (e.g. polyQ), which are thought to correlate with in-
trinsic disorder [192]. The low-complexity predictors SEG [193] and Pfilt
[194] were used both as disorder predictors and to analyze disorder predictor
performance in low-complexity regions.
Performance assessment
Disorder prediction is a binary classification problem. As such, the standard
measures accuracy, sensitivity, specificity, Matthews Correlation Coefficient
(MCC) and area under the curve (AUC) are used (see Supplementary Mate-
rial). All these measures are calculated both per residue and as average on a
per protein basis. MCC and AUC were replaced by SOV and FPreg in the
per protein analysis. SOV is the mean of the segment overlap for disorder and
structure, in analogy to secondary structure [195]. FPreg counts the number
of predicted false-positive disordered regions. Disorder content measures the
ability to recover the fraction of disordered residues in a protein indepen-
dent of residue position. We adopted two previously used measures [196],
root mean square error (RMSE) and Pearson Correlation Coefficient (PCC),
with predicted and observed disorder content normalized by the number of
annotated residues. As a large number of measures hinders a global view
of performance, we established an overall ranking as the average over all 12
quality measures. The Welch t-test was used to compute statistical signifi-
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cance.
4.1.2 Results
First large-scale disorder assessment
We report the first large-scale assessment of disorder predictions on UniProt
sequences through a comprehensive assessment of 11 fast predictors with new
performance measures and a statistical evaluation. With respect to diversity,
the UniProt set has 15,942 unique clusters at 40% identity cutoff. The 24,699
PDB chains are non-redundant by design (see Methods). Therefore, in both
sets there is no large cluster of similar sequences, guaranteeing no bias in the
analysis.
Figure 4.1 shows human P53 sequence (UniProt ID: P04637) covered by dif-
ferent disorder and structure definitions from the PDB. Using the majority
voting approach, all structural and disorder information is combined and a
more reliable global picture of the full p53 complex is constructed. Table
4.1 shows the number of proteins and residues using this annotation strat-
egy. A total of 25,833 UniProt entries are annotated and a dataset of unique
PDB chains is constructed for comparison purposes. For all sets, there is
a clear imbalance between disorder and structured residues. Similar to the
CASP10 experiment [184] where 20% of the data was completely ordered,
6271 sequences 24.3% of the UniProt dataset are completely ordered. Long
disordered regions (>20 residues) are also abundant with 3439 examples.
Table 4.2 shows the per-residue performance on the UniProt dataset. Sup-
plementary Tables S3 and S4 show similar results when excluding short PDB
fragments and conflicting positions. The same trends are also found when
separating the UniProt dataset for disorder content (see Supplementary Ta-
bles S5 and S6 and Section 3.4 below).
Table 4.3 shows the per protein and disorder content performance. Most
predictors have disorder scores significantly above random (AUCs >70). De-
pending on the prediction style, e.g. high coverage (overprediction) or highly
confident (underprediction), one could argue for and against different predic-
tors. For example, VSL2b has a lower residue specificity (81.16) predicting
many false positives (1,268,274 residues), yet its AUC is the highest. On the
contrary, IUPred-short has the best MCC (31.43) due to its high specificity.
Table 4.2 can reveal detailed future objectives such as the need to retune
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Table 4.2: UniProt per-residue performance. All values are shown as per-
centages. The top performing method in each category is shown in bold and
the second best underlined.
the VSL2b decision threshold for higher specificity. For the SOV measure,
DisEmbl-465 has the best performance (50.23). FPreg measures overpredic-
tion on segments as opposed to single residues. Again VSL2b clearly over
predicts compared with DisEmbl-465.
Similarity between measures and predictors
While the evaluation complexity arises due to predictor variability and the
quantity of performance measures, it is useful to understand the deeper pre-
dictor behavior. Although many more observations could be made, for the
sake of brevity a summarized ranking was chosen to give a clearer perfor-
mance summary. Before ranking, it is important that the measures are
evaluating different aspects of the predictions. Figure 4.2 shows that no
measure correlates highly and most are diverse (pairwise correlation value
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Table 4.3: UniProt per-protein and content performance. All values are
shown as percentages, except RMSE and PCC. The top performing method
in each category is shown in bold and the second best underlined.
>0.7 or <0.7 in only 9 of 66 cases). This diversity ensures the ranking pro-
cedure is fair. Interestingly, per-residue MCC correlates highly with both
disorder content measures (0.7 with RMSD and 0.9 with PCC), suggesting
they could be captured effectively by residue-level MCC. Both were kept be-
cause they are not completely redundant and the content measures do not
depend on residue positions. From Figure 4.3, the top-ranked predictors are
DisEmbl-465 and IUPred-short, with no statistically significant difference be-
tween performance (P-value 0.64). A second group consists of Espritz-NMR,
VSL2b and Espritz-X-ray. In Supplementary Figure S2, these top five pre-
dictors are analyzed using receiver operating characteristic curves at low 05%
false-positive rates (FPR). VSL2b starts outperforming the rest at around
2% FPR, again suggesting high-quality residue scores but a need for recali-
bration of its decision threshold.
Combining several good but complementary predictors is the heart of
most consensus methods. Figure 4.4 shows the Pearson correlation between
predictors. Examining similarity and performance is the first step in de-
signing a consensus. Both are not necessarily related, e.g. IUPred-short,
IUPred-long and RONN form a group of highly correlated predictors (PCC
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Figure 4.2: PCC among performance measures. Each cell shows the PCC
for the corresponding measures, with colors varying from green (+1) to red
(1). Res denotes per residue and Prot per protein measures.
range 0.70.8) with different performances. Figure 4.5 shows a dendrogram of
predictors grouped by SOV. This SOV difference of correlated predictors is
mainly due to their selected decision threshold with residue scores remain-
ing similar. Three methods, FoldIndex, GlobPlot and DisEmbl-HL correlate
poorly with all others (PCC < 0.5) and also perform poorly on SOV. They
nevertheless define different disorder flavors, which may be useful in cer-
tain situations. IUPred-short and DisEmbl-465 have high correlation (>0.7
PCC) in conjunction with similarly high SOV, suggesting they detect the
same disordered regions well. For a consensus approach, however, it is more
interesting to combine, for example, Espritz-NMR/X-ray with DisEmbl-465,
as they have low correlation (PCC 0.5) and quality SOV. To investigate con-
sensus further, we measure agreement among predictors. Figure 4.6 shows
the residues split into three equal groups: consensus structure, consensus dis-
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Figure 4.3: Average ranking over all performance measures with statistical
tests. The predictors to the left and bottom are ranked with P-value separat-
ing groups (Welch t-test) in each cell. Colors for the left predictor range from
green (better) to red (worse), passing through white (tied). P-values >0.05
mean the performance distributions are similar and the difference between
two predictors is not statistically significant.
order and uncertain. Uncertain is defined when there is disorder agreement
for 47 predictors because the accuracy continually decreased below 61.2%
(see Supplementary Fig. S3). When there is confident agreement, accuracy
increases as expected, i.e. both tails of Supplementary Figure S3: 03 struc-
ture and 811 disorder agreement. In these regions, a consensus can recover
88.8 and 24.5% highly confident structured and disordered residues, respec-
tively. Applying a simple majority vote in analogy to secondary structure
[197] produced 43.3% sensitivity, 95.6% specificity and an AUC of 78.8 per
residue (see Table 4.2 for comparison).
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Figure 4.4: PCC among predictors. Each cell shows the PCC for the corre-
sponding measures with colors varying from green (+1) to red (1).
Figure 4.5: Dendogram for disorder residue score and performance using the
SOV measure. On the Y axis, the cumulative SOV score difference is plotted.
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Figure 4.6: Proportion of data that can be assigned confidently using a
consensus. The pie chart shows each of the 11 possible scenarios (i.e. from 0
to 11 disorder predictions) and the corresponding fraction of truly disordered
residues (in red). Each row corresponds to a situation (structure, uncertain,
disorder) for which the percentages of occurrence are summarized.
Uniprot versus PDB chains
The most surprising result is the large decrease in performance compared
with previously published performances. As most of the assessments in the
literature are based on PDB chains, we examine whether assessments on PDB
chains behave differently from UniProt sequences. Figure 4.7 shows the per-
residue AUC differences between the UniProt and PDB chain datasets. Most
predictors perform better on PDB chains and start approaching their pub-
lished values (e.g. ESpritz-X-ray AUC 86.58 on CASP9). This is possibly
due to the fact that predictor parameters are optimized on PDB chains. An-
other possible reason may be the positional dependence in PDB sequences,
i.e. missing atoms or disordered residues in solved structures are often lo-
cated at the N and C termini. This effect was recently noted for CASP-10
[184]. Given that most methods encode the sequence context (e.g. using
sliding windows in neural networks) they will implicitly learn the position of
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the termini. This information is lost when the PDB sequence is assigned to a
part, often the middle, of the UniProt sequence. Moreover, the definition is
different in UniProt because it is a majority combination of multiple exper-
imental sources. Supplementary Table S7 shows the full set of performance
measures on the PDB chain set.
Figure 4.7: Comparison between PDB chains and UniProt.
Sequence and structure variability
Fluctuations in performance given different protein properties are often over-
looked. To our knowledge, this has never been examined comprehensively.
In all cases, performance is assessed using SOV and there are indeed some
striking performance differences. Proteins are grouped into bins of low com-
plexity content (1% intervals), and the top five predictors are analyzed for
performance changes in Supplementary Figure S4. Increasing low complexity
content increases SOV logarithmically with the largest gains in the 520% low
complexity range. A similar concept was already investigated [192], suggest-
ing that disorder predictors are generally using low complexity patterns to
predict unstructured regions. At first glance, this seems to contradict Table
4.2, which shows SEG and Pfilt producing almost random predictions. It can
be explained by the fact that no low complexity regions were detected for
40.1% of the disordered proteins. From Supplementary Figure S4 it is clear
that low complexity has a significant relationship with disorder performance
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whenever present.
Disorder region length is perhaps the most obvious sequence property,
and the majority (75.8%) of sequences in our dataset contain at most 10
disordered residues (Supplementary Fig. S5). The performance separated
on this threshold is shown in Supplementary Tables S5 and S6. This skewed
distribution may not reflect the truth in nature, especially for long proteins
where long disordered regions may be missed owing to lack of evidence, but is
nevertheless interesting, as we are using a common disorder definition [184].
Figure 4.8 shows the performance of each method separated into two sets.
Proteins containing at least one long disorder stretch (i.e. >20 residues) or
not. Detection of disorder with long regions had a decreased performance in 5
of 11 methods, but 4 of these were the top ranked ones. Conversely, methods
trained to take into account long disorder (e.g. IUPred-long, Espritz-Disprot,
RONN and VSL2b) and the folding predictors (GlobPlot and Foldindex)
showed better performance on proteins with long disorder. This suggests
that the top-ranked methods can be improved by taking into account long
disorder regions in their training.
Figure 4.8: Comparison between predictors on long and short disorder pro-
teins.
Using CATH, 9378 proteins with disorder were extracted form the UniProt
set. Supplementary Figure S6 shows the performance of the top five meth-
ods on the four main CATH classes. The CATH few secondary structure
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class is predicted considerably below average. This could be due to the high
quantity of disorder in this class (Supplementary Fig. S7). Mainly alpha
structures are clearly easier to detect, perhaps due to alpha helices being
dependent on local sequence. Conversely, mainly beta structures are harder
to predict perhaps because beta sheet hydrogen bonds are dependent on dis-
tant residues. This difficulty in capturing distant sequential dependencies is
a common problem in secondary structure prediction [198] and likely also
true for disorder.
Functional variability
The top five predictor SOV performances for proteins with at least one disor-
dered residue are separated into the three GO classes [38]. Cellular Compo-
nent covers 3458 proteins, Biological Process 4696 and Molecular Function
5260. Figure 4.9 shows how SOV varies significantly for different cellular
component terms. Virion-related proteins have the most interesting perfor-
mance drop, probably due to an increased level of disorder in these proteins
(Supplementary Fig. S8). Perhaps more interestingly, performance for mem-
brane and extracellular proteins is generally lower than average, even though
the amount of disorder was not enriched (Supplementary Fig. S8). This
may be a consequence of disorder having different amino acid composition in
these proteins [199]. For GO Molecular Function (Supplementary Fig. S9),
binding and transporter activity are predicted well but the activity relation-
ships structural molecule and receptor have the lowest performance. Disorder
performance also varies with Biological Process (Supplementary Fig. S10).
Signaling and regulation were easier to predict while biological adhesion has
a glaringly poor performance. In each of the three GO classes, SOV perfor-
mance varies by up to 10% for different GO terms.
4.1.3 Discussion
Efficient disorder predictions are vital for understanding large collections of
proteins and entire proteomes. In this work, 11 predictors are evaluated on
25,833 UniProt sequences with disorder annotations from X-ray crystallo-
graphic structures. The evaluation procedure consists in measuring perfor-
mances using 12 different scores and ranking the predictors while highlighting
statistically similar groups. Although in some cases the disorder definition
used will not represent true functional mobility, we feel that it should cap-
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Figure 4.9: Relationship between GO cellular component and disorder per-
formance of top five predictors. All proteins had at least some disorder. GO
terms only considered if the number of proteins is >50.
ture most aspects of intrinsic disorder. The assumption is that in most cases,
missing backbone atoms in PDB structures correlate with intrinsic disorder
defined in DisProt [200]. Our definition is also arguably more stable because
it is based on a majority vote on all PDB structures covering a UniProt en-
try. Thus experimental errors in X-ray crystallography (e.g. missing residues
due to low resolution) should be removed, as disorder is only considered if it
occurs most frequently in the PDB.
The evaluation reveals a strong variability in predictors across the 12
measures, indicating different prediction styles (e.g. overprediction or confi-
dent underprediction). Ranking each predictor with the 12 measures shows
both DisEmbl-465 and IUPred-short performing consistently well on each
measure. The ranking was robust because the 12 measures show little cor-
relation (Fig. 4.2). Predictors that ranked poorly still contain a good signal
across our disorder definition. In most cases, they fall behind because they of-
fer a different interpretation, which may be useful in alternative settings. At
CASP, the best disorder predictors are widely known to be meta-predictors
combining orthogonal information (i.e. unique predictors performing well).
A correlation analysis on the predictors produced similar clusters as well
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as unique predictors. Some predictors showed both uniqueness and good
performance, indicating a consensus predictor may be beneficial. Using pre-
dictor combinations, 88.8% of structured and 24.5% of disordered residues
are found with highly confident agreement. The remaining 10.0% structured
and 34.2% disordered residues classified as uncertain may be decided with
more sophisticated heuristics (e.g. high residue scores).
Highly accurate predictors on UniProt sequences are vital, considering
that users are invariably trying to understand disorder properties of unan-
notated proteins and not the PDB, which is already annotated with quality
structural information. Despite this, the literature largely concentrates on
PDB chain assessments. The performance on the UniProt disorder defini-
tion is substantially lower than the equivalent evaluation on PDB chains. A
similar effect was recently noted in the CASP-10 assessment, where database
predictions were worse than the direct submissions by the same methods
[184]. In general, increases in PDB chains are observed across all measures
(Supplementary Table S7), suggesting that the prediction of the more desir-
able UniProt disorder may be worth considering for training new predictors.
There are large performance variations when splitting the data into groups
of proteins. As expected, predictors prefer large amounts of low sequence
complexity, but the performance seems to plateau after 20% low complex-
ity. On the other hand, long disorder detection seems to be more difficult,
especially for the predictors we find to be accurate. While both trends are
somewhat expected, the dependence of performance on structure and func-
tion are less obvious. At the structural level, beta-only proteins seem to
be more difficult to predict compared with alpha-only or mixed alpha/beta.
The few secondary structure class is certainly the poorest, but this may be
due to long disordered regions being poorly detected. Given that functional
disorder analysis using predictors is gaining attention [182] [201], prediction
error is shown relative to GO. The analysis shows that the average error rate
is not universal across all functions. It is possible that enriched functions
found in genome analysis may have a slight bias. For example, the associa-
tion with disorder and binding, signaling and regulation is known, but here
we found that they are more easily detected, possibly inferring enrichment.
Compared with virion sequences, which are more abundant in experimental
disorder (Supplementary Fig. S8) and supported by the literature [201], the
error rates on their predictions are higher than average. One of the main rea-
sons for performance variation could be the distribution of protein types in
predictor training sets. Binding, signalling and regulation proteins together
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constitute a large fraction of known disorder datasets, and it is reasonable to
assume that the same distributions are used in each predictor. It is therefore
possible that predictors are optimized for these common families. Optimisti-
cally, the use of this prior knowledge could enhance predictor training or
motivate the development of specific tools.
To our knowledge, this is not only the first large scale analysis of disorder pre-
dictions from X-ray crystallographic structures but also the first attempt to
provide error rates on sequence, structure and functional protein types. We
are in the process of developing this evaluation into an automatic evaluation
server and plan to integrate it in the new version of MobiDB [189].
4.2 Experimentally determined long intrinsi-
cally disordered regions in proteins are
now abundant in the Protein Data Bank
Despite a recent consensus regarding the existence of intrinsic disorder in
proteins[43], its classification is still quite ambiguous[202]. As a result,
various flavors of disorder have been proposed, some based on amino acid
composition[167], flexibility[168] and functional roles coupled with conserva-
tion[169]. Perhaps the simplest distinction is between proteins with short and
long disordered regions. Proteins with long disorder regions (LDRs) are spe-
cial, since they seem to behave differently in function[182] and evolution[203].
Structurally, disorder can range from regions that in solution are totally un-
folded to those that present two or more different, but defined, conformations.
Unfortunately, in an x-ray crystal structure the two cases are often difficult
to distinguish, in particular at low or medium resolution. In fact, if in a
structure at resolution better than 1.5 A˚ it is in general possible to observe
loops or short areas present in two (sometimes three) different conformations,
at lower resolution this is generally not the case as these areas are not visible
in the electron density map. Consequently, the corresponding residues are
left out from the molecular model. In the rest of the chapter, portions of the
polypeptide chain that were present in the protein which has been crystal-
lized but are absent from the crystal structure will be generally defined as
disordered, without any attempt to distinguish between disordered, flexible
or mobile regions. On the contrary, regions characterized by very high ther-
mal parameters, generally an indication of flexibility, will not be taken into
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account here, but will be left for future developments. As different crystal
structures of the same protein may contain varying amounts of disorder, a
clear definition is necessary. Here, we use two different rules. In the first,
called majority rule, a segment is considered LDR if it is disordered for at
least 30 residues in the majority of the crystal structures of the same polypep-
tide chain. The second, defined zero rule, applies to the subset of majority
cases where only disorder is present for a given LDR. Figure 4.10 shows an
example of the difference 2 between both rules. In total, extraction with the
majority rule removing sequence pairs above 40% identity from MobiDB[189]
provided 1,758 unique proteins with at least one LDR (Table 4.4 for dataset
composition). Of these, 1,567 are confirmed with the stricter zero rule and
717 have a single Protein Data Bank (PDB)[171] entry. The percentage of
disorder in this dataset (13.2%) is higher by design than other datasets. The
fraction of absent residues (28.3%) could harbour a further source of LDRs
resisting crystallization, making our dataset a lower estimate for disorder.
Table 4.4: Dataset composition. The number of proteins, residues and
LDRs is shown for both the long disorder dataset from x-ray sources in Mo-
biDB and a set of completely structured proteins extracted for comparison.
Residues are unknown if there is no PDB structure assigned to those residues
in the UniProt entry. More than one LDR per protein may be present. Max-
imum pairwise sequence identity in both sets is 40
One possible factor contributing to LDRs could be the resolution of the
x-ray experiments (see Figure 4.11). As resolution increases, the length of
the disordered regions decreases slightly on average. Lower resolution seems
to favor the presence of LDRs or, more likely, the presence of LDRs in the
protein decreases the diffracting power of the crystal, reducing resolution.
The deposition dates for the PDB structures used in the dataset (see Figure
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Figure 4.10: Example of the alternative majority and zero rule LDR def-
initions on the same protein with one Pfam domain and numerous x-ray
structures shown by PDB code. Each line corresponds to a disorder anno-
tation. Notice how the C-terminus is always disordered, while the first half
has some x-ray structures suggesting order
4.12) shows that most LDR structures have been deposited in the last five
years, suggesting that the dataset will automatically increase over the next
years.
The distribution of proteins grouped by their largest LDR is shown in
Figure 4.13, with DisProt[200] and IDEAL[204] for comparison, showing an
exponential decay with increasing length. 94.4% have at least one region
between 30-119 amino acids and this decrease is consistent with IDEAL and
DisProt. The 99 proteins with extreme LDRs (up to 500 amino acids) are a
very unusual part of the PDB. Although each protein may contain more than
one LDR, one region is the norm (1,587 proteins), with two being somewhat
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Figure 4.11: Disordered region length as a function of x-ray resolution. The
box plot show median (dark bar) and upper/lower quartiles as box bound-
aries, with the 1.5x interquartile range as dashed lines. Outliers are not
shown for clarity. Each bin is statistically different(Wilcoxon test, p-value <
0.05) than the others, with exception of the two groups marked with a and
b.
common (157 proteins) but only rarely up to four. Somewhat unexpectedly,
the majority of LDRs (52%) are not at the commonly flexible N and C ter-
mini (see Figure 4.14).
The collected data is more abundant than LDR proteins in the DisProt
and IDEAL databases. While all three are derived from experimental sources,
this dataset is over three times bigger than DisProt and over 14 times IDEAL
(see Figure 4.15), with only small intersections of similar proteins. Combin-
ing the three sets will allow the construction of a larger set of 2,079 unique
proteins. Our data does not replace the excellent work of IDEAL and Disprot,
but rather offers a much larger complementary experimental LDR source.
While some of the LDRs may be the result of poor diffraction qual-
ity, it is now well established that the majority of them have functional
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Figure 4.12: Deposition dates of the PDB structures from the LDR set. The
first LDR structure was deposited in 1990. Notice that 2014 is lower because
it was analyzed with data from July 2014 and there still may be proteins
deposited in 2013 on hold in the PDB.
roles[43, 202, 200, 205, 170]. To further support this, Supplementary Table
2 shows that among the 33 proteins with unusual LDRs (≥ 200 residues), 20
have literature defining the region to be disordered or unstructured, 4 men-
tion disorder but not for a particular region, 5 were missing possibly to help
crystallization, whilst for the remaining 4 no specific reasons are mentioned.
Even the largest LDRs in x-ray structures are likely due not to specific or
accidental 3 experimental conditions, but to functional disorder, yielding a
dataset of the highest available quality.
The size of the dataset allows function and domain enrichments to be cal-
culated (Figure 4.16,4.17,4.18). Intrinsically disordered regions do not have
the same structural constraints as globular regions and are likely to evolve
more rapidly[206], making functional domain assignments difficult at the se-
quence level. In Pfam (version 27.0), 5.6% of the sequence residues in the
database were in predicted disordered regions of 50 amino acids or more[40].
Previous observations based on predictions showed a substantially increased
number of disordered residues when domain assignment is missing[202]. In
69% (1,338/1,945) of the cases there is no Pfam domain assignment inside
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Figure 4.13: Length distribution of the disorder regions found in the LDR set
and the DisProt and IDEAL databases of manually curated disorder. The
data is grouped in bins of ten residues.
LDRs. This absence was recently noted for predicted residues[202], but here
the ratios are confirmed on experimental LDRs. There are 611 Pfam domains
located in LDRs, with no clear trend about the type. The most frequent do-
main associated to LDRs is the LacI domain, with only 9 hits. At the Pfam
clan level (i.e.superfamilies), only a slight consensus emerges with the most
frequent being helix-turn-helix (25hits).
To analyze functional enrichment, the completely structured proteins are
compared to LDRs separately for the three Gene Ontology (GO) classes[207].
The three most enriched terms in molecular functions of LDR proteins are
protein binding, carbohydrate derivative binding and receptor activity. The
terms catalytic, oxidoreductase activity and cofactor binding, common in
highly structured enzymes, are instead largely absent in LDRs. Although
DNA/RNA binding is commonly considered prevalent in disorder, it is less
represented in the LDR set. Proteins binding DNA or RNA are generally
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Figure 4.14: Distribution of LDRs between N- and Ctermini and the middle
of the protein.
Figure 4.15: Venn diagram showing the overlap between the LDR dataset
and the DisProt and IDEAL databases of manually curated disorder.
crystallized with bound nucleotides, which stabilize the folded conforma-
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tion.Chromatin binding, which is a related DNA/RNA binding term, is how-
ever significantly involved in LDRs. In terms of biological processes, LDR
proteins are practically absent in metabolism, but are instead enriched in bio-
genesis, organization and regulation. Finally, for cellular components, protein
complex, membrane-enclosed lumen and its child term organelle lumen are
enriched in LDRs. In summary, many GO terms previously associated with
disorder have been confirmed[182, 208, 209] e.g.binding and regulation.
We found 1,758 diverse LDR protein sequences from missing backbone atoms
in x-ray structures.In case of relatively short regions, the missing electron
density is often a consequence of alternative conformations in highly flexible
areas, whilst for very long regions it most likely corresponds to unstructured
portions of the polypeptide chain. The use of x-ray crystal structure in this
study deserves a specific comment, since it is empirically well known that
macromolecules with long flexible parts will tend to resist crystallization. It
is common practice among crystallographers to produce different constructs
of the same protein in order to reduce the flexible portions and, in doing
so, favor crystal growth. In this sense, we would expect that our analysis
underestimates the 4 fraction of disordered regions present in the protein
world. Most likely a larger fraction of disorder is present in the proteins that
have not been crystallized yet. Most of the collective conclusions regarding
long (and short) disordered regions have until now been based on predictions.
One of the main reasons for developing computational approaches was the
scarcity of experimental data to make hypotheses. Despite this, predictors
have given some interesting hypotheses with respect to LDRs, such as a func-
tional analysis in full proteomes [182] and biological processes[210].However,
although predictors have good accuracy and can generate large quantities of
data, they still contain systematic errors. For instance, on LDR proteins the
predictor ESpritz[211] achieves 54.3% sensitivity and 91.2% specificity, while
IUPred-long[172] produces a 38.9/93.6% sensitivity/specificity. While both
prove a performance considerably above random, nevertheless substantial er-
rors remain. Our experimental LDR set is also significantly different from
the currently available curated databases DisProt and IDEAL.It is important
to stress that our data are not simply PDB entries, but rather multiple x-ray
experiments assigned to frequently multi-domain UniProt sequences. Differ-
ent x-ray experiments may be assigned to the same sequence with the final
disorder/structure decision based either on majority evidence or complete
lack of structure. This should produce a more stable definition since it will
remove noise, e.g. missing residues arising from low resolution data or not
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well refined crystal structures. The majority definition also includes folding
upon binding events (mixtures of disorder and structure), but we found these
to be a rare occurrence as shown by the comparatively small difference (ca.
10%) between both definitions. However, more work is required to generalize
the domains further, for example classifying them as wobbly domains or not.
For a good example of a wobbly domain see Glutamine-tRNA ligase[212]
from D.radiodurans (UniProt entry P56926) in our data set. It must also be
considered that the presence of a domain whose orientation is flexible with
respect to the rest of the protein may have two effects. One is to drastically
reduce the probability of growing suitable crystals, the other is that the po-
sition of the wobbly domain becomes artificially frozen by the crystallization
process, hampering its identification in the structure. Finally, for the first
time a large dataset of diverse LDR proteins are available for new predic-
tion techniques. Training a novel predictor on this large amount of quality
data using state-of-the-art machine learning algorithms can only enhance our
understanding of the phenomenon. We have provided the first attempt at
functionally classifying experimental LDRs. A clearer picture will emerge as
more x-ray structures are deposited each year in the PDB and annotated in
our LDR collection as part of MobiDB[189].
4.2.1 Methods
Long disorder data and clustering
UniProt[25] sequences with at least one x-ray annotation in MobiDB[189]
were downloaded in July 2014 producing a list of 25,833 entries. Two strate-
gies were used to define disorder. In the first majority rule, where more
than one MobiDB annotation was available, a majority vote was used, with
structure preferred if equal (see Figure 4.104.114.12). The second zero rule is
more restrictive and considers the subset of majority rule regions where only
disorder and no structure can be found. Proteins were extracted if there was
at least one long disordered region ≥ 30 amino acids. Where MobiDB cannot
find annotation for part of the UniProt sequence, residues are annotated as
unknown. All proteins with long disorder were forced to be non-redundant
using BLASTClust[213] with less than 40% pairwise sequence identity and
70% coverage. Long disordered regions of at least 30 residues from DisProt
release 6.02[200] and IDEAL available in July 2014[204] were used for com-
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Figure 4.16: Enrichment plot for Molecular Function GO terms.
parison. The same majority rule was applied for IDEAL on their disorder
definitions, with tags disorder and high rmsd used for disordered residues.
Sequences between the three sets were considered overlapping with at least
90% sequence identity and 90% coverage using BLASTClust. The data can
be accessed online from URL: http://mobidb.bio.unipd.it/long.
Pfam and function
Only high quality Pfam-A annotations were used for domain annotations.
Disordered regions having an overlap of at least 50% of residues with a Pfam
domain were considered hits (see Figure 4.104.114.12 for some examples).
Functional enrichment was calculated for the first two levels of the Gene
Ontology (GO)[207] graph as available in March 2014. Fishers exact sta-
tistical tests were carried out for the enrichment analysis using the positive
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Figure 4.17: Enrichment plot for Biological Process GO terms.
set defined above and a non-redundant set of 4,391 UniProt entries with no
disorder. A function was considered enriched if the p-value with Bonferroni
correction was outside the 95% confidence interval of the mean.
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Figure 4.18: Enrichment plot for Cellular Component GO terms. Terms
enriched in LDR are > 0, while terms enriched in structure are < 0. Only
statistical significant enrichments (Fisher test with Bonferroni correction, p-
value < 0.05).
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Chapter 5
Evaluating the Impact of a
Genetic Mutation
The rapid growth of unannotated missense variants poses challenges requir-
ing novel strategies for their interpretation. From the thermodynamic point
of view, amino acid changes can lead to a variation in the internal energy of
a protein and induce structural rearrangements. This is of great relevance
for the study of diseases. In section 5.1 I introduce NeEMO, a tool for the
evaluation of stability changes using an effective representation of proteins
based on residue interaction networks (RINs). RINs are used to extract useful
features describing interactions of the mutant amino acid with its structural
environment. Benchmarking shows NeEMO to be very effective, allowing
reliable predictions in different parts of the protein such as β-strands and
buried residues. The ability to predict the impact of a mutation can be very
important also for disease prediction. As an example, the Critical Assessment
of Genome Interpretation (CAGI) is a scientific challenge that aims to assess
the state-of-the-art of genetic variants analysis for disease risk prediction. As
a successful participant of CAGI, in section 5.2 I report the methodologies
that were proposed to estimate Crohn’s disease probability in human sam-
ples where genetic data was provided. In addition to the analysis of known
disease genes, I considered variants in the context of protein-protein inter-
action networks. The idea of guilty by association was the main diver of
this strategy: the degradation of disease pathway is probably exacerbated by
an accumulation of variants in its network. Despite the good performance
of the method in CAGI datasets, more research has to be done to achieve
confidently clinical needs in the general case. However, there are simpler
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phenotypes where the genetic background is well understood. Section 5.3
introduces BOOGIE, a tool for the annotation of all known blood groups,
like ABO and Rh, from DNA sequences. This has the potential to improve
healthcare, improving detection of rare blood types and avoiding common
blood typization errors. The simplicity of the method serves as a proof-of-
principle about the potential application of genetic testing. In fact, BOOGIE
can be easily extended to predict other genetically encoded phenotypic traits
for personalized medicine.
Genetic factors are not sufficient to explain disease. Protein-protein interac-
tions play a central role as well. In section 5.4 I introduce a Petri network
designed to model pVHL functional pathways. The germline inactivation
of this protein cause the Von Hippel-Lindau (VHL) syndrome, a condition
predisposing to the development of cancer. The model was built using func-
tional information derived from the literature, and demonstrated the ability
to reproduce VHL syndrome at the molecular level. The reliability of the
Petri Network model also allowed in silico knockout experiments, useful to
simulate the evolution of a disease.
To conclude, there are many problems related to phenotypes and disease.
With NeEMO, I tried to look at the impact of variants at the single mutation
level. This works well for Mendelian traits, as shown in the context of blood
groups. In the case of complex cases like Crohn’s disease, protein-protein
interactions has to be modeled, and Petri networks can be an effective tool.
Big challenges are still unsolved in the phenotype prediction field, but the
development of new computational approaches exploiting protein interaction
networks seem a good direction to interpret complex disease datasets.
5.1 NeEMO: A Method Using Residue Inter-
action Networks to Improve Prediction of
Protein Stability upon Mutation1
The development of Next Generation Sequencing technologies has a tremen-
dous impact on the discovery of missense variants. In humans, dbSNP [3]
1The results of this chapter have been published in Giollo, M., Martin, A. J., Walsh, I.,
Ferrari, C., Tosatto, S. C. (2014). NeEMO: a method using residue interaction networks
to improve prediction of protein stability upon mutation. BMC genomics, 15(Suppl 4),
S7. For Supplementary Material, check the online version of the paper.
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reports more than one million such variants, while only 1% of them have
functional annotation or are referenced in the literature. This gap represents
a problem for understanding disease development [214], as the proper char-
acterization of variant effects may require expensive experiments. This is
not only important for healthcare, but also for biotechnology, where alanine-
scanning mutagenesis is commonly used to study the effect of amino acid
variants on protein function and interactions [215]. Finally, designing mu-
tants for protein design [216] and to evaluate their effects on function re-
quires a deeper understanding of the mechanisms by which single variants
affect stability. The Gibbs free energy (∆G) defines the thermodynamic en-
ergy of folding compared to the denatured state. The difference between wild
type and mutant polypeptide energy (∆∆G = ∆Gwt - ∆Gmut) is a measure
of how the amino acid change affects protein stability. Polypeptide chains
are held together by non-covalent interactions between the residues forming
them. The most relevant factors affecting protein folding and stability are
hydrogen bonds, van der Waals, electrostatic and hydrophobic interactions,
backbone angle preferences and protein chain entropy [217]. Interestingly, the
assessment of stability changes has been shown to be critical for the inter-
pretation of variants in key proteins like TP53 [218], which is known to have
a strong connection with cancer development. In order to help understand
the impact of amino acid changes, the ProTherm database [44] collects the
free Gibbs energy for thousands wild type and mutant proteins. This source
of information is critical for the development of new methods that try to fill
the gap of unannotated variants. For the last 15 years, a number of compu-
tational tools have been developed for the prediction of stability changes in
mutant proteins. Energy-based methods are based on two main approaches
[219]. The first type is based on the use of molecular (or quantum mechanic)
force fields that try to reflect the physical energy of molecules [220] [221]. The
second type, also known as knowledge-based potential functions (KBPFs),
are energy functions based on statistics computed on sets of experimental
or artificially generated protein structures. Most KBPFs rely on a weighted
combination of several statistical terms, as in Eris [222] or FoldX [223]. In
particular, the latter considers nine different terms like van-der-Waals con-
tributions, solvation energy, hydrogen bonds and the entropy cost. All terms
are linearly combined after fitting to experimental data [223].
A completely different approach is adopted by machine learning algorithms
(ML). Rather than trying to explicitly describe complex models of thermo-
dynamic energy, they are trained by minimizing the classification error on a
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reference dataset. A number of ML tools have been proposed for stability
prediction of variants, like AutoMute [224], I-Mutant [33] [225], MuPro [226]
and PoPMuSiC 2.0 [227]. Most of these simulate the change by replacing the
side chain of the mutated residue, disregarding possible structural rearrange-
ments in the backbone. As an example, I-Mutant 2.0 [33] represents variants
as a vector with 42 dimensions: two for pH and temperature, 20 for encoding
the wild-type and mutant residues, and 20 to describe the residue frequency
in the environment surrounding the amino acid. Similarly, two versions of
MuPro [226] use vectors with 140 elements to encode the residue in a slid-
ing window that considers 3 positions on the left and right of the mutant
amino acid. Both methods trained a Support Vector Machine for classifica-
tion and regression purposes with the radial basis function kernel [228]. This
is a general trend of ML-based approaches for stability prediction: non-linear
functions are preferred due to their increased ability to detect patterns in the
data, leading to better performance. In addition, all methods try to encode
explicitly information about the protein of interest using either structure
or sequence information. Both information can be described effectively us-
ing residue-residue interaction networks (RINs), as suggested by RING [35].
RINs are a graph description of protein structures where nodes represent
amino acids and edges represent different types of physico-chemical bonds
(e.g. hydrogen bonds, salt bridges, hydrophobic contacts). Using RINs can
be of interest for stability estimation due to their implicit detailed repre-
sentation of different chemical interactions in proteins. These interactions
play a central role for the internal folding energy, so they may introduce new
discriminative variables for the analysis of mutants [229]. Using this insight,
in our work we trained a non-linear neural network for the prediction of sta-
bility changes based on RINs. We will show that using this effective protein
representation there is an improvement in the prediction of protein stability.
We believe that NeEMO can contribute significantly for the characteriza-
tion of un-annotated missense variants and for protein mutagenesis studies,
increasing the knowledge in this challenging field.
5.1.1 Methods
Dataset
For machine learning methods, the construction of a dataset is a critical pro-
cess requiring a meticulous selection and curation of the starting data. The
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ProTherm database [44] represents a reference dataset describing the effects
of amino acid mutations in terms of thermodynamic energy changes, cur-
rently containing information on 647 different proteins. Roughly one third of
the 22,713 entries represent the Gibbs free energy of the wild type protein,
while the reminder report the ∆G of a mutant. It is clear that there is a
remarkable redundancy of information that needs to be managed. Here, we
decided to focus on the curated version of ProTherm used to train PoPMu-
SiC 2.0 [227]. In order to avoid bias, we evaluated sequence similarity on
the 131 proteins of this training dataset. Using PANADA [230], clustering
at 90% and 40% identical sequences produces 129 and 119 different clusters
respectively. In particular, none of these clusters had more than three se-
quences in it. This high diversity is therefore a key factor for the machine
learning procedure, as it is likely to provide an effective estimation of the
data model.
This dataset is particularly informative because it corrects misinterpretations
of the original papers and considers only single-site protein variants with
known structures that are meaningful for mutation prediction. It should be
noted that none of the variants involves either prolines or mutations that
destabilise the structure by more than 5 kcal/mol, as these variants tend to
alter protein folding significantly. Due to limitations of RING [35] for the
management of PDB files with multiple chains, we focused on 113 proteins
and 2,399 mutations. Figure 5.1 shows the training set ∆∆G distribution,
highlighting how destabilizing variants are the most frequent ones and prov-
ing that the filtering procedure preserves the correct data distribution.
To perform additional tests, we created a second dataset (IM 631) from
the training data used in MuPro [226] and I-Mutant [225], containing 631
new mutations in 30 different proteins, to be used as independent samples
providing indication of overfitting. The dataset distribution is quite differ-
ent from the PoPMuSiC data (Supplementary Figure S1), especially in the
frequency of highly destabilizing variants (∆∆G > 5 kcal/mol). The latter
dataset explicitly removed strong mutants likely to yield significant changes
to the protein structure, which may represent a threat during the learning
process. On the other hand, the IM 631 dataset collects real variants with
no prior filtering, so these mutations can be used to evaluate NeEMO with-
out bias. Last but not least, the S350 dataset contains further mutations
which are typically used to compare the performances of different methods
[227]. This data will be considered to obtain a fair comparison of NeEMO
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Figure 5.1: ∆∆G distribution on the training set.
performance with other stability prediction tools.
Relevant features
Our objective is to investigate how useful RINs are in the context of sta-
bility prediction. RINs are potentially interesting because they can be used
to detect informative amino-acids in a target protein using standard graph
algorithms like Dijkstra’s shortest path or PageRank [231]. These networks
have been generated by RING [35] with default parameters, i.e. closest atom
networks where interactions are reported for residues that have atoms at less
than 5 A˚. There are four main features that we obtain with this tool, which
will be briefly described in the following. For a more detailed description of
the features see Supplementary Table S1.
Evolutionary information: The overall idea is that evolutionary informa-
tion can discriminate key residues in the protein, either for stability or func-
tional reasons. NeEMO considers conservation, Mutual Information and its
correction Average Cluster Purity as a feature for stability prediction. These
values are generated by RING, which generates a multiple sequence alignment
using PSI-BLAST [232] on the UniRef90 sequence database and computes
several measures reflecting evolutionary information of each residue.
5.1. PROTEIN STABILITY PREDICTION 107
Residue conformational propensities: The impact of variants strongly
depends on the local environment of each residue in the structure. Classical
tools for the evaluation of protein structures can highlight residues with high
structural constraints that should not be mutated. In the current implemen-
tation, RING uses TAP [86], FRST [82], and QMEAN [233] to estimate the
amino acid energy contribution. In particular, these tools evaluate statistical
potentials such as all atom distance-dependent pairwise, torsion angle, and
solvation potentials. All these numerical terms are included in NeEMO for
an accurate description of the mutant context.
Amino acid information: The wild type, the mutant and its two adja-
cent residues in the sequence (left and right) are used to describe protein
changes. One-hot encoding is used to represent the sequence information, as
it was previously shown to be effective [181]. I.e. the 20 standard residues
r, i ∈ {1, ..., 20} are translated into a 20-dimensional vector where the i-th
element is 1, and the others are 0. In addition, secondary structure and rel-
ative solvent accessibility (RSA) defined by DSSP [30] are used to describe
the local context.
Network topology: Using RING it is possible to distinguish between H-
bond, inter-atomic contacts, pi-cation, pi-pi stacks, salt bridges and the atoms
involved in these interactions [35]. The standard node parameters described
in NetworkAnalyzer [234] are computed on that information and used to
describe the mutant and its sequence neighbor (left and right) for stability
prediction. Centralities are computed by considering multiple sub-network
that consider a single chemical bond at a time. In addition, the network size
and frequency of each amino acid type in contact with the mutation position
in the RIN were also counted. Neighboring residues are defined as those
which have any atom at ≤ 5 A˚ to any of the atoms from the other residue.
The overall idea is to comprehensively assess the network connections, and
measure if the mutant is central in the protein graph topology. This informa-
tion was critically discriminative in previous work [225] [229], so we expect
it to be also effective in the context of stability prediction.
Last but not least, pH and temperature are considered during the predic-
tion. All information is stored in 184 dimensional vectors for each mutation.
Almost half of the features are needed to describe amino acid information,
due to the one-hot encoding sparsity with 20 descriptors for every residue.
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Training
Using the encoding described in the previous section, the 2,399 examples were
transformed in vectors for training a three-level neural network, with the goal
to predict variant ∆∆G values. As shown in Figure 5.2, the input layer uses
RIN information, a single hidden layer is used for non-linear projection of the
input data, and a third level is used to estimate the mutation effect in terms
of thermodynamic energy. After initial assessment, 5 hidden layer neurons
were found sufficient to encode the model data, meaning that the neural
network was able to detect a limited number of patterns during the training
process which can effectively explain the mutations impact on stability. We
used 10 fold cross-validation as implemented in WEKA [235] to estimate
the method parameters, i.e. the dataset was randomly split into 10 parts,
where 9 were used to train the model and the tenth used as test set. To
increase the robustness of the method, 15% of the training data were used
as a validation set. During model optimization, the training is stopped once
the performance on the validation set does not improve for five iterations.
All starting features have non-zero coefficients, so we expect them to be
relevant for the final prediction. Three different neural networks we trained.
NeEMO uses all 184 features. NeEMO NOCC does not use network topology
and centrality information. Finally, NeEMO NORING uses only amino acid
information, pH, temperature, conservation, QMEAN potential and protein
length.
Performance measures
Several regression and classification measures are computed for a detailed
comparison of NeEMO with other methods. Real value ∆∆G predictions
are evaluated using standard Pearson correlation r:
r =
∑
(xi − x¯)(yi − y¯)√∑
(xi − x¯)2
∑
(yi − y¯)2
where x and y represent the real and the predicted energy value. The correla-
tion of the actual ∆∆G ranking is measured against a ranking order induced
by the predictions using Kendall’s tau (τ) and Spearman rank (ρ), reporting
how predictors differentiate smaller stability changes from bigger ones. Both
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Figure 5.2: Representation of the NeEMO pipeline. The 3D structure of
a protein is transformed into a RIN. Node centralities are then computed
and combined with other RIN features, such as secondary structure, relative
solvent accessibility and sequence conservation. All numerical descriptors
are then fed into a neural network that predicts the ∆∆G for the chosen
mutation.
statistics are calculated as follow:
ρ =
∑
(r(xi)− r(x¯))(r(yi)− r(y¯))√∑
(r(xi)− r(x¯))2
∑
(r(yi)− r(y¯))2
τ =
CP −DP
0.5n(n− 1)
where ρ is identical to Pearson correlation applied to the rank of the predic-
tions, while τ accounts for the number of prediction pairs having correct order
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(CP) or wrong order (DP) with respect to the real ∆∆G for the n dataset ex-
amples. Finally, the standard error σ is used to report the expected distance
of the prediction from the real ∆∆G of the mutation.
Termophile case study
As an additional test, we consider ten pairs of mesophilic proteins with
their termophilic counterparts presented in [236]. In order to compare the
stability changes with NeEMO, each sequence pair was first aligned using
the Needleman-Wunsch algorithm from the EMBOSS package [237]. The
NeEMO energy was then calculated for each aligned residue pair from the
mesophilic to thermophilic mutation (MtoT) and vice versa (TtoM). Table
5.1 lists the 10 pairs of protein structures, their similarity and the pH and
temperature at which the ∆∆G was predicted.
Table 5.1: Summary of the 10 pairs of mesophilic and thermophilic proteins
used in the case study, their similarity and the environmental conditions (pH
and Temperature) used to perform the test [236].
5.1.2 Results
We developed NeEMO, a machine learning method that uses RIN informa-
tion, to evaluate the impact of amino acid changes in protein stability. Using
a curated ProTherm dataset, 10-fold cross validation was used for training
and performance evaluation. Finally, the tool is tested on two independent
sets of protein variants, providing an unbiased evaluation of its reliability
and a fair comparison with other methods.
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Training and cross-validation
NeEMO was trained on a large dataset previously used by PoPMuSiC 2.0
[227]. The results of 10-fold cross validation on this dataset are shown to-
gether with a preliminary comparison to other methods in Table 5.2. Our goal
was to assess if the features and the mathematical model of our method are
able to fit effectively into the traning data. Several state-of-the-art methods
were used, namely Auto-Mute, I-Mutant 2.0 and 3.0, MuPro and PoPMu-
SiC 2.0. The comparison was not straightforward, as most predictors were
occasionally not able to make a prediction for some variants due to their
inability to manage certain PDB files. We decided to compare NeEMO only
on the mutations where all tools were executed successfully. In many cases
the variants of this test set are part of the training dataset of other methods.
For this reason, this performance comparison cannot be considered unbiased,
and therefore it is just a mean to measure if the fitting procedure is as good
as the one used on other methods. As shown in Table 2, NeEMO performs
consistently well compared to other state-of-the-art tools. Auto-Mute is the
only method providing comparable results, but seems very poor in the input
and mutation management, as the method cannot make a reliable prediction
for half of the examples (e.g. NMR solved proteins, or in case if atoms with
repeated coordinate sets). In view of the good performance in the cross-
validation, we expect that the fitting process was overall good.
Table 5.2: Regression performance comparison of NeEMO with other meth-
ods on the ten-fold cross-validation test. The evaluation is performed only on
mutations where both methods were able to make a prediction. In addition,
the other methods are likely to have used the test samples in their training.
Interestingly, it seems that NeEMO performs particularly well for amino-
acids on β strands (Supplementary Table S3). This improvement is of partic-
ular interest, as it suggests that our method can capture and model accurately
long range interactions that typically occur in these secondary structures. In
112 CHAPTER 5. GENETIC MUTATIONS
addition, performance on buried residues and on coils (see Supplementary
Tables S4 and S6) indicate that the method performs very well compared
to other methods, confirming that network topology contributes significantly
to a proper description of the local amino acid context. On the other hand,
NeEMO performance for α helices and exposed residues (Supplementary Ta-
bles S2 and S5) are comparable to other methods. As a results, we believe
that the training process was successful, suggesting that chosen features and
neural networks are a good model of the data.
NeEMO in-depth analysis
In order to test the contribution of the 184 mutation descriptors, we compare
the performance of NeEMO, NeEMO NOCC and NeEMO NORING on the
IM 631 dataset. As can be seen in Figure 5.3, NeEMO regression has a steep
slope that confirms the effectiveness of the training. NeEMO NOCC and
NeEMO NORING decrease performance (Supplementary Figure S2), show-
ing larger errors for mutations producing a higher stability increase. As
expected, the quality of the ∆∆G estimation decreases when less informa-
tion is provided, suggesting the need of RIN data for good predictions.
To study how performance varies for mutations in different conditions, we
divided the cross-validation test set into subsets containing only mutations
in each of the three secondary structure states (α, β, coil) and computed
the class-specific performance (see Table 5.3). While mutations on α helices
show a similar performance compared to the entire dataset, larger differences
are found for mutations in β-strands and coils. The correlation for mutations
in β-strands is much higher than for any other subset, while performance on
mutations occurring in coils shows the lowest results. This was expected,
because coil residues tend to be on the surface of globular proteins. Having
a tendency towards mobility, they are believed to be regions where unfold-
ing begins. Increased coil mobility facilitates solvent exposure, leading to
a reduced number of interactions and hence a lower contribution in RINs.
Table 3 shows a similar result for solvent exposed (E, RSA > 25%) and
buried (B, RSA ≤ 25%) mutations. In this case, despite NeEMO working
better on buried mutations, the difference is less marked. This suggests that
secondary structure context is probably the most important feature for sta-
bility prediction upon mutations. Last but not least, use of RING network
information significantly improves prediction quality in all experiments. On
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Figure 5.3: Regression results of NeEMO versions on the training set.
the IM 631 dataset the r, ρ and τ correlations are 0.63, 0.60 and 0.43 re-
spectively. Considering how the dataset contains unseen mutations, a small
drop in performance is expected. It shows that there is no overfitting, and
that our network features describe the effect on stability of single amino acid
variants. We expect that NeEMO can also perform well in other datasets
with very different proteins.
Comparison with other methods
We compare the performance of NeEMO with several state-of-the-art meth-
ods, namely MuPro [226], two versions of I-Mutant [33], [225], PoPMuSiC
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Table 5.3: Left: Correlation measure performance of different NeEMO ver-
sions on the IM 631 dataset. NeEMO uses all input features, NeEMO NOCC
does not use node centralities, NeEMO NORING does not use any RIN fea-
ture. Comparisons are shown for the entire dataset, on each of the 3 different
secondary structure states and occurring in amino acids exposed to the sol-
vent (e, RSA > 25%) or buried (b, RSA ≤ 25%). Right: Performance of
different methods on the independent S350 dataset. The comparison is re-
ported (a) for all the mutations in the dataset, (b) the maximal subset of
mutations where each tool is able to make a prediction and (c) the maximal
subset where 10% of outliers are removed. The number of mutations (n) is
shown together with the Pearson correlation (r) and distance from the real
∆∆G values (σ). The best prediction in each column is shown in bold.
1.0 and 2.0 [238][227], Automute [224], Eris [239], CUPSAT [240] and Dmu-
tant [241]. In order to provide an unbiased evaluation of effectiveness, the
S350 dataset [227] was used, as it contains mutations unseen to each method.
NeEMO was re-trained in order to exclude examples that overlap with the
training set. Performance in Table 5.3, are reported (a) for all the mutations
that a single tool can evaluate, (b) for the maximal set of 299 mutations
where all predictors are able to make a prediction and (c) for the maximal
dataset where we additionally remove 10% of the outliers (leading to 264
mutations). In the latter dataset, outliers are selected automatically for each
method as those having the largest residuals in the regression of predicted-
observed ∆∆G values. As can be seen, performance clearly suggests that
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NeEMO is able to outperform most methods, proving the validity of the
training strategy and the strong impact of using residue-residue interaction
network data as a tool to study the mutation impact on protein stability.
PopMusic2.0 is the only tool with comparable performance, but the unbi-
ased cross validation correlation shown in Table 2 suggests that NeEMO is
considerably better on a larger set. The comparison is suitable as both meth-
ods trained on exactly the same dataset, so it should give a fair comparison
of the predictors. It is also interesting to note that the NeEMO performance
is basically the same in both the S350 and cross validation sets, while PoP-
Music2.0 has a drop in performance. NeEMO is overall reliable and shows a
very good performance on different structure types, like β strands or buried
residues (data not shown). RINs seem a clear contribution for the ∆∆G
prediction of variants, and NeEMO can be useful for variant annotation.
Termophile analysis
Effective stability predictors can be used to investigate aspects of biology
ranging from protein design to organism evolution. As a proof of principle
for NeEMO, we analyzed ten proteins from mesophilic organisms and the cor-
respondent homologs in thermophilic organisms [236]. The simple hypothesis
to test is that variants found in termophilic proteins increase stability, while
mesophilic variants have the opposite effect. Performing these experiments
is complicated by the presence of insertions and deletions in the amino acid
sequences which cannot be easily interpreted. NeEMO was used to predict
the stability changes upon termophile to mesophile (T→M) and mesophile
to termophile (M→T) for each alignable residue. As shown in Table 5.4,
the results are encouraging. In 66% of T→M variants our simple hypothe-
sis seems confirmed (53% of exposed and 76% of buried positions), leading
to an expected stability decrease. Overall, the sum of predicted ∆∆G also
confirms the mutant tendency to reduce stability.
In the M→T dataset, the expected change in folding energy is not as
marked, but there is still an interesting signal. For 6 of the 10 proteins there
is a majority of variants predicted to increase stability. This is also confirmed
in the sum of predicted ∆∆G, where 56% of the mutations support the
hypothesis of increased stability. Surprisingly, 68% of exposed positions seem
to reduce protein stability, while just 44% of buried residues increase stability.
This is in contrast with the T→M dataset, and could be due to the highly
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Table 5.4: NeEMO predictions on the mesophilic and thermophilic muta-
tions. Amount of reciprocal variants in mesophilc and thermophilic predicted
to increase or decrease the stability of the 10 proteins, and their cumulative
energy. Cases where predictions support our hypothesis of symmetric ∆∆G
behavior of variants are highlighted in bold.
divergent structures of some proteins. The well predicted Phosphoglycerate
Kinase (Figure 5.4) shows little divergence in the two PDBs. In contrast,
protein pairs with unclear support for our hypothesis tend to have divergent
3D structures. Overall, NeEMO seems to be useful in this proof of principle,
evaluating a simple hypothesis on stability change in termophiles. Although
a more thorough investigation will be necessary to confirm the generality
of these observations, it nevertheless provides evidence that NeEMO can
be used to prioritize mutagenesis experiments and may be used to support
protein design studies.
Web server
The NeEMO web server is freely available to the scientific community from
URL: http://protein.bio.unipd.it/neemo/. Once a PDB file is specified
by the user, the service computes the RIN in a few minutes, and provides
a user-friendly interface for variant prediction. Multiple amino acid changes
can be tested at a time, including different pH and temperature parameters.
The tool is also very fast. Once the multiple alignment is computed, the
effect of a residue change on the protein structure can be predicted in few
seconds, making it scalable for large-scale usage.
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Figure 5.4: 3D structure of the 3PGKA, showing well predicted buried
residues (blue) and mispredictions (red). For this protein, the mesophile
and thermophile core amino acids share a similar structure.
5.1.3 Conclusions
NeEMO represents a novel approach to predict ∆∆G changes after point
mutations in protein structures. It takes advantage of RINs created by our
previous work RING [35] to describe protein structures and interactions be-
tween the amino acids forming them. In RINs each residue is described by
several features, including secondary structure, solvent accessibility, conser-
vation and a number of residue-specific energy potentials. RING also pro-
vides detailed information about interactions found between different amino
acids, including their occurrence and types. The interactions present in the
RIN are used to compute node centralities that encode the relevance of each
RIN node in a protein structure. Inclusion of RINs and information derived
from them was shown to improve mutation stability prediction performance.
Overall, NeEMO seems able to significantly outperform all other tested meth-
ods, and shows very good accuracy across different secondary structures and
in classification. It also seems good in terms of reliability, as it can man-
age and produce a prediction for nearly all PDB files of the PoPMuSiC 2.0
dataset. For the near future, we are planning to extend NeEMO to map
multiple chains directly into an integrated RIN.
118 CHAPTER 5. GENETIC MUTATIONS
Another advantage of our approach is that it does not rely on 3D models
for the mutant proteins. Instead the RIN for the wild type protein is used
to predict the stability change. Other methods have to model the mutant
structure first, which may be computationally expensive and in some cases
can introduce errors that our protocol avoids. In addition, RINs are very
comprehensive data structures that help the management of heterogeneous
information sources like evolutionary and topological data. In fact, experi-
ments show that network data improves prediction quality without exception.
Finally, it is interesting to note that the evaluation on unseen examples in
IM 631 results in basically unchanged performance. This is a nice result, be-
cause the ∆∆G distribution of the training data was significantly different.
The overall results also prove no overfitting was introduced in NeEMO, and
confirm that it can be used effectively for the assessment of mutation impact.
As the number of known variants and PDB structures in different organisms
is rapidly increasing, we believe that the tool can be important for variant
assessment. Finally, NeEMO can also play a role for pathogenicity predic-
tion as shown in [242]. It is well known that stability loss in proteins like
TP53 [218] is associated with disease development. The ability of RINs to
describe proteins and their variants effectively can play a role for the detec-
tion of deleterious protein changes, and may also contribute to pathogenicity
prediction.
5.2 The Critical Assessment of Genome In-
terpretation2
Over the last few years, Next-Generation Sequencing (NGS) has provided
insights and generated knowledge about the role of single nucleotide vari-
ants (SNVs) in common and Mendelian diseases. Exploiting this NGS data
can contribute significantly to clinical practice. The Critical Assessment of
Genome Interpretation (CAGI) is a scientific challenge that aims to evaluate
the state-of-the-art in terms of disease prediction. Similarly to CASP, it can
be divided in three moments. In the prediction season, the participants can
make blind predictions on novel datasets. In the assessment season, all sub-
missions are evaluated against the ground truth. Finally, results are shown
2All figures are results are taken from CAGI online presentations (URL:
genomeinterpretation.org).
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during a conference to help discussion.
The Crohn’s disease (CD), Hypoalphalipoproteinemia (HA) and Familial
Combined Hyperlipidemia (FCH) datasets in CAGI are clear examples where
entire families were sequenced, and specialized bioinformatics algorithms can
play a key role for disease risk prediction. In these challenges, we used a two
stage approach. First, we clustered family members (when unknown), and
used these family groups to generate a highly personalized disease likelihood
assessment. In the second step, we collected all SNVs relevant for disease
pathways and used them to predict risk. To select SNVs several features were
used, including: conservation, interaction network centrality and expression
data. We did not stick to a predetermined set of mutations suggested by
past Genome-Wide Association Studies, since their limited power could not
handle the weak within-family genotype variability. Conversely, using SNVs
in relevant loci and in the interaction network it is easier to capture even
the smallest variance in the SNVs distribution, thus allowing a more robust
evaluation of pathogenic mutations in family members. Broadly speaking,
population stratification was used directly to identify highly penetrant vari-
ants in NGS data, while the use of candidate loci improved significantly the
accuracy of SNP selection. Finally, the disease risk score is predicted from
the SNP overall count.
5.2.1 Datasets
CAGI proposed ten challenges in 2013 related to genotype interpretation.
Given their high heterogeneity, we decided to focus on exome analysis with
the goal of predicting genetic disease risk. There were four datasets of this
type, namely the Crohn’s disease (CD), the Familial combined hyperlipi-
demia (FCH), the Hypoalphalipoproteinemia (HA) and the Personal Genome
Project (PGP):
Crohn’s disease in a dataset of 66 exomes, 15 samples are healthy and
rest are Crohn’s patient. Given the VCF file containing the variants,
participants had to predicting the disease probability for each sample.
Data was sampled from 28 different German pedigrees, and included
one monozygous discordant twin pair.
Familial combined hyperlipidemia (FCH) the dataset contained 5 ex-
omes in VCF format from a family, where the mother and 2 daughters
had high level of LDL cholesterol (LDL-C), while the father and one
120 CHAPTER 5. GENETIC MUTATIONS
daughter were healthy. There were three questions: (a) detect the mu-
tations causing high LDL-C, (b) predict the individual with abnormal
triglycerides (TG) and HDL cholesterol (HDL-C), and (c) predict TG
and HDL-C values for each family member. For each challenge, a real
value and its standard deviation were required.
Hypoalphalipoproteinemia (HA) predict the probability of hypoalpha-
lipoproteinemia disease given the 4 exomes of a familiar group (VCF
format).
Personal Genome Project starting from 291 medical profiles publicly avail-
able and the genome of 77 anonymous individuals, the goal was match-
ing the two information automatically. A total of 214 medical profiles
were given as decoys, to increase the challenge difficulty. For each
profile, the matching probability with respect to all genomes had to
predicted.
In this thesis we will focus on the CD dataset, as it contained the larger
sample size from a well designed study. Further considerations about other
challenges will be given at the end of next section.
5.2.2 Results
Crohn’s disease is a heterogeneous syndrome, whose genetic causes are still
largely unknown. Such complexity requires a highly specific analysis for each
individual of the challenge, due to different familiar background of partici-
pants. In this work, we addressed our analysis at a family-wise level. Using
an implementation of agglomerative clustering, we uncovered hidden rela-
tionships between participants, obtaining a family dendrogram. This was
particularly important, especially for the identification of discordant twins
and outliers (see Fig. 5.5). Clustering was repeated multiple times according
to bootstrap concept and including different SNVs (either common variants
or rare variants) during the analysis. Clustering also proved that few mu-
tations are peculiar of each family (black blocks in Fig. 5.5), while samples
with few shared SNVs are outliers.
We decided to use CAGI 2011 Crohn’s dataset to detect interesting mu-
tations or patterns that may be shared in the CAGI 2013 dataset. The most
striking result was the high similarity among few patient exomes in these
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Figure 5.5: Heatmap of CAGI samples generated from genetic data. Families
are automatically detected by means of agglomerative clustering. In blue,
twins are correctly shown as the most similar patients. In red, few of the
control samples grouped together as outliers.
challenges, which seems relevant for the identification of healthy individu-
als. In fact, outliers in Fig. 5.5) are strongly related to CAGI 2011 Crohn’s
challenge controls. According to knowledge transfer principle, we decided to
annotate as “healthy” these samples.
As a second step, we tried to detect important SNVs for disease risk as-
sessment in all samples. Variants annotation and filtering were performed
using ANNOVAR [243]. We discarded from our analysis SNVs with allele
frequency > 2%, low conservation score in mammals, and reported in db-
SNP v132 [3]. Also, SNVs in low entropy regions were removed, along with
the ones observed in more than 15 samples in the CD dataset. This process
was expected to select just rare variants in critical regions of the genome.
We also considered SIFT pathogenicity prediction [29] to better rank muta-
tions. Finally, we adopted a filter, expand and match approach for disease
risk evaluation (Fig. 5.6).
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Figure 5.6: Disease risk prioritization process.
Filter We selected SNVs placed in genes associated with CD. The main
source of information were literature reviews, OMIM [244] and genome wide
association study (GWAS) databases [4]. It is important to note that GWAS
databases report just SNVs and their disease association p-values. These
variants were kept into account in our analysis. In addition, we assumed
that any other mutation “close” to the associated SNVs (in the same gene)
could play a role for disease prioritization.
Expand The heritability expected in complex disease is still not completely
explained by genetics. This is due to the huge statistical challenges related
to genetic studies, like noise and confounders not taken into account by
researchers. Protein-protein interaction network knowledge is typically ex-
ploited in pathway-based association methods, like burden tests. These ap-
proaches look for SNV enrichment within a group of genes involved in a
biological process [46]. Borrowing this idea, besides the variants in CD genes
we collected SNVs in their direct interactors in STRING PPI network [6].
This database uses different strategies to report interacting genes, like exper-
imentally validated interactions, co-expression in tissue and text mining. In
addition, a reliability score for each interaction is provided. In our selection
process, text mining edges of the graph were removed. To further increase
the quality of interactors, we focused on genes having interaction quality
≥ 0.5x. To avoid irrelevant genes, we selected just the interactors expressed
in colon, small intestine or stomach (the main CD tissue) [245]. Finally, we
used a consensus of two disease gene prioritization tools (ToppGene [41] and
Endeavour [246]) to select the top-ranked (≤ 150) genes that are expected
to play a role based on CD features.
5.2. THE CAGI EXPERIMENT 123
Match After the previous filtering, we ended up with 113 variants in CD
genes and 44 among their interactors. In both cases, SIFT classified roughly
half of them as pathogenic (respectively 57 and 26). We used this data (a)
to separate cases from controls and (b) to assign a disease risk score. By
construction, healthy individuals were given a disease risk ranging from 0 to
49, which was generated from the amount of SNVs (scaled appropriately).
Controls instead were given a disease risk scaled between 50 and 100 using the
mutation count once again. To predict a disease score, we assigned manually
a weight to each mutation category. SNVs associated to CD in GWAS were
given higher score (3 in case of allele frequency ≥ 5%, 6 otherwise). Other
variants in CD genes were given a weight of 1 or 2, depending if they were
predicted to be pathogenic by SIFT. Finally, SNVs placed in interacting
genes and predicted to be pathogenic had weight 1. Ideally, these coefficients
should be estimated from real datasets, but we had no training data. Thus,
parameter values just reflected our prior understanding of the problem.
Healthy individual selection was done semi-automatically. Eight of them were
detected using CAGI 2011 data. The twin with less mutations was predicted
to be healthy (exploiting the prior knowledge of discordant phenotype). All
of these decisions resulted to be correct in the final evaluation stage. To
detect other control individual, we tried two strategies:
Clustering using bi-clustering in the original data, we separated samples.
Surprisingly, this ended up with a first group of 15 individuals con-
taining the outliers of Fig. 5.5 (assumed to be healthy) and a second
cluster with 51 samples (labeled as cases). This was shown to be one
of the best submission in CAGI (see Fig. 5.7).
Family based assessment we assumed that no more than a healthy in-
dividual was placed into a familiar group. We selected the individual
with minimal disease score for each pedigree. Among them, we clas-
sified as control the ones with overall lower disease score. Table 5.5
shows the performance gain of using all SNVs or removing variants in
the PPI genes (no network).
5.2.3 Discussion
Overall, Table 5.5 shows that clustering is very effective both in terms of
classification and risk value prediction. In fact, there are just four misclas-
sified samples, and the predicted disease score has a remarkable AUC value.
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Figure 5.7: Prediction ROC curve for the Crohn’s disease dataset. Vertical
bars show the variance obtained from bootstrapping. The average AUC
equals 0.88.
Table 5.5: Comparison of three submission in terms of true positives, true
negatives, misclassification, AUC and accuray. In the best scenario (cluster-
ing), just four samples were misclassified. When no clustering data is taken
into account, performance decrease. Interestingly, mutations on interacting
proteins seems associated with disease onset.
The family based assessment also proves that by just looking at the disease
score one still obtain very competitive AUC, even though with an increased
number of misclassifications. Categorization is however a harder problem,
since the slightest change in the disease score (e.g. change of coefficients) has
strong impact in terms of separation. This is why AUC is a better quality
5.3. BLOOD GROUP PREDICTION 125
measure for this challenge, as pointed out by the CAGI organizers. What is
very important from Table 5.5 is the contribution of variants gathered from
interacting genes: when such SNVs are removed, we can observe a dramatic
decrease of AUC value. This suggest that the PPI mutations contribute ef-
fectively for disease risk prioritization. We adopted a similar approach also
in CAGI 2011 Chron’s disease challenge, where we achieved very high per-
formance compared to other participants. Likewise CAGI 2013, we exploited
clustering and a disease score to classify patients.
We also performed well in the familial combined hyperlipidemia challenge,
where we detected the causing mutation in the LDLR gene. In the HA and
PGP we achieved mild results, showing that there is room for improvement.
In general, none of the participants did well on each challenge, and many
decisions required the human intervention. CAGI in fact is posing research
questions far from being solved, so any idea could be fundamental in terms
of future computational methods. Genotype to phenotype research is still a
flourishing topic which is getting more attention due to the potential medical
applications. We expect that the availability of additional public data will
help the tuning of better tools which could be truly helpful for the scientific
community. Finally, it is important to note that we are still in the game
stage, where there are strong bias and high variability in terms of results.
The development of next-generation sequencing is the basis of CAGI, and
we hope that future editions will establish gold standard methodologies for
genotype data interpretation.
5.3 BOOGIE: Predicting blood groups from
high throughput sequencing data.3
Advances in genome sequencing due to high throughput sequencing (HTS)
over the last years have detected a huge amount of new Single Nucleotide
Variants (SNVs) [247], producing a tremendous growth of variation databases.
Finding genotype-phenotype correlations is a critical topic in personalized
medicine, as personal genome sequencing is expected to become increasingly
common over the next few years [248]. One of the more interesting develop-
3An early version of this work appeared in Giollo, M., Minervini, G., Scalzotto, M.,
Leonardi, E., Ferrari, C., Tosatto, S. C. (2012). In silico blood genotyping from exome
sequencing data. AIMM.
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ments in this field is the Personal Genome Project (PGP), collecting genome
sequences and clinical phenotypes of participants who have signed an in-
formed consent with the goal to make genome information freely available
for research for thousands of participants [249],[250]. Using this data, a num-
ber of methods have been used to predict particular phenotypes thought to
be genetically determined, among which blood groups may provide a good
test case.
The first discovery of blood groups dates back to the early years of the 20th
century, and represent an important moment for medicine. Karl Landstein-
ers ABO system was nevertheless just a first step in the characterization of
blood. Forty years later the Rh was shown to play an important role, and
today dozens of different blood systems have been reported [47]. As an exam-
ple, the Dombrock group [251] is known to be relevant from the clinical point
of view, as it can lead to severe hemolytic transfusion reactions or hemolytic
disease of the newborn. Similar problems can also be caused by many other
blood systems, like Lan [252], Gerebich [253] and Junior [254]. Compared to
the 25 groups reported in 2000 [251], public databases currently report more
than 30 blood systems [47], so it can be thought that in the close future new
ones will be detected. All blood groups are determined by the presence of
specific proteins on the surface of red blood cells and body fluids [255]. Their
expression is fully genetically determined and cannot vary during a persons
life span. Agglutination tests have been used extensively for the identification
of the ABO and Rh groups, with an error rate below 1 out of 250,000 tests
[256]. On the other hand, it has been reported that non-ABO groups are
among the main cause of death after blood transfusion [257], mainly due to
systems like Scianna [258] where serological tests are not accurate. Sequenc-
ing techniques have been widely used as the main tool for the identification of
molecular differences among systems [254],[259],[260],[261]. Several opinions
suggest to introduce this kind of experiment as an additional blood typing
test [262],[263]. Interestingly, HTS technologies have led to the widespread
availability of sequencing in the medical and scientific community [264], mak-
ing genetic tests more and more common for diagnostic purposes. It can be
expected that genotype information will be useful for blood typing. Personal
genome sequencing is expected to become increasingly used over the next few
years [248], as it can predict patient response to drugs or diseases [265], and
help in the diagnosis and cure. The BLOODchip r system [266] is a first
example of a commercial solution using genotype data to detect blood types,
showing that modern sequencing techniques can be used for the identification
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of six different blood groups. Even though this is an appealing idea, a num-
ber of issues must still be solved, since the three billion human nucleotides
are difficult to manage [267]. In addition, experimental difficulties related
to sequencing and population variability [268] led to the versioning of the
reference genome, and the requirement of an accurate management of SNVs
linked to old genome definitions (i.e. hg18 or lesser). Last but not least,
the one mutation-one phenotype paradigm used in many public databases
[3],[269] is clearly unable to explain many traits of clinical relevance like the
ABO or Rh blood systems, where multiple co-occurring variants determine
the blood group [261] [259]. The situation is finally complicated by het-
erozygous variants, as they require inference of the correct patient haplotype
[270]. The Rh trait is just an example with good genotype knowledge and a
complicated basis, since it is encoded by two different genes resulting in the
two proteins RhD and RhCE [271]. The former is the determinant of the
most common Rh antigen while the latter is responsible for a large part of
weak inter medium Rh traits. Patients are routinely typed for D antigen and
both the common terms Rh positive and Rh negative refer to the presence
or absence of this antigen. The antigens C, c, E, e coded by the RhCE gene
[272] are typed routinely only in patients which have developed an atypi-
cal immunological response to long-term transfusions. Furthermore, Rh is
characterized by the presence of numerous hybrids resulting from genetic re-
arrangement of both the RhD and RhCE genes [271]. These hybrids exhibit
their condition with weak serological response to the routine test. This may
result in a dangerous misclassification due to both false positive and negative
blood typing [273]. To complicate this scenario further, 50 other Rh system
antigens are known. While these are not well studied and poorly understood,
such genetic complexity well explains the importance of large human variant
databases for blood groups such as BGMUT [47].
In order to improve the quality of blood typing we present BOOGIE, a
method that predicts blood groups by means of a user-defined knowledge
base of Boolean rules. Starting from HTS data, the tool solves the haplotype
phasing problem using information stored in the user database, and uses
the same data to infer the most likely blood type. BOOGIE was tested on
PGP data for the prediction of 30 blood groups and their traits reported in
BGMUT. This is novel, as it shows that a set of Boolean rules can predict
real phenotypes, which may be complex and present a large degree of het-
erogeneity. Therefore, a broad range of applications can be conceived, while
the increasing amount of genetic studies will significantly enhance the power
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of its inference engine.
Results
BOOGIE is designed to predict phenotypes using HTS data using explicit
tables that describe the correlation of SNVs with traits. These are extracted
from the BGMUT database [47] which stores information about experimen-
tally validated variants known to be relevant for determination of currently
34 different blood groups. The predictor is built to infer the closest haplo-
type to the known variant combinations, implicitly producing a haplotype
phase. BOOGIE blood group predictions thus represent the most probable
scenario of how the patient variants interact to yield a given blood group
phenotype. In the following we will describe how the predictor works with
the ABO group example, followed by validation on public PGP data for the
ABO and Rh groups and finally presenting the distribution of predicted rarer
blood groups.
ABO case study
In order to clarify how the algorithm works, we describe the example of
ABO prediction for PGP sample hu604D39 (see Figure 5.8), which is known
to have an AB blood group. In haplotype phasing, homozygous variants are
easy to manage, as they are known to appear in both chromatids. On the
other hand, heterozygous ABO group SNVs can be distributed among 32
distinct allele configurations, which may produce very different traits during
the final decision. Ranking the configurations by variant similarity shows that
there are 3 optimal choices. All three infer a first chromatid expressing the
Ax02 blood group, while the second should express either B101 or Bw19 (see
Table 5.6). In particular, the B group allele shifts all heterozygous mutations
towards a single chromatid in the best scoring configuration. This fact is
well known in the literature [274] and confirms the validity of our decision
strategy. Finally, the 13 SNVs in Figure 5.8 are fully annotated in BGMUT,
yielding high confidence for our prediction. It is also interesting to note that
the database contains just 99 SNVs for ABO blood group characterization.
Our focus on this small set of variants seems to describe effectively even the
most uncommon ABO blood groups. This is important for the efficiency as
using just few decision variables rather than the full ABO sequence decreases
prediction time.
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Figure 5.8: ABO gene exonic mutations. Given the input variants, BOOGIE
select all the key mutations specified in the Haplotype table for ABO group
that can play a role (in chromosome 9). The tool assigns all heterozygous
SNVs to the same chromatid, as this represents the most likely haplotype.
As result, the corresponding proteins will express either A102 or B101 blood
group. Genetic analysis suggests that both antigens will be present in sample
hu604D39, which is confirmed by a serological test. It should be noted that
the SNVs reported use hg19 as reference, thus differing from BGMUT defini-
tion of A and B blood groups. In addition, not all the variants reported are
necessary for the final phenotype, as few of them are common for a number
of different groups.
Table 5.6: Sample haplotype table extracted for the ABO system.
ABO performance
We tested BOOGIE on the PGP full genome dataset using ABO data from
BGMUT. The overall accuracy is 94.2%, recognizing correctly 25/27 cases for
A, 11/11 for B, 1/1 for AB and 30/32 for O group. In light of the generality
of the method this is a very good result. Being able to identify the correct
traits without systematic preference suggests that there is enough data in the
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literature to pave the way towards genetic tests for the ABO blood group. In
addition, weak antigens and subgroups were identified with no effort. This
is clearly an advantage compared to common serological tests and may also
yield good immunological results, due to the increased ability to classify
blood diversity. Regarding the amount of SNVs contained in HTS data, we
observed between 4 and 18 SNVs in the genome dataset samples.Despite this
large heterogeneity, BOOGIE correctly assigned heterozygous variants to the
chromatid and obtained good recognition performance. It is worth to note
that B typed samples typically show a higher number of exonic mutations,
as also shown in past studies [274]. Interestingly, the few misclassification
cases can be explained (see Table 5.7). In particular, profiles hu2DBF2D
and hu52B7E5 were not detected as O. This is due to the ABO c.53G>T
mutation, which has complete penetrance for the determination of the O
group [274]. Even if this position is reported in our ABO haplotype table,
our scoring system uses the same weight for all SNVs. In these three profiles,
identification of the A haplotype, which was supported by 12-14 variants,
was predicted to be the more likely. Of course, this could be solved from
the technical point, either by adding weights to the mutations or entries
to the haplotype table. Conversely, samples huFFAD87 and hu2FEC01 are
quite unexpected, and can be explained by the relevance of intronic variants,
and occurrence of a chromosome crossover during meiosis in the 6th intron
respectively. This latter scenario is quite strange, and violates our implicit
assumption of linkage disequilibrium (LD) in the coding region. It is possible
that wrong variant calling or experimental errors are present, or the reported
PGP participant data may simply not be correct. Three important loci for
A, B or O blood group determination are in the minus strand of chromosome
9. The hg19 chromosome positions of interest are reported in the first row.
The first one is a frameshift insertion, while the latter two are SNVs. With
this information, we can distinguish between the B, O and two A group vari-
ants as well.
On the 23andMe dataset, BOOGIE has 91.43% accuracy. It should be
noted that we removed 6 cases from the starting pool, because the experimen-
tal data had missing values for important positions. We correctly recalled
46/51 for group O, 44/44 for A, 18/21 for B and 4/5 for AB. The problem
at hand is very different from the first one, due to the amount of observed
SNVs (ranging from 12 to 43)and data quality. In fact, it seems that a major
issue for this data is identification of indel c.261delG, which is missing a in
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Table 5.7: Explanation for the ABO blood group mispredictions. In two
cases the solution requires an improved weighting scheme, while in the latter
two there is no definitive answer.
few cases, and possibly wrong in others. This would explain most of the
misclassifications for this validation set. It is interesting to note that having
only localized SNVs rather than complete exome data does not significantly
affect performance. In fact, the ABO group is mainly determined by an
accumulation of mutations related to known haplotypes. This confirms how
using few localized SNVs can be effective in ABO prediction, as also assumed
in previous genome-wide association studies [275]. This may have important
implications for the development of commercial genetic tests for the ABO
blood group, as the test of localized hot-spots can be significantly cheaper
than whole exome sequencing.
Rh performance
On the full genome data, BOOGIE has 94.2% accuracy. We recalled correctly
57/57 for Rh+ and 8/12 for Rh-. This is a good result, considering that we
marked profile huC14AE1 as misclassified, where the Rh+ and Rh- scores
were the same due to uncertainty in the prediction. Profile huFE71F3 and
huC30901 are quite hard to explain, because they have just two SNVs in
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genomic coordinates 25617282 and 25634204 of chromosome 1, which seem
of no impact according to the literature. A similar situation happens for
profile hu025CEA.
It is interesting to note that individuals with few SNVs in the RhD gene
are likely to show an Rh+ trait. In fact, almost 80% of the samples have
less than five variants. Conversely, a large number of variations is related
to the D-CE-D RhD hybrid group leading to a Rh- trait. CE 5-9DBT and
CE 7-8-9DIVb are just two of the groups that we observed [276]. This result
cannot be obtained with classical serological tests and may be relevant for
highly specific blood transfusions.
On the 23andMe dataset, there are 93 Rh+ and 18 Rh- samples and our
method cannot discriminate between different RhD chromatid configurations
in many situations. This is mostly due to the small number of SNVs reported
in 23andMe experiments which leads BOOGIE to predict Rh+ for all cases.
E.g., five samples (hu3B89BD, hu8B4E43, hu25BD97, huB2C416, huF7E042)
report no mutation in RhD but are marked as Rh-. On the other hand, it
is well known in the literature that this trait is connected to few mutations.
These 23andMe samples are clear examples where scarcity of information
makes correct trait prediction based on genotype data impossible.
The coordinates reported by 23andMe experiments (c.329T>C, c.676G>C,
c.712G>A, c.787G>A, c.933C>A) seem to be designed for the recognition
of RhD-RhCE hybrids, but the existence of minor Rh groups (like CE 5
Va 4) makes the recognition of the correct allele configuration impossible.
These positions may distinguish 32 distinct situations, while there are 67
known subgroups for Rh, leading to a non-universal assignment which cannot
produce reliable results. A possible solution for this ambiguity may be to use
population frequency of traits to rank tied scores. This could effectively
suggest the maximum likelihood estimate in such a weakly informed context.
Other blood groups
We tested the PGP genome dataset for the other 28 blood groups with BOO-
GIE, with striking results. As shown in Figure 5.9, a considerable amount of
samples has uncommon traits, which may be important during blood transfu-
sions or in related situations. For example, in the Junior system we reported
the case of a weak trait. This could be relevant for hemolytic disease of the
fetus and newborn, as already reported in previous studies [254]. For the
Lewis and John Milton Hagen systems we observed samples with opposite
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traits. This is not likely to be of interest from the clinical point. Neverthe-
less, these groups need more study in order to completely characterize their
medical relevance. It should also be noted that in the PGP web-site, no
information is available for the 28 blood groups, so no validation is possible.
More in general, experimental characterization of these minor blood-groups
may currently be non trivial due to the lack of an unambiguous clinical test
[263]. Routine typization is conducted with genetic analysis in patients who
manifest an atypical immunological response, such as long-term transfusion
patients. Methods such as BOOGIE may help to address the right strategy
to adopt. Clearly, the use of highly specific annotations can be considered
an additional tool to predict blood transfusion compatibility. On the other
hand, it is interesting to note that HTS data can provide detailed blood
group information compared to common serological tests. In fact, testing
only highly specific SNVs may result in good performance, as already proven
in the Rh and ABO group tests.
Amount of non-considered mutations
Genetic variations are in many situations not relevant for the determination
of a phenotype, as can be clearly seen in dbSNP. Very few mutations report
a clinical relevance tag or reference to PubMed. In order to understand how
much is known in the context of blood groups, we report the amount of
SNVs in BGMUT and in dbSNP for each blood system, and use these two
parameters to measure the completeness of our haplotype tables. Half the
blood groups considered in this work seem to cover at least 20% of the SNVs
in dbSNP (see Figure 5.10). At first glance this may seem a mixed result, but
we are not interested in full coverage. We reasonably assume that (a) a small
set of variants can be used as representative of a full haplotype, thanks to
linkage disequilibrium and (b) a large amount of SNVs are unlikely to cause
phenotypic changes. For the latter point, data from BGMUT is frequently
updated, and represents the state of art for blood group characterization, so
it is clear that we are using as much information as possible. As shown for
the ABO and Rh systems, we argue that BOOGIE can be a valuable tool for
phenotype characterization. The haplotype phase quality is also interesting
and confirms that crossover recombination hot-spots are typically localized
in non-coding regions [277]. This is also observed in HapMap data, where
linkage disequilibrium is often observed in coding DNA. It is important in
134 CHAPTER 5. GENETIC MUTATIONS
Figure 5.9: Predicted blood group distribution for the PGP full genome
dataset. For each PGP sample, the possible occurrence of uncommon blood
groups is highlighted, based on coding variants. The prediction is based
on the observation of SNVs known to be associated with uncommon blood
groups. When no known variant is found, the phenotype is assumed to be the
reference one. Clearly, the existence of non-coding or new uncharacterized
variants relevant for a blood system can influence BOOGIE, leading to a false
negative prediction.
our decision as we focus only on SNVs reported in our haplotype tables,
providing greater flexibility. We can either report the full gene sequence and
known allele, or just describe the most relevant loci. In both situations, genes
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in strong linkage disequilibrium are very likely to work very well with our
algorithm, as shown with ABO group tests. We are aware that BOOGIE
will not be very effective for the less studied systems. As the amount of data
available for trait prediction keeps growing, we expect our tool will become
increasingly valuable over the next years. It is striking that the most of the
SNVs of genes relevant for blood transfusion (RhD and ABO) are already
well characterized (see Figure 5.10), suggesting that BOOGIE can be useful
for these important blood groups.
Figure 5.10: Fraction of dbSNP variants annotated for each blood group. The
most important groups for the transfusion (grey bars) have good annotation
in BGMUT, explaining the quality of our results. Conversely, most variants
in the less studied systems still need further research for a proper automatic
annotation.
5.3.1 Discussion
In our work, we developed the tool BOOGIE for blood group prediction.
The main idea is to focus on few genetic locations with annotation from the
literature for a set of common phenotypes. Using this information, we re-
solve the haplotype phasing problem and infer the most likely trait. From
the theoretical point of view, linkage disequilibrium is the key factor leading
to high accuracy even in presence of a small number of observed mutations.
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BOOGIE was tested for human blood group prediction using PGP data and
obtained very good results. Even if performance is not as good as serological
tests and not yet suited for direct medical application, the few misclassi-
fication cases were easily detected. These provided interesting indications
for the need of good quality SNVs in relevant spots and the importance of
high penetrance mutation management, which can be easily dealt with in
haplotype tables. In fact, lack of informative observations can result in the
impossibility to properly classify sequencing data, as shown for the Rh group
in the 23andMe dataset. Nevertheless, there is a number of advantages in
our approach to be considered. The ability to directly detect ABO and Rh
blood subgroups can be useful in ordinary blood transfusions. Whenever
HTS data is available for some reason, it will be possible to test rare blood
groups. For the 28 minor blood groups, we checked the PGP genomes for
uncommon traits finding interesting results. As the experimental techniques
for antigen detection are poorly sensitive in these blood systems, e.g. the
Dombrock and Scianna system [258], genetic tests can be particularly useful.
There is evidence of consistent discrepancies for the well-known ABO and
Rh blood systems, estimated at 3.7% between real blood type and the one
reported in identity documents [278]. Genetic tests could therefore represent
an additional, albeit not exclusive, tool for checking compatibility during
transfusions. Trait assignments in this work is based on PGP data donated
by volunteers not directly connected with our laboratory. For this reason,
no further experimental validation is possible for the other considered blood
groups. The dataset nevertheless is clearly representative, as it contains sam-
ples of different ethnicity obtained with different experimental techniques.
BOOGIE uses a multivariate strategy based on maximum parsimony, which
is particularly meaningful for proper characterization of non-trivial pheno-
types, and is well explored in the context of sequence analysis. The method
is very fast and produced blood group annotation for all 30 systems in a few
seconds on a desktop PC. In light of the increasing amount of available HTS
data, this is of great practical relevance for the quick and scalable annotation
of genomes. Exponential growth of allele configurations is not a real danger,
due to the limited number of heterozygous exonic SNVs typically observed
in single genes. As long as the focus is on relevant hot spots, the number of
permutations will be strongly reduced, leading to high computational speed.
A key aspect of the system is flexibility. Simply adding more entries to the
haplotype table will allow detection of new traits, while creation of new hap-
lotype tables allows to tackle other genotype to phenotype problems. This is
5.3. BLOOD GROUP PREDICTION 137
an important step towards the automation of trait detection in personalized
medicine, in view of the constant growth of discovered phenotypes. In the
context of multifactorial diseases this may be unfeasible, as we are still far
from a clear description of key SNVs. Nevertheless, an increasing amount of
studies may clarify these complex phenotypes and will suggest putative loci
to test for mutations, as shown for cholesterol level models [279]. It should
also be noted that no interpretation is possible for variants with no annota-
tion in our knowledge base. Hence, proper reasoning will be possible only
when all relevant variants are fully annotated. Dominance so far is also not
considered, because it strongly depends on the context (e.g. X chromosome
inactivation in women). BOOGIE computes two separate predictions, one
for each chromatid. Proper interpretation of the resulting trait is left to the
user and was straightforward in the ABO and Rh context. Despite these lim-
itations, blood group traits are clearly relevant from the clinical point of view
and may be effectively detected by our strategy. In addition to phenotype
detection, the approach can also be a valuable tool for population studies.
Some anthropological marker genes are important due to ethnicity-specific
polymorphisms of certain human populations. The versatility of the tool
allows us to imagine different scenarios where similar methods may be used
for detection of rare diseases or in forensic medicine. In addition, BOOGIE
can be downloaded (URL:http://protein.bio.unipd.it/download/) and
customized for any trait prediction. Thanks to its effectiveness in HTS data
interpretation, it can be of benefit for the clinical community and may help
to develop of a new generation of tools for personalized medicine.
5.3.2 Methods
Data collection
In order to construct BOOGIE we had to extract as much information as
possible about blood system classification from the literature. BGMUT [47]
stores information about experimentally validated mutations known to be
relevant for blood group determination. 34 known blood systems are de-
scribed and are included in BOOGIE, with ABO and Rh of interest for
method validation. The prediction strategy relies on an explicit definition of
the ground truth, to be used during classification of new human samples. All
loci of interest for genome classification are grouped in haplotype tables for
each blood group. For each known phenotype, the table defines all expected
138 CHAPTER 5. GENETIC MUTATIONS
SNVs that should be observed for its determination. E.g. definition of the
177 known ABO blood groups uses 99 explicitly reported SNVs. Whenever
BGMUT reports no data about a SNV, it is assumed to be the reference hg19
gene in our tables. Only exonic mutations were used, since they cover the
largest part of the database and are more easily measurable during sequenc-
ing experiments. Obtaining the correspondence tables required meticulous
manual curation, as many blood groups and traits assumed old reference
genes. This is an important issue related to recent improvement of sequenc-
ing techniques, as they provided a number of different DNA sequence versions
of increasing quality that cannot be easily combined. E.g. the ABO reference
gene in BGMUT corresponds to the A group, while the reference gene in hg19
corresponds to the O group. This leads to a shift and re-labeling of most
mutations. In many cases, like in the Indian system, SNVs simply report a
wrong reference sequence, see variations in [280]. In addition, HTS data after
variant calling uses genomic coordinates rather than gene-based coordinates.
For this reason we used the BiomaRt [281] R package for quick coordinate
translation, and manually fixed all mismatches in case of discrepancies with
hg19. All conflicting cases were solved using the public databases dbSNP [3],
UCSC reference genes [282], Phencode [283] and the original publications
from PubMed. We decided to drop traits and mutations when the manual
conversion failed. After this process, we obtained annotation for more than
800 different traits based on almost 1,000 unique coding variants for 30 blood
groups.
Phenotype prediction
In HTS experiments, data obtained after variant calling provides an invalu-
able source of information for phenotype prediction. On the other hand,
heterozygous mutations by themselves do not explicitly specify the genomic
sample haplotype. This is known as the haplotype phasing problem in the
literature. It can be solved effectively using information from HapMap [284]
and expectation maximization approaches with Hidden Markov Models [285].
These methods are computationally expensive and based on low resolution
data, which cannot distinguish rare haplotypes or uncommon SNVs [284].
Due to these limitations, we developed a new fast tool that could deal with
(a) haplotype phasing and (b) phenotype decisions for the resulting predicted
chromatid. For a particular patient gene, we assumed without loss of gen-
erality that there are N homozygous and M heterozygous mutations. With
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no prior assumption, this would lead to 2M-1 possible allele configurations
C in the two human chromatids. As a first step, we enumerated all configu-
rations, where exactly one of them represents reality. In the second step, we
solved jointly the haplotype phasing and phenotype decision problem using
our haplotype tables H. Given a particular configuration c, we determined
its phenotype by means of a K-nearest neighbour strategy using data in the
haplotype table H. In other words, we measured the sequence distance of
c to those in H, and transferred by similarity the phenotype of the closest.
Similarity is measured as Hamming distance, i.e. number of substitutions
and insertions between two sequences, which is also important for determi-
nation of the most likely haplotype phase. The higher the value, the lesser
the chance to observe c in nature. This is clearly linked to the maximum
parsimony principle, which is well established in phylogenetic reconstruction
[286]. We ranked all allele configurations by Hamming distance and selected
the best as real allele configuration. The overall idea is that we are trying
to find an example in our haplotype table which has the same mutations,
so we can be reasonably confident that phenotype and haplotype will be the
same. Conversely, a wrong allele configuration will look very different from
the previously published ones and is not likely to exist at all.
BOOGIE system
BOOGIE was written with Java JDK 1.7, making it portable to all major
operating systems. As shown in Figure 5.11, BOOGIE requires two files
for its execution. The haplotype table for the phenotype of interest and the
target genotype file. Format details are provided in a README file. Variants
contained in the genotype file will be considered if and only if they are part
of the haplotype table, i.e., they are useful for phenotype prediction. Once
the variants have been selected, all the possible assignment to the two human
chromatids are enumerated. The phenotype of each permutation is predicted
by means of the 1-nearest neighbour algorithm, and the corresponding score
of the most similar haplotype stored. The two assignments with overall
maximal score become the predicted phenotypes. Note that dominance is
not taken into account, so it is up to the user to determine the final traits.
E.g., if the two alleles A and 0 are predicted for the ABO blood group, the
expert user should infer that the A group is dominant.
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Figure 5.11: Schematic BOOGIE overview. The tool requires just genotype
data and an haplotype table for its execution. Genotype must be specified in
a tabular file similar to VCF format, where chromosome, genomic position,
nucleotides ad zigosity are specified. Haplotypes are defined in a tabular
file, and each row specify the expected SNVs of a target phenotype. See
README file of the application for format details. BOOGIE search for key
variants in the input genotype, and optimize their assignment to a haplotypes
with known phenotype according to the 1-nearest neighbour algorithm. The
SNV permutation with best score is the one with highest phenotype likeli-
hood.
PGP dataset
The first goal for testing our method was the collection of samples with
phenotype annotation and genetic data. We chose to work with public data
5.4. PETRI NETWORKS 141
from the PGP [249],[250], mainly due to the richness of the clinical profiles.
From the 2,651 profiles accessed on 13 May 2013, entries having ABO and Rh
annotation with sequencing data were extracted. We obtained two datasets
with 69 samples with full genome sequences from Complete Genomics and
111 with 23andMe SNP data. The nature of the 23andMe data set is very
heterogeneous in array size (ranging from 570k to 1000k SNVs) and chip type
(customized Illumina Hap550+ or HumanOmniExpress BeadChip Kit). The
reference genome used was either hg18 or hg19. For a detailed description of
the data, please refer to the PGP website (URL:http://personalgenomes.
org/). The full genome dataset was used for benchmarking the accuracy of
the tool for ABO and Rh when full data is available. The 23andMe dataset
was used as a further set to evaluate our prediction strategy when only partial
information is available.
5.4 Von Hippel-Lindau (VHL) Pathway Mod-
eling using Petri Net4
Pathological deregulation of cellular pathways often results in a family of
complex and correlated diseases commonly termed cancer [287]. Cancer is
a multi factorial disease where different causes contribute to its develop-
ment. Several computational methods have been developed to explore the
functional pathways involved in tumorigenesis. Some of them focus on dif-
ferential gene expression between healthy and pathologic tissues [288, 289],
on protein-protein interaction network analysis [290, 291] or on molecular
dynamics simulations [292]. Other methods approach the disease through
discretization of pathological components that result in tumor [293]. All of
these approaches are very powerful when the variables related to the disease,
although complex, are well known and studied. A multi-factorial disease can
be approached by means of mathematical theory, building a theoretical model
where cell components are connected with each other. In biology, several
problems were dealt with network theory [294, 295]. A network is a group of
objects strongly inter-connected with each other (e.g. proteins and enzymes
4The results of this chapter have been published in Minervini, G., Panizzoni, E., Giollo,
M., Masiero, A., Ferrari, C., Tosatto, S. C. (2014). Design and Analysis of a Petri Net
Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network. PloS
one, 9(6), e96986. For Supplementary Material, check the online version of the paper.
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of a pathway or animals belonging to interacting populations). Their con-
struction and subsequent simulation is made via mathematical analysis of the
connections between nodes found in the system and their time-dependent be-
havior [296]. A biological network is generally composed of proteins, nucleic
acids and cofactors connected by biological reactions such as protein complex
formation or enzyme activity regulation [296]. Von Hippel-Lindau syndrome
(VHL) [297] is a good study case to test the network theory applied to cancer
due to the similar medical history and pathological phenotype that patients
share. While hereditary cancers represent only a small part of all human
tumors, their investigation represents a challenge to understand the pathway
leading to tumor formation. In 2010, Heiner et al. first approached VHL
using the so-called Petri Net (PN) simulation networks [298]. Their work,
inspired by a previous theoretical model of cellular oxygen-related pathways
[299, 300], was a preliminary investigation of the core oxygen sensing system
and its connection with VHL onset. Heiner and coworkers proposed three
different functional modules responsible for hypoxia network control and for
HIF-1α degradation [298]. In other words, they theorized that hereditary
forms of cancer, such as different manifestations of VHL, are the result of
different and concomitantly compromised metabolic pathways.
Von Hippel-Lindau Disease
Von Hippel-Lindau protein (pVHL) is the product of the von Hippel-Lindau
gene, located in the short arm of 3rd chromosome, and constantly transcribed
in both fetal and adult tissues [301]. Mutations of pVHL are related to a
pathological outcome termed VHL syndrome, an inherited form of cancer
[302]. VHL syndrome is characterized by cysts and tumors growing in spe-
cific parts of the organism [302, 303]. It is considered a severe autosomal
dominant genetic condition with inheritance of one person in over 35,000
[304]. The tumor injuries, which can be either benign or malign, are usually
located in the retina, adrenal glands, epididymis, central nervous system,
kidneys and pancreas [305]. As a genetic disorder, VHL syndrome follows
Knudsons two hit principle. A copy of the gene is mutated in the germ line,
but the other gene copy still produces a functional protein. Complete protein
inactivation appears during life due to somatic inactivation of the remaining
functional copy [306]. On the contrary, mutations occurring during early
fetal formation result in unsuccessful development [307]. The pVHL gene
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has 11,213 base pairs including three exons [304] and the final transcript is a
protein commonly present in two isoforms: pVHL30 and pVHL19, of 213 and
160 residues respectively. Neither isoform contains a known enzymatic do-
main, but rather appears to serve as a multipurpose adapter protein engaging
in multiple protein-protein interactions [308]. pVHL structure is organized
in an α- and β-domain and its stability was demonstrated to be ensured
by direct interaction with other proteins such as Elongins B and C [309].
Both Elongin B and C are also required for the best characterized function
of pVHL, the ubiquitination dependent degradation of Hypoxia Inducible
Factor (HIF) via the proteasome [310]. However, pVHL is considered a mul-
tipurpose protein due to its high number of known interactors. At the time
of writing, the IntAct database [311] presents more than 200 different inter-
action partners, with some of them competing for the same Elongin binding
site. Indeed, pVHL was found in different cellular compartments and seems
to be involved in many different cellular processes such as apoptosis, cell
proliferation, survival and motility [312]. Considering the huge number of
interactors and multiple cellular localizations, many different functions have
been described or hypothesized, such as regulation of cytoplasmic micro-
tubules during mitosis [313] and endothelial extracellular matrix deposition
[314]. On the other hand, considering the huge number of players involved
in VHL syndrome and the lack of reliable kinetic data, a PN based approach
may be a preferable option for an entire VHL pathway simulation.
Petri Net for Interaction Pathways
Since their invention, by Carl Adam Petri in the early sixties, PNs were
mostly used to describe technical systems, but later the utility in describing
biological and biochemical functions has also been demonstrated [315]. PNs
were successfully used in many studies to describe biological networks [48],
such as the regulation and etiopathology in human Duchenne Muscular Dys-
trophy [316] and the hypoxia response network [298]. PNs are qualitative
mathematical models that can graphically represent many object types, not
only metabolites but also different protein states and are useful to simulate
networks where not only metabolites are involved. Indeed, PNs can be a
powerful tool to study all concurrent interactions in a specific pathway, even
if the proteins or kinetics are not well-known. Due to the large number of
different pVHL functions involved in VHL disease progression, we decided
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to extend the PN based analysis of [298] increasing the number of consid-
ered protein-protein interactions. We generated a novel manually curated
PN model of the entire VHL regulation system collecting data from the lit-
erature and including the signaling pathways and glucidic metabolism. In
order to build a realistic network, literature from both biochemical experi-
ments and in silico predictions were used as source. It was decided to build a
PN with only confirmed pVHL interactions whose function was also known.
The resulting PN was validated using an analysis of specific properties as
suggested by previous studies using the same method [315]. After validating
the PN structure, in silico knock outs of specific proteins were done in order
to observe the different network behaviors and the resulting biological effect.
5.4.1 Methods
The network was designed in the Snoopy PN framework (version 2, revi-
sion 1.13) [317], respecting the mathematical PN formalism as described in
[298, 318]. PN were demonstrated to be useful in describing discrete and
concurrent processes in a simple graphical representation [48] and have been
used to describe biomedical processes due to their capacity of representing
sequential steps in a process. PN modeling methods are actively used to
describe, simulate, analyze, and predict the behavior of biological systems.
The Snoopy PN framework provides an extensible multi-platform framework
to design, animate, and simulate Petri nets [317]. We chose Snoopy to facili-
tate future extensions of the VHL pathway presented here. Among different
available PN types a standard PN was chosen to limit the number of vari-
ables. Both Charlie and PInA analyzers were used for PN analysis and
validation [319]. Further, in silico knock out experiments were used to test
the biological reliability of the model. Structural model validation was made
by analysis of the T-invariants to demonstrate whether the system was cov-
ered by T-invariants and to confirm the biological meaning of each invariant.
The use of T- and P-invariants is given by their own properties: they are
a set (of transitions or places, respectively) that allow the reproduction of
the same state after n transformations. A P-invariant represents a set of
places where the number of tokens is constant and independent on the fir-
ing rate. A T-invariant instead represents a set of transitions that cyclically
comes back to show the same initial set. Biologically a P invariant can rep-
resent the process of regulating a protein, whereas T invariants can represent
cyclical biochemical transformations such as metabolic reactions. To this
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end, the computed invariants were grouped in Maximal Common Transition
Sets (MCTS) and Clusters, the former based on occurrence of specific sets of
transition inside the various T-invariants, and the latter based on similarities
between T-invariants. Different numbers of clusters will be defined depending
on the resulting square matrix. Where MCTS create disjunctive nets, Clus-
ters merge together similar T-invariants. Behavioral validation was made by
selectively deleting tokens inside the model, imitating possible biological dis-
ruptions such as disease-causing mutations. The resulting network behavior
was compared to what is reported in the literature. Total runtime for in-
variants computation were less than ten seconds on a mainstream Linux x86
workstation. Literature sources used to build the model are reported in Table
S1. The Snoopy framework for PN construction, Charlie and PInA tools for
analysis are available at the website (URL:http://www-dssz.informatik.
tu-cottbus.de/DSSZ/Software). Finally, the model was used to simulate
the network behavior through visual inspection of both token movement and
accumulation in specific parts of the network. For a visual explanation of
token movement in a PN refer to Video S1.
Model Availability
The resulting VHL disease PN model is available in File S1.
5.4.2 Results
Notations and Assumptions
The PN built here focuses on pVHL interactions that were already proven
by biochemical experiments and reported in the literature. We chose to
model a realistic VHL disease pathways based on confirmed literature data,
including all known VHL functions, VHL related signal pathway and glucidic
metabolism. All bibliographic sources used to design the model are presented
in Table S1. The final PN is composed of 323 places and 238 transitions, con-
nected by 801 arcs. Tables S1 and S2 show all places and transitions and the
related biological correspondence. Places are mainly proteins and enzymes,
while some represent DNA or small molecular substrates such as glucose and
cofactors (e.g. ATP). Notation for both pre- and post-places and their bio-
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logical meaning are explained in Table S1. In a few cases, places are used
to represent a whole group of changes generated by DNA transcription, (e.g.
p 32 and p 33 or Et eff1 and Et eff2). Transitions instead symbolize complex
formation between two proteins or post-translational modifications. Output
transitions stand for degradation or movement to other parts of the cell or
organism to complete their functions (e.g. degrad 1 and degrad 2) whereas
input transitions show the generation of a substrate or protein. In order to
simplify the design of such a large network, we decided to use macro nodes to
group reactions representing complex molecular pathways such as signaling
pathways or secondary signal cascades. The whole process is merged into
a single node with a given name to allow visual inspection only in case of
need. From the top level all transitions can still be found in a hierarchical
lower layout level. Logic nodes were used for places participating in many
reactions throughout the network such as ATP and ADP (7 logical copies
each) or NAD and NADH (4 logical copies each). A total nesting depth of
two was chosen to model macro nodes. Special arcs were not used while we
chose to model the permanent presence of some objects using double arcs
(e.g. for elob, eloc and places standing for enzymatic activity). In case of
proteins which are actively degraded, it was preferred to create an input
transition simulating constant production (or synthesis) and an output for
consumption. This is the case for pkcz2, Jade1, pVHL and HIF-1α. As can
be seen from Figures 5.12 to 5.14, which represent the entire model, two
major nodes can be immediately identified: pVHL and vcb, the complex
made by pVHL and the two elongins. Another relevant part is the glucidic
metabolism, modeled due to its hypoxia induced regulation. It is represented
in detail in Figure 5.13.
HIF-1α Transcription Activity
The HIF-1α transcription factor stimulates proliferation of endothelial cells
to create new blood vessels during localized or broad hypoxia. In human,
it is present as three different paralogs: HIF-1α, HIF-2α and HIF-3α. The
sequence is quite conserved between the former two, whereas the latter is
slightly shorter and seems to have completely different functions compared
to the other two [318, 319]. Both HIF-1α and -2α stimulate DNA transcrip-
tion but the exact products of this activity are still poorly understood. In our
model, only HIF-1α in vivo activity was considered. It cannot be excluded
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Figure 5.12: Top level model. The colors of some tokens were arbitrarily
chosen to give a clearer identification of the central nodes (ATP, Vcb and
oxygen) or for nodes involved in more reactions such as GSK3β. The group
of nodes in the bottom left is not disconnected from the central body of the
network thanks to the presence of logic nodes for ATP synthesis (t 97).
that other biological effects depend on the second paralog. Indeed, both have
a pro-angiogenetic function and are degraded by pVHL via proline-directed
hydroxylation. HIF is a heterodimer of HIF-1α and HIF-1β, the latter being
also termed Aryl hydrocarbon Receptor Nuclear Translocator (ARNT). We
started from the transcription activity of HIF due to its regulation is the
most studied pVHL function. Our model, as expected from literature data,
shows that HIF-1α enters the nucleus when not degraded by pVHL. It sub-
sequently binds HIF-1β to form the HIF heterocomplex which interacts with
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Figure 5.13: Lower hierarchical PN levels. Pathways from the top level
are grouped in macro-nodes (functional subordinated layer), in particular
glucidic metabolism and various VHL functions.
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Figure 5.14: Lower hierarchical PN levels, in particular HIF-1α reg-
ulation and HIF-1α-dependent pro-angiogenic signaling. VEGF and
EPO pathways are at a lower hierarchical level than the pro angio macro-
node.
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DNA. Our model correctly simulates the increased affinity of HIF towards
DNA. Transcription is enhanced by some co-factors binding both subunits
of HIF and other proteins such as p300, Creb and cjun. This takes place
in a specific DNA promoter sequence termed Hypoxia Response Element
(HRE). Furthermore, during transcription some pro-angiogenic factors are
produced: Vascular Endothelial Growth Factor (VEGF), Endothelin (ET)
and Erythropoietin (EPO). All described pathways are in agreement with
previous observations reported in [320]
Metabolic Processes
HIF-1α transcription activity includes some proteins which are dependent
on oxygen but involved in other pathways (e.g. oxidative metabolism) or
completely independent (e.g. metallo-proteinase MT1MMP). Further, HIF-
1α stimulates production of proteins involved in the glucidic pathway. The
final product of the metabolism is adenosine triphosphate (ATP), a molec-
ular form of energy, composed by adenosine, an adenine ring connected to
a ribose sugar, and three phosphate moieties. When a phosphate moiety
is hydrolyzed it releases energy, used by cells for enzymatic reactions. The
glucidic metabolism is composed of glycolysis, Krebs cycle, glycogen forma-
tion and respiratory chain with ATP synthesis. Glucose is absorbed in cells
by enzymatic glucose transporters (GLUT), which carry the molecule to the
location inside the cell where the metabolism takes place [321]. There are
many isoforms of these transporters: GLUT1 is present in all cells and in
particular in erythrocytic membranes, neurons and glia [322]. GLUT2, lo-
cated in both liver and pancreatic beta cells, is characterized by low affinity
for glucose, hence it requires a higher glucose concentration to be activated
[323]. Right after eating, glucose concentration increases, thereby quickly
activating them. GLUT2 stimulates production of insulin, a hormone regu-
lating the plasmatic glucose concentration. Glucose plasmatic concentration
can also increase due to an opposite pathway, originating from liver glycogen
being decomposed into glucose and reaching systemic circulation. GLUT3
is mostly present in neurons, whereas GLUT4 is the insulin activated trans-
porter located in myocytes, adipocytes and cardiomyocytes [321, 324]. In
our model, we chose to exclude GLUT3 due to its specific role in neuronal
cells. Glycolysis occurs in the cytoplasm and during this process each glucose
molecule is phosphorylated, consuming two molecules of ATP, then divided
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into two smaller molecules. Further modifications of these two molecules re-
sult in new ATP production. The molecule obtained at the end of glycolysis
is pyruvate, which can be again modified through three different pathways.
It can be decarboxylated and linked to Co-enzyme A to form acetyl-Co-
enzyme A. It can then be carboxylated to obtain oxalacetate, or transformed
through lactate dehydrogenase into lactic acid. Pyruvate can also be gener-
ated by other metabolic pathways, like protein or fatty acid disruption and
amino-acid modifications. Acetyl-CoA and oxalacetate are the molecules
used in the following glucidic metabolism process, the Krebs cycle, taking
place in the mitochondrial matrix. The Krebs cycle starts with acetyl-CoA
and oxalacetate merging to create citric acid, which continues undergoing
modifications until oxalacetate is formed again. During the process some
co-enzymes are modified. Decarboxylation of pyruvate to form acetyl-CoA
already transforms a NAD+ (Nicotinamide Adenine Dinucleotide) in NADH
(reduced form), afterwards obtaining one more of ATP, GTP, FADH2 (Flavin
Adenine Dinucleotide) and three more NADH per pyruvate molecule entering
the Krebs cycle. The redox co-enzymes are considered electron transporters.
During metabolic reactions they reduce themselves and get electrons (and
protons) to oxidize the substrate of the enzymatic reaction. Electrons taken
during the glucose metabolism are then used in the respiratory chain taking
place in the internal mitochondrial membrane. The respiratory chain consists
in transporting electrons through enzymes called cytochromes and others co-
enzymes, characterized by the capability to receive and donate electrons.
NADH (FADH2) is oxidized again by cytochromes going back to the form
of NAD (or FAD). Electrons gained through oxidation are used to reduce
half a molecule of oxygen into water, releasing more energy. The FADH2
and NADH redox chain establishes a chemical potential causing the push of
protons outside the internal membrane towards the inter-membrane space,
which stays between the mitochondrial inner and outer membrane. This also
causes a higher concentration of protons outside the inner membrane. The
resulting gradient causes the tendency of protons to enter the cell. The final
step is ATP-synthetase, formed by a channel that allows protons to enter,
pushed by the gradient, allowing the enzyme to change conformation and
make its reaction. This kinetic energy is converted into ATP. In our model,
the glycolytic and Krebs cycles were described in detail, represented at the
hierarchical second level by the coarse transition Glycolysis. The respiratory
chain was instead merged into a single node (t 97). We chose to represent
creation and consumption of ATP in order to show the effects of lower and
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higher oxygen concentration on the network. On the other hand, oxygen
consumption for ATP synthesis during the respiratory chain creates a flow
of oxygen in the model. Oxygen is not the only connection between glucidic
metabolism and hypoxia. Indeed, HIF-1α transcription activity enhances
the transcription of many GLUT isoforms (such as 1, 3 and 9) and the pyru-
vate dehydrogenase kinase, which determines the pyruvate dehydrogenase
(PyrDH) inactivation and consequent Acetyl-CoA formation from pyruvate.
Finally, Lactate dehydrogenase is also produced, to ensure an alternative
compound, creating energy needed for cell survival [321, 322, 323, 324, 325]
pVHL-dependent Processes
Some interactors can bind pVHL in regions interacting with Elongin C. These
are HuR, Nur77, p53 and Jade1. Nur77 has a complex function and its role
in pVHL tumor suppressor activity is still not entirely clear. Nur77 can bind
pVHL, inhibiting Elongin binding while allowing HIF-1α binding. Its tran-
scription is stimulated by HIF-1α itself, and pVHL-HIF-1α-Nur77 complex
formation stabilizes the transcription activity of HIF-1α by inhibiting the
pVHL-dependent degradation [326]. Another Nur77 function is the stimu-
lation of proopiomelanocortin (POMC) transcription, which is a precursor
for adrenocorticotropic hormone (ACTH) formation. This hormone has an
important stress response function, stimulating cortisol production and other
neurotransmitters from the adrenal glands, to enhance the organism reaction
to danger and stress stimuli e.g. increase of gluconeogenesis and muscle mass.
An excess of this hormone can cause desensitization of its receptors for feed-
back down-regulation and thus muscular weakness, tiredness, hyperglycemia
and osteoporosis [327]. p53 can bind to pVHL avoiding the degradation of
this tumor suppressor. Instead, it stimulates the apoptotic signal cascade via
the p300 co-activator, which stimulates production of proteins enhancing the
cell programmed death. If p53 cannot bind pVHL, two more mechanisms are
described in the model. One is its modification and degradation by Mdm2
and the other is the pVHL-independent degradation of HIF-1α. Interac-
tion with Mdm2 is needed in both cases [328, 329]. Jade1 is a short-lived
protein whose main function is to stimulate the phosphorylation-dependent
degradation of β-catenin. This is a subunit of the cadherin protein complex
acting as an intracellular signal transducer in the Wnt signaling pathway.
It seems that β-catenin is able to stop cell division via a contact-dependent
inhibition signal, whereas in Wnt signaling it is also involved in proliferative
5.4. PETRI NETWORKS 153
transcription. When Wnt is not present, β-catenin can be phosphorylated
by Glycogen Synthetase Kinase, type 3β (GSK3β) in complex with APC
(Adenomatous Polyposis Coli) and Axin. β-catenin can interact with Jade1
and be only successfully degraded after this interaction [330]. Related func-
tions are represented in the macro node Jade1 pat. GSK3β seems to be a
protein involved in many different pathways. GSK3β is involved in Glycogen
Synthetase deactivation and can even phosphorylate pVHL and HIF-1α. In
the case of HIF-1α, it generates a pVHL-independent degradation pathway,
where phosphorylation allows ubiquitination, whereas in the case of pVHL,
it inhibits pVHL stabilization of microtubules [331].
Structural Model Analysis
Based also on previous observations of Heiner et al., [332], in 2008 Grunwald
et al., demonstrated that PN can be used to describe large and complex
metabolic pathways [316]. They postulated the following set of minimal
rules that a PN should satisfy to be considered biologically reliable: (1) the
network should be entirely connected, (2) the network should be covered by
T-invariants, and (3) each T-invariant and P-invariant should have a bio-
logical meaning. The model described here was tested with respect to what
previously done by Grunwald and co-workers [316] and resulted to be covered
by T-invariants, connected, homogeneous and each place has a pre-transition
and a post-transition. Transitions without pre- or post-places were used to
simulate the system interface to the surroundings. The network is alive, in
other words, it continues to work forever, with all transitions contributing to
the net behavior forever, and no dead transitions. The MCTS and Cluster
analysis were used due to the large number of T- and P-invariants included
in the model. Both methods are used in PN theory to reduce the complexity
connected with such a large network and to reduce the errors connected with
manual investigation. From the 238 transitions present at the beginning in
the model, 393 T-invariants were computed without considering 10 trivial
invariants. The latter consist in a pair of transitions that usually represent
a forward and backward reaction, such as the active and inactive state of
a protein. Trivial invariants could be erased to reduce the dimension of the
network without disturbing the overall system when the interest is focused on
the steady state behavior [298]. T-invariants were grouped into 44 Clusters
using the Tanimoto coefficient with similarity threshold of 65%, as described
in [316]. Only 11 of these 44 comprised more than one T-invariant. The
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three biggest Clusters are C9, composed of 144 T-invariants, C8 of 72 and
C11 of 64 T-invariants. Separation into clusters allows easier analysis of net-
works pathways represented by each T-invariant, since they are grouped by
similarity, specifically the common transitions by which they are composed.
T-invariants named in the text are shown in Table S3, while T-invariants
grouped in C8, C9, C10, C11 are explained in Table S4 and described as
follows.
Cluster C8
Cluster C8 groups all transitions included in HIF-1α pathways, including
transcription, signaling cascades, degradation via pVHL, p53 and GSK3β,
and eventually the Krebs cycle. For the EPO signaling pathway, two tran-
sitions (t 35 and t 36) are not included which cause Jak activation and con-
sequent Stat5 activation to stimulate DNA transcription. Matrix stability
regulation is also part of the cluster due to the destabilization induced by
HIF-1α transcription of metallo-proteinase (MMP), transitions from t 134
to t 140. The largest T-invariant in C8 is Inv 280 (93 transitions) while the
smallest is Inv 377 (81 transitions). The differences between T-invariants
show the possibility of alternative pathways inside the model. For example,
the VEGF dependent signal cascade can proceed in three different ways: t 13,
t 14 and t 15, which lead to the pathways being merged in the coarse nodes
Vegf path3, Vegf path2 and Vegf path1, respectively. The occurrence rate in
C8 is 24 transitions for each path. The Endothelin, VEGF and Erythropoi-
etin pathways are not in conflict and occurring together. Disaggregation of
the matrix via MMPs is present in 18 T-invariants, whereas inhibition of these
proteins, i.e. matrix stabilization, is present in the remaining 54 transitions.
Regarding the Krebs cycle, 47 T-invariants have t 91, of which only 24 reach
t 92 and t 93, representing the last three steps of the cycle: succinate to fu-
marate, fumarate to malate, and malate to oxalacetate. All the malate being
produced is used to regenerate oxalacetate. Degradation of HIF-1α occurs in
any T-invariant of the cluster. The pVHL-dependent degradation of HIF-1α
is always present (transitions t 116 to t 119). In 19 T-invariants degradation
takes place via p53 (t 191 to t 193) or, alternatively, via phosphorylation
by GSK3β in another 17 T- invariants. Two of the three pathways can
be present in the same T-invariant, as in Inv 227, where degradation via
pVHL and degradation via p53 are both present. This was considered as the
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HIF-1α dependence on the lack of degradation by these proteins. All three
degradation pathways never appear in the same T-invariant. The p53 and
GSK3β paths are never present together but each of them is accompanied
by pVHL-dependent proteasomal degradation. Inv 377 lacks the EPO sig-
naling pathway but is the only one in this cluster to have t 34, t 33 and t 37.
These invariants have all input and output transitions. For example, t 202
the second input for pVHL, is present in only 18 invariants. Other inputs
are t 98, always present, leading to formation of HIF-1α and pVHL, t 192,
producing p53 and t 216, representing other pyruvate generating metabolic
pathways. The latter is also present in each invariant allowing formation of
the pyruvate needed for Krebs cycle progression.
Cluster C9
Cluster C9 is the largest cluster in our model and includes 144 T-invariants.
It is characterized by complete EPO pathway abrogation which goes through
formation of the Shc-Grb-Sos complex and the consequent mapk-dependent
phosphorylation cascade. Transition t 127, representing EPO effects on oxy-
gen production, is absent. In its place, t 35 and t 36 are considered, which
are present in 72 T-invariants. In cluster C9, the largest T-invariants are
Inv 278 and Inv 279 (74 transitions) while the shortest ones are Inv 101,
Inv 105, Inv 144 and Inv 148 with 65 transitions each.
Cluster C10
Cluster C10, composed of 52 T-invariants, is characterized by the presence
of glycolysis between many transitions grouped in the cluster. This is also
the cluster containing the most populated T-invariant of all computed 393
non-trivial T-invariants. This is Inv 245, including 101 transitions and cov-
ering almost half of the whole model. Cluster C10 also includes Inv 125,
the shortest invariant of this model, composed by 85 transitions due to lack
of the Krebs cycle. Another difference with the other three major clusters
is that here both EPO paths are present, specifically, the Jak pathway be-
longs to 4 T-invariants and Shc-Grb-Sos is observed throughout the cluster.
Vegf path1 seems to be more common in this cluster, being present in 36 T-
invariants, whereas the other two are present 12 times each. This time they
are present even in the same invariant, as for Inv 60, Inv 129, Inv 172 and
Inv 215, with both t 13 and t 15, and Inv 142, Inv 185 and Inv 228 with t 14
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and t 15 and all subsequent signaling appearing at the same time. Despite
glycolysis being present in all cluster invariants, the Krebs cycle appears only
in 11 cases. p53-dependent degradation of HIF-1α occurs in 11 cases while
the phosphorylation-dependent one appears in 13. An input transition has
been added with respect to the other major clusters so far analyzed (i.e.
t 69 eating) without which glycolysis could never take place.
Cluster C11
Cluster C11 is composed of 64 T-invariants. Only part of the EPO pathway
is described here, with the major difference that the Krebs cycle is completely
abrogated while Prolyl Hydroxylase type 2 (PHD2) regulation by oxalacetate
is included. HIF-1α interaction with Nur77 and transcription of VEGF by
Sp1 are also present. t 80 (transformation of pyruvate in oxalacetate) is not
present in the first 42 cluster T-invariants. Nur77 interaction with HIF-1α is
present only in 8 T-invariants, specifically Inv 87 to Inv 94. Sp1 transcription
activity is appearing in twice the amount, including the same 8 invariants
just mentioned. VEGF transcription via Sp1 activity is aPKC2 phosphoryla-
tion dependent, which does however not appear in the cluster. When VEGF
is synthesized, it is subsequently stabilized by Hur, followed by t 178 and
Hur is recreated to allow other functions. Indeed, it is one of the few places
without input transition but with a token that goes forward and backward
again. Compared to the other clusters, C11 also shows one less transition in
the coarse PHD regulation node, specifically t 81, which shows the transfor-
mation of pyruvate by pyrDH into acetyl-Coenzyme A, needed for the Krebs
cycle. The four clusters C-8 to C12 are very similar to each other, as can
be seen from the distance tree in Figure 5.15. They all contain the HIF-1α
transcription activity and signaling pathways caused by EPO, VEGF and
the HIF-1α degradation options. They include the effects of other transcrip-
tion activity products, like metallo-proteinase and pyruvate dehydrogenase
kinase, which regulate the activation state of PyrDH. All include part of the
glucidic metabolism but not Glycogen formation itself. Other five clusters
from C12 to C16 have a smaller number of T-invariants and fewer transi-
tions present in each invariant. They do not include transcription activity
but are only formed by the VEGF and glycolytic pathways. The information
contents of these clusters turned out to be uninformative and their analysis
was not included. The same applies to clusters composed by 13 T-invariants.
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Finally, some transitions are not present in the clusters and not listed in
the T-invariants because trivial invariants were excluded from cluster analy-
sis. These transitions are shown in Table 5.8 with their respective biological
meaning.
Figure 5.15: PinA Distance Matrix clustering, using Tanimoto coef-
ficient and 65% threshold of. The numbers indicates clusters. In C8,C9,
C10, C11 are highlighted a red square.
Table 5.8: List of Trivial T-invariants excluded from calculation with their
associated biological meaning.
MCTS Analysis
Another way to group invariants is by the amount of single transitions present
in them. Maximal common transition set (MCTS) analysis provides a PN
decomposition into non-overlapping subnets, sharing parts of the same T-
invariants [315]. In a biochemical network, MCTS could be interpreted as
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enzyme subsets operating together under steady state conditions, computed
based on the support of a T-invariant. MCTS computation does not con-
sider stoichiometric relations, describing exclusively sets of reactions present
in a maximal number of T-invariants resulting shared by different signaling
pathways [333]. A total of 40 non-trivial MCTS were identified, with results
and related biological means shown in Table 5.9. Some transitions do not
belong to a non-trivial MCTS, because their occurrence has no similarity
with other transitions and they create separate MCTS (specifically: t 69,
t 82, t 91, t 94, t 98, t 114, t 116, t 120, t 121, t 122, t 179, t 202, t 209,
t 212, t 216, t 225 and t 229). MCTS define transitions that always take
place together, but are not necessarily connected, thus representing disjunct
building blocks constituting the network. Considering both analyses, a table
was automatically built in PInA [315] showing a correlation between clus-
ters and MCTS. Transitions (t) or MCTS (M) are compared to evaluate how
many T-invariants clusters cover the selected M or t (if the transition is not
already part of the MCTS, as listed above). The more covered a transition or
set is, the more central it could be considered for the network behavior. Re-
cently, a network coarsening method based on abstract dependent transition
sets (ADT) was presented [334]. It is formulated without the requirement of
pre-computation of the T-invariants and is a tool commonly used for the de-
composition of large biochemical networks into smaller subnets. Due to the
manually designed nature of our model, we preferred to maintain a logic hier-
archy based on metabolic pathways in order to maintain the network centered
on pVHL and its interaction. The MCTS calculation results shows that the
most covered set by cluster T-invariants is M20 with 358 T-invariants cover-
ing all transitions in the set, indicating that this MCTS corresponds to more
T-invariants than the others. All transition sets are an important link to the
others, as tokens pass through these transitions more often. A transition not
present in any set but most covered by T-invariants is t 98, which is also the
most frequently occurring transition, see Figure 5.16. The 10 most occurring
transitions are listed in the Table 5.10.
P-invariant Analysis
Although the network is not covered by P-invariants, it has 130 P-invariants.
47 of these are trivial P-invariants, comprising a single place, connected with
double arcs to imitate an activator arc function. Another object represented
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Figure 5.16: Transitions occurrence T-invariants. Transitions are or-
dered by name and t 98 is highlighted in red.
with double arcs is the enzymatic activity catalyzing a reaction and imme-
diately going back to the steady state. P-invariants show places or sets of
places where token numbers always remain equal and do not move outside
the subnetwork induced by the P-invariant in the initial marking. In other
words, they do not grow nor diminish. The remaining P-invariants are mostly
located in signal transduction pathways, such as situations in which a protein
is sequestered from its function and then goes back after a second reactiva-
tion mechanism. This scenario is present in p 41, p 42 and p 45 located in
invariant P 58. It is important to notice that ATP and ADP, as well as
NAD and NADH, are modeled as P-invariants. P 90, P 91 and t 97 are able
to transform ATP and ADP. More in general, all energy consuming transi-
tions are considered to be backward transitions of invariants. Invariants not
related to signal transduction are places located in the Hur system, where
Hur is removed from its function by pVHL. This is a good approximation
for sequential modifications that momentarily activate proteins. Afterwards,
Hur can go back and stabilize VEGF to increase its transcription activity.
In Silico Knock Out Experiments
The previously described clustering and MCTS analysis for T-invariants al-
lowed us to identify the most common transitions and to understand which
transitions can be depleted in our knock out experiments in order to get
the most important biological effect. The knock out experiments were per-
formed erasing selected transitions or tokens and observing which transitions
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Table 5.9: List of MCTS and transitions from PInA.
or MCTS become inactivated. Considering our results and the literature, we
decided to knock out the following pathway elements: (i) pVHL, (ii) HIF1α
alone and with Sp1, (iii) t 98, (iv) PHD2, (v) MCTS1, (vi) t 97 and (vii)
GSK3β. In the following, we describe the effect of each knock out scenario
on our model.
(i) pVHL knock out. Degradation of HIF-1α is not completely depleted
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Table 5.10: Ranking of the 10 most occurring transitions with biological
meaning and percentage of occurrence.
due to presence of both p53- and GSK3β-dependent alternative degrada-
tion pathways. All other processes usually inhibited by pVHL take place
in an uncontrolled way, including creation of VEGF via Sp1 transcription
activity and increased matrix regulation due to lack of fibronectin crosslink-
ing. Hur resulted constantly activated and nur77 can stimulate synthesis of
Proopiomelanocortin, precursor for the Adrenocorticotropic hormone. Card9
increases release of tumor necrosis factor, and NF-kB when not inhibited by
pVHL. Instead, Jade1 is unable to survive long enough to inhibit βcatenin,
generating a proliferation signal with Wnt. Lactic acid is also not produced
due to LDH enzyme production being HIF-1α transcription activity depen-
dent.
(ii) HIF-1α knock out. VEGF is still created thanks to Sp1, thus oxy-
gen is still generated even if in lower proportion. If HIF-1α and Sp1 are
both knocked out at the same time, oxygen is quickly consumed and the
metabolism is soon unable to proceed. Lactic acid is not produced due
to LDH enzyme production being HIF-1α transcription activity dependent.
Glycolysis and glycogen are produced normally and the metabolism is not
inhibited by PyrDH negative regulation and lactic acid formation. Since
pVHL is present, other tumor suppressor activities are enabled, except for
proteasomal degradation of HIF-1α due to the substrate being non-existent.
(iii) HIF-1α and pVHL double knock out.This generates a situation
where the metabolism is normal but oxygen regeneration is less produc-
tive, with only Sp1 acting for transcription. Due to absence of pVHL, all
proliferation-stimulating processes are active, causing an unbalanced con-
sumption of resources. Our model shows that this condition is compatible
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with cell growth and multiplication, but new blood vessel generation is con-
sistently slower and glucidic metabolism appears principally based on the
glycolysis reaction. Similar activity reduction applies to both tight junction
and cellular external matrix (ECM) pathway regulation. It cannot be ex-
cluded that some observed effects could be mitigated by both HIF-2α and
HIF-3α activity in vivo.
(iv) PHD2 knock out. The protein is involved in pVHL mediated and
oxygen dependent degradation of HIF-1α. Further, PHD2 is involved in hy-
droxylation of the RNA polymerase II subunit Rpb1 to allow its translocation
to less chromatin-concentrated areas of the nucleus. When it is knocked out,
HIF-1α degradation can continue via alternative pathways as seen in the
pVHL knock out experiment and there is more RNA polymerase II activity,
even if rpb7 can still be inactivated by pVHL.
(v) MCTS1 knock out. MCTS1 groups some reactions involved in the
HIF-1α p53-dependent degradation pathway (Table 5.9). To perform this
knock out, we erased the necessary token in mdm2, making the precondition
insufficient to enable the MCTS transitions. p53 is not degraded and can
continue its proapoptotic signal. On the other hand, a HIF-1α degradation
mechanism is also knocked out resulting in an increased HIF-1α transcription
activity.
(vi) t 97 knock out. This is the ATPase transition, allowing the model
to imitate oxygen consumption for ATP synthesis. If this transition is in-
active, oxygen accumulates infinitely and ATP is not regenerated after few
simulation steps. At the beginning, ATP is formed during the first step of
glycolysis but afterwards it is consumed again. At some point, these reac-
tions do not have any ATP available to allow the system to re-balance the
consumed ATP. After few simulation steps, oxygen reaches a high level due
to slower consumption in the PHD2 regulation process. Biologically, this
means that the metabolism stops and the cell is not able to create energy to
survive. There is no accumulation other than glucose in the model. A few
oxygen creation processes are blocked as well due to absence of ATP, e.g.
t 15, t 41 and t 57.
(vii) GSK3β knock out. This enzyme is involved in negative glycogen
synthetase (GS) regulation and is inactivated when phosphorylated. When
GSK3β is knocked out, glycogen is continuously produced due to the enzyme
remaining in an active state. In a real organism there are alternative forms of
GSK3β which can inactivate GS, hence the effect will be less sharp. GSK3β
is also involved in the degradation of HIF-1α, causing its phosphorylation
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and following ubiquitination. It is also involved in the degradation of β-
catenin, where it is responsible for primary phosphorylation. If knocked out,
even if Jade1 can be stabilized by pVHL, the effect will be similar to a knock
out of Jade1, where β-catenin is free to continue proliferation stimulating
transcription activity.
5.4.3 Discussion
We started from a core model of hypoxia response [298] and extended the
original network with functional data derived from the literature in order to
represent a complete description of the pVHL interaction pathway accord-
ing to current knowledge. VHL syndrome is characterized by the forma-
tion of tumors and cysts affecting different organism districts and tissues.
Indeed, pVHL is a tumor suppressor whose functions are connected to in-
hibition of proliferation and survival, growth and stability of extracellular
matrix and microtubules, as well as cell polarity and migration. The In-
tAct database reports more than 200 suspected pVHL interactors and for
most of them interaction and function details remain largely unknown. We
chose to model the pVHL interactions in a credible cellular context with
many protein activities occurring at the same time. The main idea was to
create a novel manually curated PN description of the entire VHL disease
pathway, including glucidic metabolism and signaling pathways. The model
was designed as a standard PN and is composed of 238 transitions and 323
places, connected by 801 edges. A biologically realistic PN model needs to
be covered by T-invariants, meaning each transition in the model has to
be included in a T-invariant, and each invariant needs to have a biological
meaning [316, 317, 318, 319, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329,
330, 331, 332]. We used the T-invariant analysis to validate the reliability
of the model. We computed a total of 393 T-invariants, plus 10 trivial in-
variants, which were excluded from analysis. These were grouped into 44
Clusters and, through use of T-invariants, transitions were grouped into 40
MCTS. The model obtained is connected, covered by T-invariants with each
invariant holding a biological meaning. MCTS analysis was used to identify
the most frequent crucial transitions occurring in the model. This specific
subset was further used to plan in silico knock out experiments and for the
model validation and analysis of expected biological behavior. The model
was then used to perform in silico knock out experiments inactivating spe-
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cific transitions during qualitative network analysis. Our results showed that
the model is able to represent important transitions reflecting real biologi-
cal outcomes, i.e. transitions involving species such as oxygen or ATP are
correctly inactivated under certain circumstances as expected from the bib-
liographic data. Biological energy-related reactions (e.g. ATP production
from ADP) were modeled as P-invariants. Although the network is inten-
tionally not covered by P-invariants, P-invariant analysis was used to verify
all modeled energy consuming transitions. Both the ATP and NADH bal-
ances appeared constant during the simulation, with irrelevant P-invariants
located in the Hur system. This approximation was used to verify the Hur-
dependent regulation of VEGF, with results in accordance with [335]. The
specific pVHL knock out suggests that this protein alone is not sufficient for
complete HIF-1α inactivation. Indeed, other concurrent HIF-1α degradation
pathways promote a sort of cell cycle regulation backup. On the contrary,
simple deletion of pVHL turned out to be sufficient to increase all its other
inhibitory functions, showing similar effects to pathological VHL symptoms.
Indeed, ECM destabilization increases cell migration to other areas, promot-
ing metastasis outbreak in case of tumor cells. Further, pVHL-dependent
inhibition of tight junction formation by aPKCII participates in an easier
cellular detachment. The interactions of Nur77 could be considered a good
example for pathological effects. It is a stimulator of Proopiomelanocortin
production, a precursor for the Adrenocorticotropic hormone. If excessively
released, it promotes an overproduction of adrenergic neurotransmitters by
adrenal glands. Coming at clinical condition known as Cushing syndrome.
On the very long term, Nur77 deregulation is known to cause tumors of the
pituitary and adrenal glands [336, 337]. This happens in pheochromocy-
toma, which is one of the main VHL disease manifestations. We speculate
that continuous VEGF transcription, even in situations where HIF-1α (but
not Sp1) is knocked out, could be the explanation for clinical studies where
VEGF-targeting drugs have turned out to be effective in kidney cancer treat-
ment as reported in [338]. Although we used only confirmed data from the
literature, Nur77 may be involved in other regulation systems which were
not considered in our model. The transitions for pVHL fibronectin stabi-
lization show a behaviour which is coherent with biochemical experiments,
illustrating a complete abrogation of ECM stabilization and an increased
matrix metallo-proteinase action. Although the results are encouraging, the
presented model will need further improvements since standard PNs do nei-
ther allow a complete transition control nor enzymatic activity modulation.
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Nevertheless, thanks to its manual curation our model can be used to plan
new in vitro and in vivo experiments. The results are convincing enough to
suggest our model as a comprehensive pathway model to simulate the main
pVHL functions.
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Chapter 6
Conclusions
In this thesis, I explored the contribution of data science to meet biologists
need. With millions of protein sequences and thousands of PDBs, knowledge
discovery requires strong efforts in order to combine different data sources
and learn natural laws. My research was mainly divided into two activities:
the analysis of data and the development of computational methods. These
two process are intrinsically related, as one’s output is the input for the other.
I developed four machine learning methods for gene and protein automatic
classification and annotation called BOOGIE, NeEMO, RING MD and INGA.
These tools are radically diverse in terms of data sources (exome data, PDB
structures and on-line database), since they address completely different
problems. In BOOGIE, gene variants are used to predict human blood groups
using an optimized version of nearest neighbour algorithm. RING MD and
NeEMO are designed to study a protein residue interaction network. The
former detects key amino acids and interactions using k-means algorithm
and Hidden Markov Models on molecular dynamics data, while the latter
predicts stability changes due to mutations by means of neural networks.
INGA is a consensus of three information retrieval systems that exploit pub-
lic databases to predict protein function. It uses a combination of generalized
additive models and Bayesian methods to achieve higher predictive accuracy
than previously published tools, as shown during the Critical Assessment of
Function Annotation.
In terms of data analysis, I focused on flexible protein regions called intrin-
sic disorder and on their characterization. Firstly, a dataset with one order
of magnitude more samples than anyone previously published was gathered.
Such a collection was used to assess the disorder prediction accuracy for
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state-of-the-art methods. Their limitations and bias were highlighted espe-
cially for long disordered regions, which were well represented and deserved
themselves a second analysis.
In the midst between exome data analysis and genetic disease risk prioritiza-
tion lays the Critical Assessment of Genome Interpretation (CAGI). CAGI
organizers published datasets of human genetic studies where cases and con-
trols were taken into account. The goal was the automatic classification of
samples with Crohn’s disease, familial combined hyperlipidemia and other
illnesses. After a first analysis and selection of relevant mutations, a semi-
automatic prioritization approach based on patients clustering was proposed,
which was shown to be among the top methods.
To conclude, data science seems today a very consolidated approach spanning
different areas of biology. It promotes data reuse and can simplify complex
tasks, enabling previously unthinkable analysis. The biggest challenges for
the future are surely data openness and integration, mainly due to the co-
ordination of thousands research groups and institutes. The gap between
database content and the knowledge encoded using natural language inside
papers is also an unsolved problem where lots of work is done by human
curators. In terms of statistical issues, correlation and causality are different
concepts that might be confused when dealing with an high volume of data.
Statistical significance and effect size became also a big limitation in the con-
text of big data, since research is trying to address very complex topics with
noisy data. Thus, computer science and statistics will be once again among
the main players for science development in the coming years, but their ef-
forts must address inter-disciplinary challenges where the only solution is a
skill mixture. Bioinformatics seems a natural example for biology, and will
become a central area of expertise for life science applied research.
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